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SUMMARY 
Hypoxia is a stress condition in which tissues are deprived of an adequate O2 supply; this may 
trigger cell death with pathological consequences in cardiovascular or neurodegenerative 
disease. Reperfusion is the restoration of an oxygenated blood supply to hypoxic tissue and can 
cause more cell injury. The kinetics and consequences of reactive oxygen and nitrogen species 
(ROS/RNS) production in cardiomyoblasts are poorly understood. The present study describes 
the systematic characterization of the kinetics of ROS/RNS production and their roles in cell 
survival and associated protection during hypoxia and hypoxia/reperfusion. H9C2 cells showed a 
significant loss of viability under 2% O2 for 30min hypoxia and cell death; associated with an 
increase in protein oxidation. After 4h, apoptosis induction under 2% O2 and 10% O2 was 
dependent on the production of mitochondrial superoxide (O2
-•
) and nitric oxide (
•
NO), partly 
from nitric oxide synthase (NOS). Both apoptotic and necrotic cell death during 2% O2 for 4h 
could be rescued by the mitochondrial complex I inhibitor; rotenone and NOS inhibitor; L-
NAME. Both L-NAME and the NOX (NADPH oxidase) inhibitor; apocynin reduced apoptosis 
under 10% O2 for 4h hypoxia. The mitochondrial uncoupler; FCCP significantly reduced cell 
death via a O2
-•
 dependent mechanism during 2% O2, 30min hypoxia. During hypoxia (2% O2, 
4h)/ reperfusion (21% O2, 2h), metabolic activity was significantly reduced with increased 
production of O2
-•
 and 
•
NO, during hypoxia but, partially restored during reperfusion. O2
-• 
generation during hypoxia/reperfusion was mitochondrial and NOX- dependent, whereas 
•
NO 
generation depended on both NOS and non-enzymatic sources. Inhibition of NOS worsened 
metabolic activity during reperfusion, but did not effect this during sustained hypoxia. Nrf2 
activation during 2% O2, a sustained hypoxia and reperfusion was O2
-•
/
•
NO dependent. Inhibition 
of NF-κB activation aggravated metabolic activity during 2% O2, 4h hypoxia. In conclusion, 
mitochondrial O2
-•
, but, not ATP depletion is the major cause of apoptotic and necrotic cell death 
in cardiomyoblasts under 2% O2, 4h hypoxia, whereas apoptotic cell death under 10% O2, 4h, is 
due to NOS-dependent 
•
NO. The management of ROS/RNS rather than ATP is required for 
improved survival during hypoxia. O2
-•
 production from mitochondria and NOS is cardiotoxic 
during hypoxia/reperfusion. NF-κB activation during hypoxia and NOS activation during 
reperfusion is cardiomyoblast protective. 
Keywords; mitochondria; superoxide; nitric oxide; NOS; protein oxidation; NOX, NF-κB; 
Nrf2; reperfusion; H9C2 cells 
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NAD     Nicotinamide adenine dinucleotide
 
FAD     Flavin adenine dinucleotide 
NADH    Nicotinamide adenine dinucleotide hydrogenase 
NADPH     Nicotinamide adenine dinucleotide phosphate 
NF-κB    Nuclear factor κB 
nNOS     Neuronal nitric oxide synthase  
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NO     Nitric oxide 
NOS     Nitric oxide synthase  
NOX     NADPH oxidases 
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Nrf2       Nuclear factor E2-related factor 2 
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Superoxide 
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OD    Optical density  
OH
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PDGF     Platelet derived growth factor 
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SOD     Superoxide dismutase 
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TNF-α    Tumor necrosis factor -α 
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VCAM-1    Vascular cell adhesion molecule-1 
VDAC    Voltage-dependent anion channel 
VSMCs   Vascular smooth muscle cells  
WT     Wild type 
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XIAP    X-linked Inhibitor of Apoptosis Protein 
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1.1 What are free radicals? 
A free radical is an atom or molecule which is stable and exists with one or more unpaired 
electrons in its molecular orbital such as superoxide anion (O2
•-
), hydroxyl (HO
•
) and nitric oxide 
(
•
NO). If an orbital in the outer shell of a molecule lose an electron from a pair, the molecule 
becomes a radical, which is unstable and therefore highly reactive (Mason, 1995). Free radicals 
often react with another molecule(s) to be stabilized (Shackelford et al., 2000). Partially reduced 
O2 metabolites are known as ―reactive oxygen species‖ (ROS) due to their higher reactivity over 
molecular O2. In other terms, reactive oxygen species may be identified as any chemical species 
containing one or more unpaired electrons potentially capable of independent existence.  
 
The main reactive oxygen species include superoxide (O2
•-
), hydroxyl radical (OH
•
) and H2O2, 
which is a non-radical. O2
•- 
can be dismutated (by cytosolic or mitochondrial superoxide 
dismutase; SOD) to hydrogen peroxide (H2O2) which is a biologically active and stable molecule 
(Figure 1.1). H2O2 is non-polar and often diffuses into the cytosol of cells through membranes 
(Henderson and Chappell, 1993). Myeloperoxidase which is the most abundant enzyme in 
neutrophils, catalyses the conversion of H2O2 and Cl
-
 to hypochlorous acid (HOCl) (Kettle et al., 
1993) (Figure 1.1). This potent oxidant can cause considerable tissue damage in many 
inflammatory diseases as reported by Kettle et al., (1993).  
A newly formed radical may react with another species to become stable by donating the 
unpaired electrons, or may react with a free radical scavenger (i.e. primary antioxidant or chain 
breaking species), to become unreactive   (Nordberg and Arner, 2001). Free radicals are known 
to damage cells and tissues through reactivity with another molecule. In this way, radical species 
are reported to perturb cellular antioxidant defence systems, damaging biological molecules 
including protein, carbohydrates, lipids and nucleic acids (Tahara et al., 2009). Free radical 
generation is a consequence of many metabolic reactions in living systems that may generate low 
levels of radicals. There are number of enzymes, which employ radicals for synthesis of specific 
enzyme products; cyclooxygenase, tyrosine hydroxylase, nitric oxide synthase, lipooxygenase 
and ribonucleoside reductase (Thomas, 2000).  
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Figure 1.1 Schematic ROS generation from oxygen (O2), adapted from Hool (2005). 
Superoxide (O2
•-
) is generated directly from the reduction of oxygen and then dismutated to 
hydrogen peroxide (H2O2) in the presence of superoxide dismutase (SOD). Reactions with 
chloride ion (Cl
-
), nitric oxide (
•
NO) and iron (Fe
2+
) are as indicated. 
 
Reactive nitrogen species (RNS) include 
•
NO and their related species such as peroxynitrite 
anion (ONOO
-
) (Figure 1.1). O2
•-
 undergoes a diffusion-controlled reaction with 
•
NO to produce 
ONOO
- 
(Beckman and Koppenol, 1996). Peroxynitrite is relatively long-lived, stable molecule, 
which has an ability to reach critical targets of cells, as it is membrane permeable (Glebska and 
Koppenol, 2003). Each of these reactive oxygen and nitrogen species are reported to impair 
cellular homeostasis through alterations in cellular thiols, protein, lipid, and nucleic acid 
structure and function with resultant disruption of cell signalling cascades (Patel et al., 1999). 
  
This can be explained by potent oxidising capacity of ROS/RNS which lead to oxidation, 
nitrosation or nitration of amino acids/residues (Griffiths, 2005). To minimize potential damage 
to macromolecules and cellular environment, cells express antioxidant enzymes including 
superoxide dismutase to reduce O2
•-
 to H2O2, catalase and glutathione peroxidase which reduce 
H2O2 to H2O (Thannickal and Fanburg, 2000). Glutathione peroxidase uses the low MW thiol 
glutathione as a reducing agent in this reaction. Oxidative stress is defined as an imbalance 
between oxidant production and antioxidant capacity.  
•NO SOD 
Myeloperoxidase + Cl
-
 
 
Fe+2 
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Oxidative stress has been implicated in many pathological injuries within the cardiovascular 
system including atherosclerosis, hypertension, hypoxia, and ischaemic reperfusion.  
 
 1.2 Sources of ROS/RNS production 
Superoxide is the intermediate precursor of reactive oxygen species in most oxygenated 
biological systems. It is formed when molecular oxygen acquires an additional electron 
(Wardman, 2007). Having two unpaired electrons in antibonding orbital with parallel spins 
makes ground state O2 able to accept one electron at a time. Superoxide anion is potent 
damaging molecule probably indirectly, and is less reactive than 
•
OH. Therefore, O2
-•
 can diffuse 
longer distance until it encounters critical molecular targets, whereas 
•
OH reacts indiscriminately 
and expendably within a smaller radius from the site of generation (Benov et al., 1998).  
 
1.2.1 Superoxide production from mitochondria 
The mitochondrion is believed to be a major superoxide producer in many cells. The principle 
function of the mitochondrion is to harness the free energy release from electron transport from 
complex I and III and IV by coupling the transport of protons out of the mitochondrial matrix to 
the intermembrane space with the production of ATP according to the chemiosmotic theory.   
 
The transfer of protons from the matrix to the intermembrane space may create an 
electrochemical gradient, which maintains mitochondrial membrane potentials (Ψmt) across the 
inner membrane. The proton gradient or electrochemical gradient is used to generate a 
chemiosmotic potential (between the mitochondrial matrix and intermembrane space) or proton 
motive force which is critically important to ATP production. This electrochemical gradient 
plays a major role in converting the energy derived from redox reactions of electron transport to 
the potential energy stored in ATP.  
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Complex IV harnesses the energy from the electrochemical gradient to make ATP energy from 
ADP + Pi at ATP synthase. The ATP synthase is made up of two subunits; F0 and F1. F0 creates 
the channel for proton movement across the membrane where F1 harvests the free energy derived 
from proton movement down the electrochemical gradient (from the intermembrane space to the 
matrix during aerobic respiration) by catalyzing the ATP production (Figure 1.2 and 1.3). 
 
  
 
 
            Figure 1.2   Mitochondrial electron transport system (ETS), taken from  
            Moncada and Erusalimsky (2002). 
 
  
During mitochondrial respiration, the kinetic and thermodynamic factors underlying the 
interaction of potential one-electron donors with O2 and that control mitochondrial ROS 
production depend on the standard reduction potentials and pH value of the mitochondrial 
matrix. The standard reduction potential for the transfer of an electron to O2 to form O2
•−
 is −160 
mV at pH 7, for 1M O2 under standard conditions. This standard reduction potential is stable 
across most biological pH values including mitochondria (Murphy, 2009). In mitochondria, it 
has been reported that electron transport complexes I and III (Figure 1.2) are important sources 
of mitochondrial ROS (Murphy, 2009). However, mitochondria produce less ROS at higher 
respiration rates, including enhanced oxidative phosphorylation or in the presence of uncouplers 
and under oxidative stress due to certain pathological conditions.  
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O2
•−
 release from complex I occurs via forward electron transfer, electron release from NADH 
(reduced nicotinamide adenine dinucleotide) and reverse electron transfer from succinate. 
Additionally, mitochondrial enzymes, particularly flavoenzymes including α-ketoglutarate 
dehydrogenase and glycerol phosphate dehydrogenase, are involved in the production of O2
•−
. 
(See Tahara et al. (2009) for review) (Figure 1.3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Mitochondrial electron transport system showing O2
-• 
generation by substrate 
metabolism, electron leakage sites, and effects of respiratory chain inhibitors and 
uncouplers. Taken and adapted from Tahara et al. (2009). The sites of action of the complex 
I inhibitor, rotenone; the complex III inhibitors, myxothiazol and antimycin A; the complex V 
inhibitor, oligomycin and the uncoupler, FCCP are shown. 
 
 
Mitochondrial complex I is a major site of superoxide production from NADH in the respiratory 
chain. The FMN (Flavin mononucleotide) cofactor accepts electrons from NADH and passes 
them through a chain of seven Fe-S (iron–sulphur) locations to the CoQ (Co-enzyme Q) 
reduction site, with another Fe-S centre close to the FMN with any reverse transfer of electrons 
to CoQ. Mitochondrial complex II is known to be a second funnelling site of electrons into ETS.  
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In complex II, electrons from succinate enter the ETS via FADH2. Then, electrons are 
transferred to CoQ and carried through the rest of electron transport chain. Complex III has for a 
long time been regarded as a source of O2
•−
 within mitochondria (Chandel et al., 1998; Chandel 
et al., 2000). Mitochondrial complex III fluxes the electrons from the CoQ pool to cytochrome c 
which is a bridge between complex III and complex IV. Mitochondrial cytochrome c consists of 
three haem and Fe-S locations, and those interact transiently with CoQ during electron transfer 
(Iwata et al., 1998). It has been reported that generation of O2
•−
 is increased when complex III is 
inhibited by antimycin where O2
•−
 is derived from the reaction of O2 with an ubisemiquinone 
radical bound to the Qo site. This O2
•−
 is released from complex III to the mitochondrial matrix 
and intermembrane space as shown in Figure 1. 3. O2
•−
 is unable to penetrate mitochondrial lipid 
membranes although it may be transferred through anion channels and therefore it may be 
trapped in a compartment where it is produced, including inside the mitochondrial matrix 
(Murphy, 2009).  
 
During normal metabolic respiration, mitochondria can produce superoxide, especially in the 
electron rich aerobic environment in the vicinity of the inner mitochondrial membrane within the 
ETS. Mitochondria can reduce nearly 1-3% of the O2 consumed in aerobic respiration (Boveris 
and Chance, 1973, Boveris et al., 1972) by transferring a one single free electron to molecular 
oxygen at the level of NADH CoQ reductase (Complex I). Subsequently CoQ cytochrome C 
reductase (Complex III) donates a single electron to O2 for O2
•−
 production (Turrens, 1997). 
 
 
1.2.2 Nitric oxide and peroxynitrite generation from mitochondria  
Nitric oxide (
•
NO) is a reactive and transient radical molecule  that can diffuse across the cell 
membrane. It is known that common 
•
NO is generated from guanido nitrogen of L-arginine by at 
least three distinct isoforms of nitric oxide synthase in the cells (Pacher et al., 2007). It appears 
that 
•
NO can damage biological molecules after forming ONOO
-
 with O2
•−
. Peroxynitrite is a 
strong biological oxidant and nitrating species formed from the near-diffusion-limited reaction of 
the free radicals, nitric oxide and superoxide anion (Beckman and Koppenol, 1996).  
24 
 
•
NO at nanomolar level can interact with the mitochondrial ETS by causing rapid and selective 
reversible inhibition of cytochrome oxidase. 
•
NO related species or RNS in mitochondria 
including ONOO
-
, NO2, N2O3 and S-nitrosothiols (from 
•
NO and thiol reaction) cause slow, non-
selective, weak, but irreversible or slowly reversible inhibition of many mitochondrial 
components including proteins, lipids and mt-DNA. Moreover, the inhibition observed in most 
cells in response to 
•
NO or expression of inducible nitric oxide synthase (iNOS or NOS2) 
appears to be largely competitive with O2 (Brown and Borutaite, 2007) (Figure 1.4). 
 
 
 
 
Figure 1.4  Interactions between 
•
NO, reactive nitrogen species, reactive oxygen species and 
the mitochondrial respiratory chain, taken from Brown and Borutaite (2007). The oxidation 
of 
•
NO with oxygen in the inner membrane of mitochondria produces NO2 and N2O3, and further 
•
NO can react with thiols (RSH) to produce S-nitrosothiols (RSNO). 
•
NO and RNS inhibit 
respiratory complexes I, III and IV. O2
•−
 reacts with 
•
NO to form ONOO
-
, which further inhibits 
the ETS, aconitase and the Mn-SOD. A lightning bolt illustrates the sites of RNS mediated 
inhibition (Brown and Borutaite, 2007). 
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1.2.3 Superoxide production from NADPH oxidase 
In phagocytes and certain non-phagocytic cells in the colon, kidney, brain and vascular smooth 
muscle cells (VSMCs), cell membrane bound NADPH (nicotinamide adenine dinucleotide 
phosphate) oxidase functions as the major ROS generating centre (Cheng et al., 2004). The 
enzyme complex is comprised of several subunits, including cytochrome b558 and two 
membrane bound subunits (the small subunit p22phox bound to the catalytic subunit gp91phox 
(Nox 2) and cytosolic units, Rac1 in non-phagocytic cells and Rac2 in phagocytes as well as, p47 
phox and p67phox which are recruited to the membrane bound Nox/p22phox complex upon 
activation.  
 
Rac1 and Rac2 belong to the low molecular weight G protein Rac family. Some studies suggest 
that NADPH oxidase activity may decrease during hypoxia with a reduction in ROS production 
(Mohazzab and Wolin, 1994; Paky et al., 1993). In atherosclerotic inflammatory sites, 
recruitment of neutrophils and over-production of ROS, mainly by NADPH oxidase, leads to 
lipid oxidation. Protein expression studies suggest that p47phox expression is predominant in 
neutrophils compared to non-phagocytes such as smooth muscle cells/fibroblasts, offering 
further insight into putative ROS generation in vascular inflammatory sites. Some reports 
suggest ROS generation may also be increased due to mechanical forces and agonist-stimulation 
by certain hormones such as Angiotensin II (Griendling et al., 2000). Mechanical forces that 
induce ROS generation in endothelial cells through NAD(P)H include cyclic stretch and laminar, 
oscillatory shear stress (Griendling et al., 2000).  
 
Angiotensin II is a major peptide hormone in the renin-angiotensin-aldosterone system. It is 
reported that Angiotensin II plays a pivotal role in signalling in the cardiovascular system by 
generating ROS through NADPH oxidase (Yoshimoto et al., 2004). The NAD(P)H/NADH 
oxidase in VSMCs, endothelial cells and adventitial fibroblasts has been shown to elicit an 
increase in intracellular superoxide production after AngII treatment.  
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It has been reported that PDGF (platelet derived growth factor), TNF-α, thrombin and 
lactosylceramide stimulate NAD(P)H oxidase dependent O2
•−
 production in smooth muscle cells 
(Griendling et al., 2000). ROS generated by NADPH in VSMCs is required for cell 
differentiation, proliferation, migration, secretion of inflammatory cytokines and apoptosis 
(Clempus and Griendling, 2006).  
 
1.2.4 Other sources of ROS/RNS 
In addition to mitochondria and the NADPH oxidase complex, there are number of other cellular 
sources of radical species. They include nitric oxide synthase (NOS), xanthine oxidase, 
peroxisome and endoplasmic reticulum. Other minor level O2
•−
 producers in the cytosol include 
enzymes of the arachadonic acid cascade that may produce ROS during lipid metabolism. Some 
cytochrome P-450 isozymes are also reported to generate O2
•−
. Autooxidation of ascorbic acid, 
low molecular weight thiols, adrenalin and flavin coenzyme can also produce ROS under various 
conditions. ROS/RNS producers are tabulated (Table 1.1) along with any cellular defence 
mechanism. In addition to the above sources of endogenous free radical production, there other 
ways of free radical production via exogenous agents; cigarette smoking, air pollution and toxic 
radical generation from drug metabolism including nitrofurantoin and penicillamine (Mason, 
1995). 
 
1.3. ROS/RNS as signalling molecules 
ROS and RNS can act as signalling molecules in various cell types, mediating and/or modifying 
physiological events related to gene transcription and transduction after receptor ligand binding. 
In vascular homeostasis and pathogenesis, ROS/RNS play a pivotal role in downstream and 
upstream intracellular cell signalling. Downstream signalling cascades operate by second 
messengers such as Ca
2+
, cAMP, phospholipid metabolites and phosphorylation cascades. These 
pathways subsequently lead to activation of transcription factors that govern specific gene 
expression patterns.  
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Table 1.1  The sources of ROS/RNS production and associated antioxidant defence, 
adapted from Nordberg & Arner (2001). SOD - superoxide dismutase, GPX - glutathione 
peroxidase, CAT - catalase, PRX - peroxidase, GRD - glutathione reductase, Trx –thioredoxin 
and TrxR - thioredoxin reductase and NOS – nitric oxide synthase. 
 
However, there are important implications of ROS/RNS in intracellular cell signalling and 
regulation, including cytoprotection and antioxidant defence during hypoxia/reperfusion. O2
•−
 
and H2O2 are considered the most important ROS signalling molecules (Griendling et al., 2000). 
The ROS/RNS molecules in signalling are structurally diverse and include 
•
NO, O2
•−
, H2O2 and 
peroxynitrite (Griendling et al., 2000; Harrison et al., 2003).  
Intracellular signalling pathways are implicated in cell death during hypoxia and/or following 
reoxygenation, although the mode of cell death; apoptosis or necrosis may vary among different 
cell types. ONOO
-
 has been identified as a mediator of cytotoxicity due to its variable reactivity 
with cellular thiols, proteins and DNA (Patel et al., 1999). ONOO
-
 or 
•
NO is also important as a 
cell-signalling molecule, in addition to its pathological roles. For instance, low concentrations of 
•
NO are formed by endothelial nitric oxide synthase (eNOS) in vascular endothelial cells and 
function as a mediator of vasodilatation (Thannickal and Fanburg, 2000). 
•
NO inhibits 
proliferation and migration of smooth muscle cells, platelet aggregation and adhesion of 
leukocytes to the endothelium (Tarpey and Fridovich, 2001).  
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ROS generation from mitochondria has been implicated in vasodilatation of cerebral artery and 
vasoconstriction in pulmonary arteries (Schumacker, 2003; Beardsley et al., 2005). However, 
particular ROS species have not been investigated. O2
•−
 and superoxide dismutase exhibit many 
modulatory effects in 
•
NO dependent cell signalling and endothelial dependent-relaxation in 
vascular systems (Tarpey and Fridovich, 2001). Generation of O2
•−
 and H2O2 mediates 
proinflammatory events by regulating the transcription and expression of vascular cell adhesion 
molecule-1 and monocyte chemotactic protein-1 (Tsao et al., 1996; Marumo et al., 1997).  
 
1.4 Free radicals as damaging molecules 
Oxidative stress can be induced by variety of environmental factors including oxygen 
deprivation (hypoxia and anoxia), UV stress and herbicide metabolism (Kobayashi et al., 2003; 
Štajner et al., 2003; Renzing et al., 1996; Flores-Sanchez and Verpoorte, 2008). The cellular 
components susceptible to damage by free radicals are lipids (peroxidation of unsaturated fatty 
acids in membranes), proteins (nitration, oxidation and denaturation), carbohydrates and nucleic 
acids. However, the outcome of oxidative stress mainly depends on organs/tissue, species, 
endogenous antioxidant content and defence signalling pathways. It is postulated that 
overproduction of radicals may overcome the cellular antioxidant defence, and free radical 
mediated damage may persist in pathological conditions including ageing, chronic inflammation 
and ischaemia/reperfusion. 
 
1.4.1 DNA damage 
Oxidative damage to DNA is associated with many pathological conditions such as 
ischaemia/reperfusion, carcinogenesis, mutagenesis and ageing. One of most reactive free 
radicals, hydroxyl radical (
•
OH) causes damage to DNA. The presence of oxidized DNA is 
known as a marker for ROS-mediated DNA damage (Halliwell, 1999; Nakano et al., 2003). The 
guanine base is more sensitive to oxidation, thereby, it is considered as a reasonable biomarker 
for oxidative injury (Kehrer, 2000). 
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Figure 1.5   The mechanism of formation of guanine products from 
∙
OH addition to the C8   
position of guanine, adapted from Dizdaroglu et al. (2002). 
 
 
Mechanisms of damage involve abstractions and addition reactions by free radicals leading to 
carbon (C)-centered sugar radicals and 
•
OH- or H-adduct radicals of heterocyclic bases, which 
may be further fragmented after additional reactions with free radicals. The modification of 
DNA takes place by the 
•
OH which attacks the deoxyribose moiety leading to the release of free 
bases from DNA and generates strand breaks. Other changes occur in bases, with the resultant 
cross linking as a result in additions and abstractions (Dizdaroglu et al., 2002). The formation of 
guanine products from the C8-OH adduct, which is formed by attack of 
•
OH to the C8-position 
of guanine, is a common alteration in the DNA molecule (Figure 1.5). It is important to note the 
presence of oxidized purines or pyrimidines at low levels and at critical sites may cause 
functional problems (Kehrer, 2000). There are nearly 200,000 base lesions formed per day after 
oxidation with endogenous ROS generation. Adversely, DNA damage may lead to impaired 
hydrogen bonding, fidelity of DNA and/or RNA polymerase and conformational changes to the 
DNA template during DNA synthesis (Kehrer, 2000). The presence of 8-hydroxyguanine is a 
marker of oxidative stress in nuclear and mitochondrial DNA (nDNA and mtDNA).  
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It has been reported that oxidative damage is significant in mitochondrial DNA, especially, since 
the absence of bound histones and deficiency in repair mechanism renders mtDNA susceptible 
compared to whole nDNA (Zastawny et al., 1998). Moreover, Bristow and Hill, (2008) reported 
the genomic instability of DNA repair mechanisms in tumor cells in respect to transcription and 
translational proteins during acute and chronic, severe hypoxia. Oxidative mtDNA damage is 
associated with induction of nuclear phosphorylation and the dysfunction of mitochondria in 
ischaemic heart disease (Ferrari, 1996). 
 
 
1.4.2 Lipid Damage 
Oxidation of lipids refers to the loss of hydrogen from lipids in cells that may result in cell 
damage. Lipids include polyunsaturated fatty acid (PUFA) that may contain multiple double 
bonds in between which lie methylene –CH2- groups containing reactive hydrogen. The reaction 
proceeds by a free radical chain reaction which consists of initiation, propagation and 
termination. Disruption of PUFA in the phospholipid bilayer may result in functional and 
structural impairment leading to irreversible cell damage. The reaction may be initiated by ROS, 
such as 
•
OH whereby a fatty acid radical and H2O are produced by the abstraction of a hydrogen 
atom from a double bond in a polyunsaturated carbon chain (Figure 1.6). The resultant fatty acid 
radical is unstable and readily reacts with diradical O2 to form a peroxyl radical.  
 
The peroxyl radical is highly reactive and can abstract another hydrogen atom from 
neighbouring fatty acid molecule, yielding another radical species and lipid hydroperoxide, 
thereby establishing the propagation step of the chain reaction. The lipid hydroperoxide formed 
is unstable and can decompose to various species including malondialdehyde, or it can be 
reduced to the more stable alcohol form. The lipid bilayer itself may also become more 
permeable thereby disrupting ion homeostasis (Young and McEneny, 2001). In addition, some of 
the oxidized fatty acid species that are formed such as the isoprostanes or the hydroperoxides can 
regulate the apoptosis (Kehrer, 2000). Other lipids may also undergo significant oxidation, 
particularly cholesterol, resulting in several hydroxycholesterol products (Griffiths et al., 2002).  
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Figure 1.6 Schematic representation of ROS induced lipid damage in polyunsaturated     
fatty acid, taken from Young and McEneny, (2001). 
 
 
1.4.3 Protein damage 
Protein damage can occur as a result of oxidation or nitration of amino acids within a 
polypeptide chain due to the interaction with ROS and RNS. Accumulation of these oxidized or 
nitrated proteins may have deleterious effects including disruption of ion channel transport, 
inactivation of enzymes and ultimately lead to necrosis and apoptosis in vitro (Obrosova, 2006; 
Davidson et al., 2001; Ischiropoulos and Beckman, 2003).  
 
Oxidation and nitration of proteins has been identified from in vivo tissue isolated from several 
chronic conditions such as inflammation and ageing. Protein oxidation may also be a radical 
chain reaction where initiation takes place when 
•
OH
 
radical (Reaction a and b) abstracts a 
hydrogen atom of an amino acid residue, thereby, forming a carbon-centered radical (Reaction c) 
(Figure 1.8).   
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Then C-centered radical reacts rapidly with O2 to form an alkylperoxyl radical (Reaction d) 
which is an intermediate in generation of alkylperoxide and formation of alkoxyl radical 
(Reaction h). The alkoxyl radical is converted to a hydroxyl protein derivative (reaction j). 
Alkyl, alkylperoxyl, and alkoxyl radical intermediates in this pathway may undergo side 
reactions with neighbouring  amino acid residues in the same or a different polypeptide chain to 
produce to a another carbon-centered radical (Figure 1.7 and 1.8) (Berlett and Stadtman, 1997). 
 
 
 
Figure 1.7  ROS mediated oxidation of protein - C centred radicals, taken from Berlett  
    and Stadtman, (1997). 
 
 
Interestingly, in the absence of oxygen under conditions of hypoxia or anoxia or when tissues 
become ischaemic, when Reaction d in figure. 1.8 is prevented; the carbon-centered radical may 
react with another carbon-centered radical to form a protein-protein cross-linked derivative 
(Berlett and Stadtman, 1997). 
 
Direct oxidation of amino acids including lysine, arginine, proline, and threonine residues may 
yield carbonyl derivatives on side chains. Alternatively, carbonyl groups may be introduced into 
proteins by reactions with aldehydes (4 hydroxy-2-nonenal, malondialdehyde) produced during 
lipid peroxidation (Figure 1.6) (Berlett and Stadtman, 1997; England et al., 2003). The 
formation of protein carbonyls has been used as a marker of ROS-mediated protein oxidation, 
and determination of carbonyl may reflect the degree of oxidative stress (England et al., 2003; 
Berlett and Stadtman, 1997).  
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Figure 1.8  ROS mediated oxidation of protein-protein cross linking and peptide bond     
cleavage, taken and adapted from Berlett and Stadtman (1997). 
 
 
The nitration of proteins is a marker of ONOO
-
generation. Tyrosine and tryptophan residues are 
selective targets of ONOO
- 
- dependent nitration, but, methionine and cysteine residues are 
particularly vulnerable to oxidation by ONOO
-
. Nitration of aromatic residues and oxidation of 
thiol containing residues depend on the availability of CO2 and ONOO
-
 reacts rapidly with CO2 
to form O=NOOCO2
- 
or O2NOCO2
- 
derivatives which may direct the modifications to nitrate 
aromatic compound in the protein chain (Berlett and Stadtman, 1997). 
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1.5 Physiology and pathophysiology of hypoxia and hypoxia/reperfusion injury 
Hypoxia is a stress condition in which tissues are deprived of adequate oxygen supply whereas 
ischaemia is a condition in which the blood flow (oxygen and glucose) is restricted to a tissue 
and results in anoxia. The effect of hypoxia and ischaemia may not be identical, but they are 
difficult to separate clinically (Peters et al., 2000). Hypoxia and subsequently ischaemia is an 
important cause of reversible or irreversible tissue injury, but it depends on severity and duration 
of the insult. The German pathologist Rudolf Virchow in 1858 first defined and described 
ischaemia in the heart, as an imbalance between myocardial oxygen supply and demand due to a 
decrease of blood flow as a result of narrowing of the coronary artery (Liem et al., 2007). 
Coronary heart disease is one of the leading causes of death and disability in the world. 
Epidemiological data indicate that its morbidity and mortality rates will exceed those of cancer 
and infectious disease in the near future (Murray and Lopez, 1997). Hypoxia could arise due to 
narrowing of a blood vessel due to fatty deposits (atherosclerosis) and restricted blood supply to 
neighbouring tissue or cells. If this process takes place in the coronary artery, the condition is 
known coronary ischaemia and leads to coronary heart disease (Figure 1.9). It is therefore 
essential to restore coronary flow to the ischaemic myocardium by interventions such as 
angioplasty, thrombolytic treatment or coronary bypass surgery (Jennings and Reimer, 1991).  
 
 
Cardiac hypoxia as a result of ischaemia mainly results in irreversible cell damage, which may 
further progress to contractile failure, ventricular remodelling and arrhythmias. Reperfusion is 
the restoration of oxygenated blood supply to hypoxic or ischaemic tissues. Reperfusion injury 
refers to irreversible damage to a tissue caused when blood supply carrying oxygen returns to the 
tissue after a period of ischaemia or hypoxia. The absence of O2 alone or O2 and nutrients for a 
period from blood result in a condition in which inflammation and oxidative stress is typical in 
many organs including heart, brain, liver, kidney and intestine. The energy demand for these 
tissues depends on limited mitochondrial respiration and possibly glycolysis alone (de Groot and 
Rauen, 2007). In general, the susceptibility of cells or tissues to hypoxia or ischaemia 
reperfusion injury is a major clinical challenge after an infarct and after successful organ 
transplantation. 
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                          Figure 1.9  Coronary heart disease and myocardial infarction  
                                      (www.focalcool.com). 
 
 
Inflammation during hypoxia/reperfusion includes both the cellular and humoral responses. 
Many metabolic changes are induced in hypoxia or ischaemia/reperfusion injury. Coronary 
occlusion in the heart or microvascular occlusion in other tissue may result in complete 
deprivation of the O2 supply (anoxia) which triggers loss of the mitochondrial ATP supply, 
accumulation of lactic acid, overload of intracellular Ca
2+
, osmotic swelling due to loss of Na
+
 
homeostasis, mitochondrial permeability transition and disruption of membrane potential and 
finally, cell death via necrosis (de Groot and Rauen, 2007) (Figure 1.10 and 1.11).   
 
During reperfusion injury in a tissue, release of ROS/RNS by macrophages, endothelial cells, 
neutrophils, lymphocytes, platelets, parenchyma cells and leukocytes add to the existing damage 
to the endothelium, thrombus formation, cytotoxic enzyme release, increased vascular 
permeability and increased cytokine release. These effects contribute induced tissue injury 
through effects on signal transduction pathways mediated by ROS and/or Ca
2+ 
leading to 
activation of enzymes or mediators involved in cell death and dysfunction (de Groot and Rauen, 
2007; Björk et al., 1982; Mueller et al., 1997; Weiss, 1989). The progression of cell death in 
ischaemia under anoxia is shown schematically in figure 1.11.   
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Deleterious effects may persist for a period of time, weeks or months. This depression of cardiac 
function (myocardial stunning) of the ischaemic-reperfused heart is common in patients after 
coronary bypass surgery or in patients with a heart transplant (de Groot and Rauen, 2007). 
 
 
 
 
Figure 1.10 Paradoxical effects of reperfusion in the ischaemic heart. Reperfusion      
contributes to further tissue damage, taken from Dhalla and Duhamel (2007). 
 
 
 
Irreversible or reversible cell death or infarction size induced by an acute coronary occlusion 
mainly depends on severity and duration of ischaemia. Several treatments restore blood flow 
(reperfusion therapy) in patients with acute myocardial infarction; but clinical reperfusion 
therapy such as thrombolysis is not effective in supporting survival of ischaemic cells. Cardiac 
cell death is mainly associated with restoration of blood supply; reperfusion. Recent 
development of current methods for improving the efficacy of thrombolysis and percutaneous 
coronary interventions during revascularization or cardioprotection therapy have improved 
survival, but many effects of these therapies remain unresolved.  
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Figure 1.11  Schematic presentation of progression to cell death in ischaemic tissue under      
anoxia, adapted from de Groot and Rauen (2007) and Crompton (1999).    - increase  or     - 
decrease. 
 
1.6 ROS/RNS signalling in cardiovascular disease 
Signalling mechanisms of ROS/RNS are of particular relevance to cardiovascular diseases 
(CVD); myocardial infarction, ischaemia/reperfusion, atherosclerosis and hypertension, and have 
been studied recently in vascular cells. During atherosclerosis, activation of the enzymes in both 
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infiltrating macrophages and vascular cells generate high levels of ROS/RNS, thereby changing 
the oxidation status of thiols on signalling proteins (Harrison et al., 2003; Taniyama and 
Griendling, 2003; Levonen et al., 2001). The ROS/RNS involved in redox signalling pathways 
can be generated from the NADPH oxidases and NOS or mitochondria as a major ROS 
generation site. Mainly, mitochondrial ROS formation is associated with the cell signalling that 
controls proliferation (Li et al., 1997), hypoxia, necrosis and apoptosis (Chandel and Budinger, 
2007; Bonavita et al., 2003; Kim et al., 2003). The redox cell signalling pathways that are 
activated are balanced between those that protect endothelial and vascular smooth muscle cells 
with those that initiate cell death through apoptosis (Sauer et al., 2001; Schafer et al., 2003).  
 
A major challenge at the present time is to understand how the localized production of 
ROS/RNS contributes to the atherosclerotic lesion formation and how it makes a plaque (Patel et 
al., 2000). Therefore, particular attention is being made to associated mechanisms through which 
cells generate and detect ROS/RNS and their metabolic products, particularly oxidized lipids or 
proteins produced by enzymatic and non-enzymatic mechanisms (Li and Jackson, 2002). There 
is increased interest in how ROS/RNS contribute to cellular protection in addition to deleterious 
effects as a number of therapeutic interventions based on reactive species which have not 
demonstrated clinical benefits in treating vascular diseases. Strikingly, use of low molecular 
weight antioxidants and inhibitors of cyclo-oxygenase pathway has not been successful 
(Taniyama and Griendling, 2003). It was assumed these agents would have therapeutic benefits 
as some ROS/RNS and oxidized lipids have potentially beneficial effects as signal transduction 
molecules in cytoprotection (Taniyama and Griendling, 2003). Therefore, it is important to 
examine sources of free radical generators; mitochondria, NADPH oxidase and NOS in vascular 
systems in the pathophysiology of cardiovascular disease.  
Interestingly, lipid oxidation products are implicated in the progression of atherosclerosis which 
is the underlying cause of myocardial infarction and strokes. The mitochondrion is a site of 
redox signalling which is mediated by oxidized lipid products (Zmijewski et al., 2005).  
In general, vascular pathologies are multifactorial, but it is known that mitochondrial dysfunction 
can contribute to the pathophysiology of vascular diseases; ischaemia, hypoxia and reperfusion. 
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It is not only the dysfunction of mitochondrial energy production, but also mitochondria- 
dependent redox signalling pathway that contribute to cell survival and/or injury (Zmijewski et 
al., 2005). 
 
1.7 Cell death during hypoxia, anoxia, or hypoxia/reperfusion 
Cell death during hypoxia was thought to be by necrosis based on various ultrastructural findings 
in hypoxic cells (Jennings et al., 1975). However, recent biochemical investigations have 
demonstrated the feasibility of hypoxia-induced apoptosis (Muschel et al., 1995). McCully et al. 
(2004) reported that both necrosis and apoptosis contribute to myocardial infarct size during 
ischaemia/reperfusion. Therefore, cell death in cardiomyocytes is induced by two mechanisms; 
necrosis and apoptosis, which are different morphologically (Watkins et al., 1995).  
 
1.7.1 Necrosis  
Necrosis has been reported as a passive degenerative process induced by direct toxic and 
physical injuries (Shimizu et al., 1996) in addition to cellular stress conditions. Cellular necrosis 
is associated with chronic, severe hypoxia or anoxia condition due to absence of O2, which may 
have impaired ATP production. However, cellular endogenous factors such as intrinsic adaptive 
mechanisms, hypoxic tolerance and tissue type may determine the degree of necrotic cell death. 
Characteristically, necrotic cells swell, accumulate intracellular water, chromatin clumps, DNA 
degenerates, large cytosolic vacuoles are seen, ATP is depleted, mitochondria swell, and the 
cells lyse with intracellular contents spilled into the extracellular space (Figure 1.12). This 
results in activation of inflammatory reactions with recruitment of macrophages (Shimizu et al., 
1996; Naoi et al., 2000; McCully et al., 2004). Necrosis can occur during trauma, and 
thrombosis, with depletion of high energy stores, and disruption of the cellular membrane 
involving fluid and electrolyte alterations, the loss of potassium and magnesium ions, and 
accumulation of sodium, chloride, hydrogen, and calcium (McCully et al., 2004).  
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1.7.2 Apoptosis 
Apoptosis is a conserved process of cell suicide that plays an integral role in embryonic 
development, tissue homeostasis and tissue remodelling. Deregulation of apoptosis may result in 
excess cell death, and is implicated in pathogenesis of human disease.  It is now evident that 
apoptosis plays a key role in the pathogenesis of a variety of cardiovascular diseases including 
myocardial infarction, ischaemia/reperfusion heart failure and stroke (Crow et al., 2004).  
 
 
 Figure 1.12   The sequence of ultra structural changes in apoptosis and necrosis, taken 
from Cruchten and Broeck.  (2002). 
 
Cardiomyocytes may undergo apoptosis in response to hypoxia and reperfusion. Acidosis, serum 
or glucose deprivation, metabolic inhibition and other stimuli such as stretch, tumour necrosis 
factor and Fas ligand also trigger cardiomyocyte apoptosis (McCully et al., 2004; Adrain and 
Martin, 2001; Bromme and Holtz, 1996; Clerk et al., 2003; Crow et al., 2004). Apoptosis is an 
ATP-dependent mechanism of cell death, which is known as programmed cell death whereby 
damaged cells are cleared out in controlled manner without provoking inflammation. Apoptosis 
is characterized by the generation of fragmented nuclei with highly condensed chromatin and 
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fragmented DNA, plasma membrane blebbing, externalization of phosphatidylserine and cell 
shrinkage due to reduction in cytoplasm or protrusion of cytoplasm and organelles and then 
formation of membrane-bound apoptotic bodies (Crow et al., 2004; Shimizu et al., 1996; 
Cruchten and Broeck, 2002). These membrane-bound apoptotic bodies containing cytosol and 
processed organelles are formed and then removed by recruited macrophages via phagocytosis 
(Cruchten and Broeck, 2002) (Figure 1.12). Clinically, apoptosis has been observed in samples 
collected from patients after myocardial infarction and end-stage heart failure (Olivetti et al., 
1996; Narula et al., 1996) and also, in animal models of ischaemia/reperfusion injury (Levrand et 
al., 2006; Cruchten and Broeck, 2002; McCully et al., 2004).  
 
Two major pathways of apoptosis exist; the extrinsic, death receptor-mediated pathway and the 
intrinsic pathway. The intrinsic pathway triggers a mitochondrial mediated pathway involving 
cytochrome c release. The immediate effect of apoptosis via the intrinsic pathway is the 
activation of procaspases and dysfunction of the mitochondria. Therefore, apoptosis follows via 
specialized machinery; the central component of this machinery is a proteolytic system involving 
a family of proteases called caspases. These enzymes are involved in a cascade that is triggered 
in a response to proapoptotic signals and culminates in cleavage of structural proteins and DNA 
resulting in disassembly of the cell (Thornberry and Lazebnik, 1998, Nicholson et al., 1995). In 
apoptosis, procaspase activation is regulated by members of the Bcl-2 and inhibitor of apoptosis 
(IAP) protein families. Both intracellular and extra cellular signals mainly act by regulating the 
levels or activity of members of the Bcl-2 and IAP families (Alberts et al., 2008; Galonek and 
Hardwick, 2006;Kim et al., 2006). 
 
The Bcl-2 family of proteins; pro-apoptotic factors regulate the activation of procaspases, but, 
some other proteins of the same family such as Bcl-2 or BcL-XL; anti-apoptotic factors inhibit 
apoptosis at least by inhibiting release of cytochrome c from mitochondria (Alberts et al., 2008; 
Kim et al, 2006; Galonek and Hardwick, 2006). The Bcl-2 family anti-apoptotic factors include 
Bcl-2, Bcl-xL, Bcl-w/Bcl2L2, Mcl-1, Bcl2A1/Bfl-1, NR-13, Boo/Diva/Bcl2-L-10 and Bcl-B as 
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reported. The first group of pro-apototic factors include Bik/Nbk, Blk, Hrk/DP5, BNIP3, 
Bcl2L11/BimL/Bod, Bad, Bid, PMAIP1/Noxa, PUMA/Bbc3 and Bmf (Willis and Adams, 2005; 
Kim et al., 2006; Galonek and Hardwick, 2006; Huang and Strasser, 2000; Adams and Cory, 
2001; Borner, 2003). All members listed above holds only a specific BH3 domain unlike other 
members in Bcl-2 family (Huang and Strasser, 2000). The second group of pro-apoptotic factors 
includes Bax like pro-apoptotic factors including Bax, Bak, Bok/Mtd, Bcl-xs (Kim et al., 2006; 
Galonek and Hardwick, 2006; Huang and Strasser, 2000). PUMA and Noxa are both BH3-only 
proteins which are known as other pro-apoptotic factors which can activate p53-mediated 
apoptosis (Willis and Adams, 2005; Yu and Zhang,2008; Vousden, 2005). BH3 only members 
and their ability to interact with other pro-survival family members to permit bax/Bak to form 
mitochondrial pores. The proapototic factors, like Bad, function by binding to and inactivating 
the anti-apoptotic factors, whereas Bax and Bak, trigger the release of cytochrome c from 
mitochondria (Jiang and Wang, 2004; Galonek and Hardwick, 2006) and Bid in Bcl-2 family can 
promote the activation of both Bax and Bak (Willis and Adams, 2005;Jiang and Wang, 2004; 
Kim et al, 2006). If the genes encoding Bax and Bak are not activated or expressed, cells can 
resist to apoptotic stimuli (Kim et al., 2006; Galonek and Hardwick, 2006; Huang and Strasser, 
2000). 
 
 
IAP (i.e. X-linked inhibitor of apoptosis, XIAP) are known to inhibit apoptosis either by binding 
to procaspases, like 9 and/or 3  to prevent their activation or binding to active caspases, like 
caspae-9 (Verhagen et al., 2001;Crow et al., 2004). When Bax and Bak stimulate the release of 
cytochrome c, it can activate Apaf-1 and at the same time, the other protein released by 
mitochondria can block the activity of IAPs (Verhagen et al., 2001;Crow et al., 2004, Kim et al., 
2006; Galonek and Hardwick, 2006). Caspases are a subclass of cysteine proteases that cleave 
substrate after aspartic acid residue which are crucial to the activation of execution of apoptosis 
(Thornberry and Lazebnik, 1998). Caspases are constitutively expressed and synthesized as 
inactive zymogens referred commonly as procaspases, containing an N-terminal prodomain and 
a C-terminal catalytic domain consisting of ~17-24kDa (p20) and ~10-12kDa (p10) subdomain.  
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Caspases are classed according to their function, as either upstream (initiator) caspases; caspases 
2, 8, 9, 10 and 12 or downstream (effectors, executioner) caspases; 3, 6 and 7 (Nicholson et al., 
1995; Crow et al., 2004) (Figure 1.13). Induction of cell death largely depends on the 
interactions between different modulators, typically activation of apoptosis in cardiac myocytes 
is multiple stressor-dependent. In cardiovascular disease multiple stressors include cytokines, 
increased oxidative stress, and DNA damage. Upstream procaspases are activated by 
dimerization and autolysis and inactive downstream procaspases activated by proteolytic 
cleavage mediated by initiator caspases. Procaspase-3 has a major role in apoptosis, when it is 
cleaved, in turn; it activates other executioner caspases and leads to the subsequent characteristic 
features of apoptosis (Thornberry and Lazebnik, 1998; Nicholson et al., 1995) (Figure 1.13).  
 
 
1.8 Hypoxia induced apoptosis of cardiomyocytes 
Despite the convincing evidence that apoptosis occurs following hypoxia, the molecular 
mechanism and signalling pathway(s) activated by hypoxic stimuli and resulting in cardiac cell 
apoptosis are enigmatic to date. Ischaemia/reperfusion mediated cardiomyocyte apoptosis is 
regulated by several redox- sensitive transcription factors and genes including NF-κB and AP-1 
respectively (Maulik et al., 2000; Sun and Oberley, 1996). Satriano and Schlondorff. (1994) 
reported the activation of NF-κB by O2
-•
 in mouse glomerular mesangial cells in response to 
tumour necrosis factor-alpha, whereas Pignatti and Stefanelli (2003) reported the modulation of 
NF-κB activity with NOS-dependent •NO in cardiomyocytes. In contrast, Levrand et al. (2005) 
reported the inhibition of NF-κB activation by ONOO- during ischaemia/reperfusion in 
cardiomyocytes. However, the role, duration of production and specific type of ROS/RNS to 
activate NF-κB and modulation of apoptosis during hypoxia/reperfusion remains unknown. In 
accord with previous reports, prolonged hypoxia of 24-72h was needed to induce significant 
apoptosis in primary cultures of neonatal rat cardiac myocytes (Yaoita et al., 1998). Hypoxia 
alone is reported to be a very weak apoptotic stimulus in H9C2 cardiomyoblasts, however serum 
withdrawal can significantly enhance the proapoptotic actions (Bonavita et al., 2003). Unlike 
other cells, cardiomyocytes have an intrinsic pathway to protect themselves from severe hypoxia.  
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Figure 1.13  Central apoptotic pathway, adapted from Crow et al. (2004) and Kim et al. 
(2006). In the extrinsic pathway, death receptor activation stimulates procaspase-8 activation. 
Then, activated caspase-8 cleaves downstream procaspase-3, which triggers proteolytic digestion 
of the cell. In the intrinsic pathway, intracellular and extracellular death stimuli carry signals to 
mitochondria through Bax and Bid, which translocate to outer membrane and then stimulate 
release of apoptogens; cytochrome c , Smac and DIABLO. Bcl-2 and Bcl-xL are anti-apoptotic 
factors. In the cytoplasm, cytochrome c + dATP+Apaf-1 and procaspase-9 form apoptosome. 
Then, activated procaspase-9 induces proteolytic cleavage of procaspase-3. XIAP can inhibit 
activation of procaspase-9, active caspase-9 and 3. Activated caspase-8 cleaves Bid and then the, 
C-terminus of cleaved Bid translocates and inserts into the outer membrane of mitochondria, 
thereby activating Bax and Bak and release of cytochrome c.   
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It has been suggested the presence of high levels of endogenous apoptosis inhibitors such as 
apoptosis repressor caspases (ARC) that interact selectively with the death domain of the Fas 
(CD95/Apo-1) death receptor and upstream initiator caspases 2 and 8, respectively support cell 
survival (Bonavita et al., 2003). Furthermore, other survival factors for cardiomyocytes include 
interleukin-6, cardiotrophin 1 and insulin-like growth factor 1 and have been shown to be 
protective by inhibiting cardiomyocyte apoptosis pathways (Bonavita et al., 2003). An absence 
of glucose in neonatal rat cardiac myocytes during hypoxia-induced significant apoptosis as 
reported by cytochrome c release and DNA fragmentation (Malhotra and Brosius, 1999). 
However, the mechanism by which enhanced glycolysis protects against hypoxia-induced 
apoptosis is unknown.  
 
1.9 ROS/RNS generation in cardiovascular system 
Mitochondria and NAD(P)H enzymatic complexes are considered the main centres of ROS 
generation in the cardiovascular system (Abramov et al., 2007). Other sources of ROS 
generation can become significant in non-physiological conditions including superoxide 
generation from xanthine oxidase in hypoxic tissues (Abramov et al., 2007). NADPH oxidase 
has been proposed as the major superoxide producer in the vascular system (based on the use of 
inhibitors of flavoproteins such as diphenyleneiodonium (DPI)) compared to xanthine oxidase, 
NOS, cytochrome P-450 reductase and oxidoreductases of the mitochondrial respiratory chain 
and ubiquinone oxidoreductase (Balcerczyk et al., 2005). It has been reported that NOS-
dependent and independent 
•
NO production occurs in the cardiovascular system and in rat heart 
(Raat et al., 2009; Brown and Borutaite, 2007; Zweier et al., 1999; Strijdom et al., 2009).  
 
Many investigators have demonstrated that there is a NOS-dependent increase in 
•
NO production 
in the myocardium during early ischaemia (Strijdom et al., 2009). However, these studies do not 
clearly specify the cellular sources of 
•
NO production and/or which NOS isoforms are 
responsible for 
•
NO generation under pathological conditions (Strijdom et al., 2009; Brown and 
Borutaite, 2007).  
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Several studies have shown that increased expression of eNOS and iNOS generates 
•
NO during 
ischaemia, but their regulation and activation are not well understood during hypoxia (Raat et al., 
2009). Recently, studies have shown that activation occurs of cellular nitrite sources to generate 
•
NO during ischaemia and also in reperfusion as a cytoprotective measure, but their mechanism 
and contribution are not well described  (Raat et al., 2009). Peroxynitrite is involved in 
myocardial cytotoxicity by direct oxidation of lipids, proteins, and DNA (Pesse et al., 2005; 
Pacher et al., 2005), the activation of metalloproteinases (Wang et al., 2002) and nitrotyrosine 
formation. Moreover, ONOO
-
 generation associates with myocardial oxidative stress, which may 
contribute to myocardial apoptosis (Kumar and Jugdutt, 2003). ONOO
-
 acts as a potent 
signalling molecule in cardiomyocytes by activating all members of the MAP kinase family 
(Pesse et al., 2005), and inhibiting the activation of nuclear factor kappa B (Levrand et al., 2005). 
 
1.10 Mitochondria in hypoxia/reperfusion 
The mitochondrion is the energy producer for cell survival, but is involved in the cell death 
during hypoxia/reperfusion. Mitochondrial death during hypoxia/reperfusion is associated with 
mitochondrial permeability transition pore (MPTP) opening  during both necrosis and apoptosis 
(Crompton, 1999). MPTP opening results in depolarization of membrane potential (Δψm) which 
may in turn reduce the proton motive force to harness energy from ATP synthase at 
mitochondrial complex IV. Instead, ATP depletion occurs as cells attempt to maintain lost 
membrane potential in an adaptive process. However, sustained opening of MPTP results in 
release of cytochrome c and activation of the apoptogenic molecules, Smac/DIABLO and 
APAF-1 within the intermembrane space (Honda et al., 2005). This may result in the induction 
of cell death via by cleaving procaspase-9 during apoptosis. It has been reported that generation 
of ROS/RNS plays a critical role in determining the opening of MPTP (Zhao, 2004).  
Sustained opening of MPTP may result in matrix swelling due to diffusion of water and 
ultimately rupture of the outer membrane. It is believed that intracellular Ca
2+
 overload in the 
mitochondria plays a role in mitochondrial swelling and rupture of outer membrane and Ca
2+
 
buffering mediated hypoxia/reperfusion induced-cell death is widely established (Lemasters et 
al., 2009).  
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Moreover, MPTP opening is pH-sensitive, but its relative sensitivity is unknown under 
hypoxia/reperfusion conditions (Crompton, 1999; Crow et al., 2004). Typically, MPTP opening 
can be activated by overexpression of proapoptotic factors such as Bcl-2 family members; Bax, 
Bak, Bad, Noxa, Puma, and Bid (Kim et al., 2003; Crompton, 1999; Honda et al., 2005).  MPTP 
opening during hypoxia may be further sustained during reperfusion; however, this depends on 
the interplay between matrix Ca
2+
 level, ROS, intracellular Mg
2+
 and pH (Crompton, 1999; 
Zhao, 2004). As a cardiac protective mechanism, particularly during preconditioning, cells may 
adapt by; (1) opening of Mg
2+
 and ATP dependent mt-KATP channels leading to depolarization, 
and  decreasing the electrochemical gradient for Ca
2+
 during reperfusion; (2) opening of mt-
KATP channels to promote matrix swelling that can help to maintain membrane integrity where 
it can run efficient electron transport; (3) opening of mt-KATP that  may reduce ROS 
production, thereby, preventing MPTP opening (Crompton, 1999; Honda et al., 2005; Penna et 
al., 2009). mt-KATP channel function during preconditioning is under investigation as an 
approach to improve therapeutic interventions against reperfusion injury. 
 
1.11 ROS/RNS generation during hypoxia/reperfusion 
During normoxia, O2
•-
 anion radicals are produced by the mitochondrial electron transport 
system at NADH coenzyme Q reductase (complex I); and ubiquinol–cytochrome c reductase 
(complex III). During ischaemia,  reduction of iron-sulphur and ubiquinone components occurs 
with an inhibition of complex I which may trigger the decline in superoxide dismutase activity 
and result in the mitochondrial superoxide burst (Murphy, 2009). In the myocardium, it is 
believed that the mitochondrion is the main source of ROS from the respiratory chain (Becker et 
al., 1999). The ETS often generates a large flux of electrons which may be potentially capable of 
reducing O2 (Becker et al., 1999). After exposure to hypoxia, probably redox components of the 
respiratory chain impair complexes I and III in their reduced state, causing more superoxide or 
ROS formation possibly via ubisemiquinone radical intermediates (Becker, 2004a). Experiments 
with the electron transfer inhibitors amytal and myxathiazol demonstrated complex III as a major 
site of ROS production during ischaemia (Becker et al., 1999).  
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Recent studies show that NADH dehydrogenase in complex I is inactivated partially during 
hypoxia-reperfusion due to accumulation of O2
•-
 and ROS which may cause loss of the Fe-S 
clusters in the complex. Moreover, complex II may also produce ROS during hypoxia, by 
switching its catalytic activity from SDH to fumarate reductase activity at reduced oxygen 
tension (Murphy, 2009). There is no clear evidence of ROS generation from complex IV, except 
for its role as a cellular oxygen sensor with the function of cytochrome c oxidase (Palacios-
Callender et al., 2007). During normoxic respiration, antioxidant enzymes such as Mn 
superoxide dismutase (Mn-SOD) in mitochondrial matrix and Cu/Zn superoxide dismutase 
(Cu/Zn-SOD) in the mitochondrial intermembrane space and cytosol swiftly dismutate excess 
O2
•-
 produced within the matrix, intermembrane space and outer membrane to H2O2 (Murphy, 
2009; Okado-Matsumoto and Fridovich, 2001). The resultant H2O2 is then degraded to O2 and 
H2O by cytosolic or mitochondrial catalase, glutathione peroxidase (Thannickal and Fanburg, 
2000) and peroxiredoxin (Vivancos et al., 2005). The contribution of ROS in promoting 
ischaemic damage has been demonstrated by the reduced damage observed in reperfused heart of 
transgenic mice overexpressing Mn-SOD (Chen et al., 1998). GSH peroxidase-catalysed 
removal of H2O2 reduces GSH concentration and can result in a redox change in the 
mitochondria and cytosol.  
 
Overproduction of ROS during a prolonged hypoxic insult can further disrupt mitochondrial 
homeostasis by irreversibly oxidising proteins such as cytochrome oxidase (Murphy, 2009), 
DNA and lipids. In contrast, a lower level of ROS generation is required to induce 
cardioprotective mechanisms that preserve mitochondrial integrity and the myocardium during 
episodes of hypoxia or ischaemia. Within the hypoxic heart, mitochondria are likely to be the 
main source of ROS in muscle cells (Vassilopoulos and Papazafiri, 2005; Turrens, 1997; 
Suleiman et al., 2001). Other sources such as the NADPH oxidase complex in vascular cells 
(Souza et al., 2002) or xanthine oxidase in endothelial cells, pulmonary cells and neuronal cells 
can generate O2
•-
 (Pearlstein et al., 2002; Abramov et al., 2007; Becker et al., 1999; Becker, 
2004a). Moreover, NOS isoforms also can produce O2
•-
 and H2O2 when L-arginine substrate is 
limited in supply (Pou et al., 1999).  
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However, the relative contribution of aforementioned sources for O2
•-
 production during hypoxia 
alone in cardiomyocytes has not been clearly established.  
 
1.12 NOS in hypoxia/reperfusion 
Nitric oxide (
•
NO) can be generated in many cells or tissue types including myocardium in the 
heart and have profound effects on cardiac function. 
•
NO is principally generated by 
•
NO 
synthases (NOS), which catalyze the conversion of L-arginine to 
•
NO and L-citrulline, however, 
there are non-enzymatic sources including endogenous nitrite stores, generating 
•
NO or their 
related species during ischaemia/reperfusion.  nNOS and eNOS are constitutively expressed and 
their activation is calcium/calmodulin-dependent. However, iNOS is expressed only under 
stimulated conditions such as microbial or immunological stimuli, and there is no relation to 
intracellular calcium level (Kanno et al., 2000).  
 
There is considerable interest in mitochondrial NOS as previously reported by Zenebe et al. 
(2007). Even in the presence of mtNOS, the contribution of mitochondria to 
•
NO production 
might not be important under in vivo ischaemia/reperfusion. Some authors have reported that the 
main site of 
•
NO synthesis is non-mitochondrial, probably by nitrosyl-heme complexes as those 
are formed in ischaemic hearts (Tiravanti et al., 2004). Several authors have documented the 
beneficial effects of administration 
•
NO donors attenuating ischaemic injury (Pabla and Curtis, 
1995; Wainwright and Martorana, 1993; Kanno et al., 2000; Strijdom et al., 2009). Moreover, 
pharmacological inhibition of NOS and transgenic iNOS or eNOS knockout (KO) mice show 
more severe hypoxic injury in the heart (Kanno et al., 2000).  
 
In further support of a protective role of 
•
NO, eNOS-KO mice attenuates cardiac recovery after 
ischaemia/reperfusion, but overexpression of eNOS accelerates functional recovery of the heart. 
Moreover, pharmacological inhibition of NOS attenuates the developed pressure after 
ischaemia/reperfusion in mice and guinea pig hearts; to NOS-dependent 
•
NO formation is 
cardiacprotective and can attenuate myocardial stunning in mice and guinea pigs (Schulz et al., 
2004).  
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However, the protective efficacy of NOS-dependent 
•
NO is species dependent, as NOS isoforms 
expression is species dependent (Pabla and Curtis, 1996). In rats, both low and high 
•
NO 
concentration are ineffective in activating cardiac protection while intermediate concentrations 
are protective (Schulz et al., 2004). eNOS-KO mice have an increased infarct size after 
ischaemia reperfusion, suggesting the importance of eNOS activity during ischaemia/reperfusion 
(Schulz et al., 2004). Moreover, addition of a 
•
NO donor at the time reperfusion or just before 
reperfusion had beneficial effects, such as a decrease in irreversible injury and reduced 
neutrophil adhesion to the endothelium (Sato et al., 1995).  
 
 
1.13 Quantification of ROS and RNS during hypoxia-reperfusion using fluorescent probes 
There are number of direct and indirect methods available to detect ROS/RNS at an intracellular 
level; but facile detection of ROS is still problematic. The use of reliable and precise methods to 
assess ROS/RNS production is crucial. Fluorescent probes are widely used for in vitro 
determination of ROS and RNS. Fluorescent probes are fluorophores that may be designed to 
localize within a specific region of a biological tissue and to respond to a specific signal such as 
amount of ROS and RNS. ROS/RNS cause oxidation or nitration of the fluorescent probe which 
is initially in a chemically reduced state and an associated increase in fluorescence. Therefore, 
the proportion of fluorescence is correlated to the amount of intracellular ROS/RNS. The 
reduced dyes are known to be colourless and non-fluorescent; once oxidized, the dyes are highly 
coloured and fluorescent. It is important to understand the chemical properties of the probe, 
particularly their chemical reactivity towards ROS/RNS.  
 
Most dyes have variable sensitivity, but some have specificity for a particular reactive species. 
However, in complex biological research, physical properties also play an important role, 
therefore understanding the physical properties such as solubility in the culture medium, 
biodistribution, absorption spectra, fluorescent emission spectra and fluorescent lifetime is 
important (Wardman et al., 2007).  
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In hypoxia-reperfusion experiments, the ideal properties of fluorescent ROS/RNS sensor would 
include (a) being cell membrane permeant and exhibiting stochiometric binding to intracellular 
ROS (b) having no cellular toxicity (c) undergoing efficient oxidation to a fluorescent product by 
ROS (d) showing intracellular sequestration of the fluorescent oxidised form (Kudin et al., 2005) 
(e) having mono-specificity for a particular species and (f) stability within the intracellular 
environment. The following section explains the particular fluorescent probes that can be 
employed in ROS/RNS-related research.  
 
1.14 The construction of new reporter systems for ROS/RNS detection 
There is increasing evidence suggesting that mitochondrial dysfunction, mitochondrial-based 
O2
•-
 generation and other ROS/RNS are implicated in the pathophysiology of cardiovascular 
disease, aging, cancer, neurodegenerative disease, inflammatory disorders, diabetes, and diabetic 
complications (Mukhopadhyay et al., 2007). Chemiluminescence and fluorescence-based assays 
have been widely available to measure cell-derived superoxide.   
 
Detecting O2
•-
 using fluorescent probes provides benefits of analysis by fluorescence 
microscopy, flow cytometry, a fluorescence microplate reader, and a cell sorter. However, 
selectivity, simplicity, reactivity and availability are important factors. The novel fluoroprobe; 
MitoSOX Red (MitoSOX) has been used for selective detection of O2
•-
 (Mukhopadhyay et al., 
2007), but only in mitochondria, not as a global O2
•-
 indicator. Other new approaches are 
dependent on the effects of O2
•-
 and other radical species on gene expression systems. Some 
organism such as E.coli have various gene expression systems sensitive to ROS/RNS. Those 
systems have been utilized to construct reporter systems to monitor environmental stress factors 
(Belkin et al., 1996), and also to monitor O2
•-
  and other radical species generation in in vivo 
animal models (Koo et al., 2003;Kim et al., 2005; Niazi et al., 2007). If the promoter region of 
O2
•-
- sensitive gene segment is fused to a Renilla reniformis luciferase gene as a reporter, that 
system can be used as a quantitative indicator to assess intracellular O2
•-
 production.  
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This type of system may have number advantages including accurate quantification of 
superoxide produced, exclusion of O2
•-
  related species which may have evolved from secondary 
oxidations, detailed information about the redox state of the cell or tissue and possible in  vivo 
detector of O2
•-
  production in animal models. A reporter gene system has been described for the 
individual detection of H2O2 and singlet oxygen generation in Chlamydomonas reinhardtii, a 
plant model organism. This system employs various HSP70A promoter segments fused to a 
Renilla reniformis luciferase gene as a reporter (Shao et al., 2007).  
 
Other reporter systems have been reported that use SOXRS of E. coli and green fluorescent 
protein (GFP) of Aequorea victora where GFP showed an increased fluorescence in the presence 
of O2
•-
  (Shibuya et al., 2004). It is clear now, there is a raised possibility of using those reporter 
gene plasmid constructs to quantify O2
•-
 generation in vivo and in vitro animal models under 
hypoxia or hypoxia/reperfusion.   
 
1.15 The validity of the fluorescent probe for 
•
NO determination compared to EPR 
There are three widely used major methods available for detection of 
•
NO; such as 
chemiluminescence, electron spin resonance (ESR) /Electron Paramagnetic Resonance (EPR)  
and fluorometric methods including selective fluorescent probes. There are several advantages 
and disadvantages in all methods. However, direct 
•
NO measurements are difficult due to low 
concentrations and short half-life, therefore, EPR spin trapping has been reported as one of best 
methods for quantification of 
•
NO (Kleschyov et al., 2007). ESR or EPR based techniques show 
higher sensitivity and selectivity for radical species or paramagnetic species in variety of 
application methods (Archer, 1993, Tsuchiya et al., 1996, Berliner et al., 2001).  
EPR is a tool that determines the resonant absorption of microwave radiation by paramagnetic 
systems in the presence of an applied magnetic field (Kleschyov et al., 2007). EPR can be used 
as a direct or non-direct in vivo and in vitro methods to analyse endogenous or exogenous 
•
NO 
production in intact tissues or isolated organ or small animals (Kuppusamy and Zweier, 2004).  
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Despite above advantage of EPR tools, they are limited by expensive instrumentation, sample 
preparation, and complicated and intensive operation under laboratory conditions, where 
fluorescent probes are an easier and rapid method for 
•
NO detection in cell culture systems. 
Moreover, with the development of fluorometry techniques, there are new small molecule probes 
which are available that can discriminate between ONOO
-
 and nitroxyl radicals in culture 
systems when determining 
•
NO generation, with increasing development of biocompatible 
probes for use in animals and tissues (Kleschyov et al., 2007; McQuade and Lippard, 2010). 
 
1.16 Cardiac protection during hypoxia/reperfusion 
1.16.1 Defence mechanisms in biological systems 
In vivo and in vitro biological systems have natural defence mechanisms against ROS/RNS to 
prevent damage if they are overproduced. Natural defence mechanisms consists of endogenous 
antioxidant enzymes; superoxide dismutase, glutathione peroxidase, catalase and thioredoxin 
reductase and non-enzymatic antioxidants; coenzyme Q, thioredoxins, glutathione, endogenous 
nitric oxide, and antioxidant vitamins (Elsässer et al., 2001; Downey and Cohen, 2006). 
•
NO 
itself has been reported as a protective molecule during hypoxia in several reports (Beckman and 
Koppenol, 1996; Bereesewicz et al., 1995). The addition of exogenous antioxidants, radical traps 
and low molecular weight ROS scavengers can also overcome deleterious effects of excessive 
generation of ROS/RNS. The presence of excess ROS/RNS can in turn trigger activation of a 
number of redox-sensitive transcription factors such as NF-κB and Nrf2 that in turn promote the 
expression of antioxidant enzymes such as MnSOD and GCS respectively (Penna et al., 2009; 
Maulik et al., 2000; Thimmulappa et al., 2002). 
 
In addition to ROS/RNS mediated cytoprotection during hypoxia/reperfusion via NF-κB and 
Nrf2, hypoxia inducible factor (HIF)-1α activation plays an essential role in triggering protection 
against cellular injury and metabolic alterations from the consequences of oxygen deprivation 
during hypoxia.  
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According to recent reports, HIF 1α activation confers protection against ischaemia–reperfusion 
(I/R) injury, provided that HIF 1α activation has been induced before the onset of lethal 
ischaemia (Loor and Schumacker, 2008). The term ―cardiac protection‖ defines an activation of 
protective mechanism during hypoxia to adapt cells for survival. Numerous reports describe 
cardiac preconditioning under mild hypoxic conditions that protects against later severe hypoxia. 
But low concentrations of ROS/ RNS play a vital role in modulating signalling mechanisms of 
cardioprotection. 
 
 
1.16.2 Preconditioning in the heart with hypoxia and hypoxia/reperfusion 
Reperfusion after ischaemia may restore function to the myocardium, but paradoxically, also 
results in additional damage to the tissue. The proliferative ability of cardiomyocytes is limited; 
therefore, loss of cardiomyocytes cannot be compensated for and a strategy of controlling cell 
death is required to attenuate the heart damage induced by reperfusion. Cardiac protection during 
ischaemia has been unsuccessful with therapeutic interventions to date, which have attempted to 
minimize infarct size or subsequent reperfusion damage. Preconditioning makes tissue more 
resistant for subsequent episodes of ischaemia or reperfusion insult (Murry et al., 1986). There 
are two types of preconditioning; first window protection (classical preconditioning) and second 
window protection. The classical preconditioning occurs after first 5min of reperfusion and it 
extends until 3h whereas the second window of protection occurs between 12-72h later (Yellon 
and Downey, 2003; Ardehali, 2006; Balakumar et al., 2009).   
The mechanisms of these two processes are not clear; however, first window protection is 
associated with posttranslational modifications of proteins whereas the second window of 
protection depends on cardiac protective agents available intracellularly. Cardiac preconditioning 
is associated with complex redox signalling mechanisms in rat heart (Penna et al., 2009). It has 
been reported that redox activity of endogenous and exogenous ROS/RNS generated at low 
concentrations during transient ischaemia may trigger protective mechanisms (Costa et al., 
2005). Mitochondrial ROS/RNS mediate first window protection, with O2
•-
, 
•
NO and H2O2 
reported as the major molecules in the cascade.  
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Moreover, scavenging of hydroxyl radical and ONOO
-
 have shown their involvement in 
preconditioning (Kevin et al., 2003; Becker, 2004b; Becker et al., 1999). Other sources of O2
•- 
production are also important in preconditioning; NADPH oxidase plays a pivotal role in 
ischaemic preconditioning, as NADPH oxidase KO-mice cannot be preconditioned (Bell et al., 
2005). It has been reported that ROS mediates PKC and, thereby to induce associated effects of 
cardiac protection with MPTP, mitochondrial KATP channels and BAX/BAD (Penna et al., 
2009).  
In ischaemic heart and also during reperfusion period, 
•
NO production takes place and is 
involved with preconditioning via the mitochondrial K ATP channels (Penna et al., 2009). 
Moreover, inclusion of exogenous 
•
NO by 
•
NO donors and endogenous 
•
NO have shown to 
produce cardiac protection during ischaemia/reperfusion in various tissues including 
myocardium. It is believed that endogenous 
•
NO is involved in cardiac preconditioning during 
ischaemia/reperfusion through several mechanisms including reducing platelet aggregation, 
neutrophil activity and adhesion in a cGMP-dependent manner in in vivo models (Penna et al., 
2009).  
 
1.16.3 Post conditioning in the heart with reperfusion 
Post conditioning is defined as intermittent interruption of coronary flow in the very early phase 
of a reperfusion, to activate cardiac protection. Cardiac effects of postconditioning depend 
critically on the duration of index and severity of ischaemia at the early phase of reperfusion. 
Moreover, it has been shown recently that redox signalling is paramount at the time of 
myocardial reperfusion (i.e. after period of hypoxia or ischaemia), to mediate the 
cardioprotection elicited by ischaemic preconditioning (Dave et al., 2008; Liu et al., 2008). Post 
conditioning is associated with multiple mechanisms including reduction of apoptosis, necrosis, 
endothelial dysfunction so as to, minimise endothelial/leukocyte interactions, and to reduce 
inflammation. The contribution of 
•
NO in cardioprotection has been shown by administering of 
L-NAME, 5min before the beginning of reperfusion in rabbit heart; this exacerbates the 
reperfusion injury (Xi-Ming et al., 2004). The significant role of nitrite in ischaemia/reperfusion 
injury has recently been suggested.  
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It is argued that whether 
•
NO (from either enzymatic or non-enzymatic sources during 
reperfusion) or ONOO
- 
(produced after reaction with O2
-• 
and 
•
NO) mediate the cardiacprotection 
during ischaemia/reperfusion (Penna et al., 2006). However, the mechanism of the involvement 
of ONOO
- 
in the cardiac protection and post conditioning remains unclear (Dawn and Bolli, 
2002; Yellon and Downey, 2003; Pagliaro, 2003).  
 
In summary, the mechanism of postconditioning includes occupation of adenosine receptors, 
activation of NOS and non enzymatic processes to produce 
•
NO, opening of mitochondrial KATP 
channels and blockage of MPTP under acidosis and production of ROS, thereby producing 
ONOO
- 
and triggering the activation of PKC and MAPKs. However, ROS/RNS may be 
protective in the pre-hypoxic phase and/or play roles in redox signalling during cardiac 
protection, but they can act deleteriously in the post-ischaemic phase causing reperfusion injury. 
Therefore future investigations are warranted.  
 
1.17 Cellular defence mechanism-signalling via NF-κB and Nrf2 activation 
There are only a few transcription factors, including NF-κB and NE-E2-related factors (Nrf2; 
Nrf1, Nrf2 and Nrf3 and Nrf2-associated factor INrf2), known to be activated by ROS and/or 
electrophiles generated during oxidative stress or chemical exposure of cells respectively. The 
activation mechanism of Nrf2 is different from the NF-κB pathway (Jaiswal, 2004). 
 
1.17.1 Nrf2 activation and ARE 
As a protective pathway against ROS/RNS under oxidative stress conditions, higher organisms 
have developed elaborate defence mechanism comprising phase II detoxification enzymes and 
antioxidant proteins. These antioxidant proteins include NAD(P)H: quinone oxidoreductase 
1(NQO1) a flavoprotein, glutathione, S-transferase (GST), heme oxygenase 1 (HO-1), 
superoxide dismutase (SOD1), NOS and glutamate cysteine ligase (GCL). All these genes 
contain specific nucleotide sequence in their gene promoter; the antioxidant response element 
(ARE) which can drive gene transcription. The consensus sequence of ARE is 5′-
TA/CANNA/GTGAC/TNNNGCA/G-3′ (Wasserman and Fahl, 1997).  
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The antioxidant responsive element (ARE) is a cis-acting regulatory element or enhancer 
sequence, which is the promoter gene sequence of phase II detoxification enzymes and the 
aforementioned antioxidant proteins. Under unstimulated conditions, Nrf2 is sequestered in the 
cytoplasm by Keap1. Activation signals include  protein kinase pathways (MAPK, PI3K and 
PKC) and ROS or electrophiles that can dissociate the Nrf2-Keap1 complex which may result in 
nuclear translocation of Nrf2 with small Maf proteins, thereby causing the transcriptional 
activation of downstream target genes; NQO1,GST,GCL,SOD1 and HO-1 (Heiss et al., 2009; 
Lee and Johnson, 2004 ) (Figure 1.14). The cytoplasmic Keap1 protein acts as a repressor of 
Nrf2-mediated ARE activity (Heiss et al., 2009). 
 
Among antioxidant proteins, NQO1 plays an important role in detoxification of metabolic 
reduction of redox cycling quinones (Sally et al., 2007; Nioi et al., 2003; Nguyen et al., 2009; 
Heiss et al., 2009) and evidence from gene-knockout models has shown the pivotal role of 
NQO1 in the cytoprotective responses invoked by electrophilic stress (Nioi et al., 2003). 
Moreover, activation of ARE promoter and NQO1 gene up-regulation occurs during ischaemia-
reperfusion (Leonard et al., 2006). In the activation of NQO1 protein, Maf protein must be 
bound to NQO1-ARE independent of Nrf2 (Itoh et al., 1997), unlike other antioxidant genes.  
 
 
1.17.2 NF-κB activation 
NF-κB (nuclear factor κB) is a redox-sensitive transcription factor which plays a pivotal role in 
the regulation of immune, apoptotic, cell proliferation, survival and inflammatory responses. NF-
κB is ubiquitously expressed and can be activated by variety of stimuli including cytokines, 
endotoxin and oxidative stress.  NF-κB activation regulates expression of various genes, thereby, 
co-ordinating cellular homeostasis with the control of balance between cell survival and cell 
death (Kukreja, 2002). At rest, NF-κB is sequestered in the cytoplasm by IkB and then can be 
activated upon multiple steps of phosphorylation through a protein kinase cascade of activation 
signals (Adrienn et al., 2003; Beinke and Ley, 2004). Under stimulated conditions, IkB 
immediately undergoes phosphorylation and ubiquitination and result in release of sequestered 
NF-κB (Figure 1.15). 
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Figure 1.14  ARE-driven gene expression by Nrf2, taken from Lee and Johnson (2004 ). 
 
 
Then, NF-κB translocates into the nucleus and binds with the promoter region of genes where it 
can promote transcription of specific, regulated genes including inducible nitric oxide synthase 
(iNOS), cyclooxygenase II (COX-2), Mn-superoxide dismutase (MnSOD), anti-apoptotic agents 
such as Bcl-2, inhibitor of apoptosis activation factors (IAFs), A1, and cytokines, tumour 
necrosis factor (TNFα), HO-1, interleukins; IL-1 and IL-6, cell adhesion molecules; ICAM, 
VCAM, selectins, FAS ligand and other transcription factors such as p53 (Kukreja, 2002, 
Adrienn et al., 2003). NF-κB/DNA binding activity associates in ischaemia/reperfusion and 
preconditioning under oxidative stress due to its redox sensitivity.  
Activation of NF-κB may reflect an early pathway to promote gene transcription for cardiac 
protection during preconditioning. Ischaemic preconditioning induces NF-κB DNA binding 
activity after coronary occlusion in rabbit hearts (Kukreja, 2002). In the presence of NOS 
inhibitors, NF-κB DNA binding was blocked, where ONOO- and •OH are responsible for 
activation of NF-κB under ischaemic conditions.  
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Adding to this, Takano et al. (1998) reported NF-κB dependent gene transcription of iNOS and 
synthesis of 
•
NO in heart during delayed preconditioning. NF-κB activation is involved in 
hypoxia/reperfusion injury, particularly in the vascular endothelium in where NF-κB activation 
promotes neutrophil adhesion. Early studies showed that NF-κB nuclear binding increased in 
microvascular endothelial cells during reperfusion but not during hypoxia (Kupatt et al., 1997). 
However, it is possible to induce cardiac dysfunction through overexpression of myocardial 
cytokines if NF-κB is activated for a long time during ischaemia/reperfusion (Kukreja, 2002). 
Therefore, NF-κB is a key regulator of the balance between cell death and survival.  
 
 
 
 
 
Figure 1.15   Generic pathway of NF-κB activation, taken from Beinke and Ley (2004). 
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1.18 What remains unknown in hypoxia and hypoxia/reperfusion? 
In the present study, there are still unanswered questions related ROS/RNS generation and their 
associated detrimental effects and beneficial effects during hypoxia and hypoxia/reperfusion. 
Previously, there has even been a dispute about whether hypoxia increases or decreases the 
production of ROS from mitochondria (Duranteau et al., 1998; Toescu, 2004; Waypa and 
Schumacker, 2005; Lesnefsky et al., 2004; Murphy, 2009).  
However, the effects of severity and duration of hypoxia for particular cells or tissues that 
induces ROS/RNS generation, detrimental effects or induces cellular antioxidant defence 
mechanism against hypoxia insult remains unknown. The development of therapeutic 
interventions requires clearer understanding of pathways for treating ischaemia/reperfusion. 
 
1.19 Hypothesis and aims 
1.19.1 Hypothesis 
An increase in ROS/RNS generation leads to myocardial cell death during hypoxia or 
hypoxia/reperfusion, which is dependent on the severity and duration of ROS/RNS 
production. Inhibition of specific sites of ROS/RNS generation prevents hypoxia and 
hypoxia/reperfusion-induced cell death. Hypoxia and hypoxia/reperfusion-induced 
superoxide and/or nitric oxide increase the activity of redox sensitive transcription factors 
that can influence cell survival.  
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1.19.2 Aims 
 
1. To optimise analytical conditions for using fluorescent probes in order to achieve 
optimum oxidation with intracellular ROS/RNS in vitro. 
 
2. To develop and determine the stability of the hypoxic system. 
 
3. To characterise the kinetics and sources of ROS/RNS production during mild (10% O2) 
and severe hypoxia (2% O2) under acute (30min) and chronic time periods (≥ 1h). 
 
4. To investigate the amount of cell death and effects on metabolic activity during mild and 
severe hypoxia at different time points. 
 
5. To investigate the mode of cell death (necrosis or apoptosis) during mild and severe 
hypoxia under acute and chronic conditions.  
 
6. To investigate whether pharmacological inhibition of ROS/RNS generating enzymes or 
antioxidant treatments can afford protection against hypoxia-induced cell death and 
hypoxia/reperfusion-induced changes in metabolic activity. 
 
7. To develop appropriate reporter assays in order to investigate whether activation of 
transcription factors NF-κB and Nrf2 mediates the cellular defence against hypoxia or 
hypoxia/reperfusion. 
 
8. To investigate whether ROS/RNS activate Nrf2 and/or NF-κB during hypoxia and any 
role for NF-κB in cell death or survival using pharmacological inhibitors of NF-κB 
transcription. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 Preface 
This chapter describes the different methods employed in this thesis to collect accurate data for 
the investigation of the experimental hypotheses. It includes standard experimental methods, 
modified methods and in-house developed novel techniques. Due to limitations of some 
published methods, they were modified and optimised accordingly for application to a particular 
experimental model or time point. 
 
Standard methods include cell culture, Winkler assay for dissolved oxygen measurements, 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), western blot, protein 
quantification assays, MTT cell viability assay, protein carbonyl ELISA, plasmid DNA 
transfection, Maxiprep of plasmid DNA extraction, plasmid DNA sequencing, analysis of 
plasmid DNA by restriction digestion and agarose gel electrophoresis. In house-developed 
techniques and modifications of protocols are described separately under each experiment. Those 
include induction of hypoxia/reperfusion and validation of the hypoxic chamber, time of addition 
of drug and/or probe solutions under hypoxic/reperfusion conditions, optimisation of various 
fluorescent probe conditions to quantify ROS/RNS during hypoxia/reperfusion, necrotic and 
apoptotic cell death analysis. The western blot analysis for procaspase-3 cleavage and a Dual 
Glo luciferase reporter assay for co-transfection studies were also modified. 
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2.2 Materials 
The solvents were purchased from Fisher Scientific (Loughborough, UK) unless otherwise 
specified. H9C2 (1-2) myoblasts (CRL-1446) were obtained from LGC Ltd (Middlesex, UK). 
DMEM (12-614F), foetal bovine serum (FBS), trypsin-EDTA (0.53mM) solution (17161E), 
penicillin (100U/ml)-streptomycin (100µg/ml) mixture (17-603E), L-glutamine (17-605E) were 
obtained from Cambrex Bioscience, Wokingham Ltd (Berkshire, UK). Cell culture plates, 
culture flasks and petri dishes were obtained from Corning Ltd, UK. Trypan Blue Solution 
(0.4%) was purchased from Sigma (UK).  
All gases and premixed special gases were from BOC Ltd (Guildford, UK). Eppendorfs and 
universals were obtained from Appleton Woods Ltd. Specific reagents, chemical products and 
instruments are as stated in the method. 
 
2.3 Methods 
2.3.1 Cell culture  
In hypoxia-reperfusion injury research, in vivo models or primary cardiomyocytes are routinely 
used. The embryonic heart-derived rat myoblasts were used throughout the project as they are 
similar to cardiomyocytes biochemically and offer a reproducible model for the study of 
myocardial hypoxia/reperfusion. Specifically routine cell culture and handling was possible for 
long term studies. Cells were passaged at 70-80% confluence to prevent them differentiating to 
myotubes at higher confluency as previously described (Kimes and Brandt, 1976). Experiments 
were performed with cells between passage numbers 14 – 20. 
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2.3.1.2 Routine cell culture 
ATCC H9C2 (1-2) rat-myoblasts were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) and supplemented with heat inactivated 10% fetal bovine serum (FBS), 4mM L-
glutamine and 1% penicillin/streptomycin  according to the supplier’s instructions. This is 
referred to as complete culture medium. Cells were grown in cell culture - treated T75cm
2
 flasks 
at 37 °C in a humidified atmosphere of 5% CO2 and 95% air. 
 
2.3.1.3 Passage of H9C2 cells 
At 70-80% confluence, cells were trypsinised (0.125% (w/v) trypsin, 0.02% (w/v) EDTA and 
0.02% (w/v) glucose) in 5ml of 0.15M phosphate buffer saline (PBS)) for 1-3 minutes. Complete 
culture medium was added to each flask and mixed with the trypsinised cells to inactivate 
trypsin. Cells were centrifuged at 400g for 5minutes at room temperature in a 50ml-centrifuge 
tube. The supernatant was removed and the pellet manually agitated and resuspended into 8ml of 
culture medium. Following the cell counts by trypan blue exclusion, cells were subcultured into 
T75/T150 flasks at 1:2 to 1:4 ratios. Media was replaced routinely every 2 days.  
 
2.3.2 Trypan blue exclusion test for cell viability 
In order to obtain accurate results and reproducible data from an experiment system, it is 
important to maintain the same cell number between experiments. Therefore, a haemocytometer 
was used to count cells. The viable cell density was determined as the number of trypan blue 
excluding cells in a haemocytometer. The advantage of the trypan blue exclusion test is it is 
simple, rapid and able to provide results comparable to other dyes such as Erythrosin B or 
Nigrasin. The chromopore of trypan blue is negatively charged and does not enter the cell unless 
the membrane is damaged (Thomadaki et al., 2007). Therefore, all the cells which actively 
exclude the dye were considered as viable. Dead cells stain a blue colour. 
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2.3.2.1 Method 
When the cells were at 70-80% confluence, the monolayer was washed three times with PBS and 
trypsinised by addition of 5ml of trypsin EDTA for 2-3 minutes at 37ºC. Cells in suspension 
were harvested and resuspended in 8ml of complete medium. Trypan blue (15µl) was added to 
an equal volume of cell suspension and mixed by gentle agitation.  
Then the mixture (30µl) was transferred to both chambers of a haemocytometer (Weber 
Scientific International, Teddington, UK). Total live cells were counted in the 1mm centre 
square as viewed under the microscope (Magnification10x; Olympus, Japan). The count was 
repeated twice. The volume of each square of the haemocytometer with a cover slip in place 
represents a total volume of 0.1mm
3
. The viable cells actively excluded the dye whereas dead 
cells absorbed the dye and were visible as blue in colour.  
 
The viable cell density was determined as follows: 
Cell density (per ml) = average count per square x dilution factor x 10
4 
 
2.3.3   Hypobaric and normobaric oxygen chamber for cell culture 
As described in the general introduction, there are various methods available to model hypoxia, 
however, in this thesis; a cost effective and reproducible system was preferred. To determine 
consistent hypoxia conditions in the chamber, the system was optimised and then validated 
routinely. 
 
2.3.3.1 Chamber design and optimisation 
A hypoxic or normoxic environment was established inside a special metal (wall thickness 4mm, 
length 25cm, area of the cylinder 125cm
2
) chamber (McIntosh and Fildes, USA) using  premixed 
gases (2% O2+98% N2, 10% O2+90% N2 and 21% O2 +79% N2; BOC, UK).  
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Two metal chambers were mounted inside a commercially available incubator (BioRad, UK) at 
37°C. The chambers have airtight lids which are fitted with gas inlet and outlet ports. A screw 
was fitted to each gas inlet and outlet ports to control the gas flow and perfusion into the 
chamber (Figure 2.1). The medium was replaced and reagents were added by opening the door 
at the front of the main incubator. 
 
 
Figure 2.1  Complete hypoxia chamber 
Complete hypoxia chamber set up in a climate incubator at 37ºC. 
 
 
A thermometer was set up inside the incubator to allow monitoring of the internal temperature. 
The chambers and apparatus were maintained at 37ºC during hypoxia or normoxia. To create 
humidified conditions in the chamber, a small water tray was placed at the bottom of each 
chamber and the cell culture plate holder was constructed top of it (Figure 2.2A). The gas inlet 
was externally fixed with gas tubing (4mm diameter, BOC, UK) which was connected to the 
appropriate hypoxic (2% or 10% oxygen + balanced nitrogen) or normoxic (21% oxygen + 79% 
nitrogen) gas cylinder.  
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The main gas flow into the chamber was controlled by a flow meter (BOC, UK). It was 
connected between the chamber and premixed gas cylinder. Premixed gas was allowed to flow 
through a sterile filter (0.2µМ, Millipore, UK) after passing the flow meter. Through the inlet, 
premixed gas at 25ml/min flow rate was allowed to enter the airspace (3L) of the chamber 
(Figure 2.2A and 2.2B). Gas exited through the outlet at same flow rate and prevented the 
pressure build-up or backflow of air. 
 
 (A) 
  
 
 
 (B) 
 
 
Figure 2.2  Hypoxic gas chamber  
(A) Inside chamber view, (B) View of full incubator system. 
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2.3.3.2 Hypoxic/normoxic medium preparation 
Cells were maintained in preincubated hypoxic or normoxic Dulbecco’s modified Eagle’s 
medium (Phenol red-free DMEM) which was supplemented with 25mM HEPES (4- (2-
hydroxyethyl) -1-piperazine ethanesulfonic acid), 1% penicillin/streptomycin. Prior to hypoxia 
or normoxia experiments, the medium was preincubated for 24h in hypoxia (2% O2 + 98% N2 or 
10% O2 + 90% N2) and for control experiments in normoxia (21% O2 + 79% N2) (BOC, UK). To 
assess the stability of pH value throughout the hypoxia or normoxia, a sample of each 
preincubated medium was measured for pH using the pH probe (Appleton Wood, UK).  
 
2.3.4 Winkler Test for dissolved oxygen in the medium 
To measure oxygen tension, there are wide range of oxygen electrodes or probes available in the 
market, however, they require larger volumes than available in  culture medium (1ml) in a well, 
therefore, the Winkler assay was routinely employed to measure dissolved oxygen concentration 
in culture medium as previously described (Grant and Griffiths, 2007; Helm et al., 2009) . 
 
2.3.4.1 Method 
The Winkler test was used to determine the level of dissolved oxygen in culture medium under 
hypoxia or normoxia. This method was adapted from Winkler, 1888. After pre-equilibrating the 
medium at 37°C in various oxygen tensions (2%, 10%, 21% O2) for 24h, the dissolved oxygen 
level in each sample (1ml) from the flasks (75cm
2
) was measured by addition of manganese II 
sulphate (40 μl, 48%, w/v). The mixture was swirled gently to minimise the risk of incorporation 
of air into the sample. Then potassium iodide (80 μl, 15% w/v, dissolved in 70%, w/v, potassium 
hydroxide) was added to yield a pinkish-brown manganese hydroxide precipitate. Sulphuric acid 
(120 μl, 50% w/v) was added to dissolve the precipitate and the sample was allowed to stand for 
2min. Starch solution (400µl, 0.1% w/v) was added, turning the solution blue due to formation of 
iodine–starch complex.  
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Sodium thiosulphate (0.31% w/v) was titrated into this solution, with swirling, until the solution 
turned colourless. The dissolved oxygen level is proportional to the volume of sodium 
thiosulphate titrated. The addition of 1 ml sodium thiosulphate is equivalent to 
10 mg dissolved oxygen/l. To verify that the dissolved oxygen level at different oxygen tensions 
did not change over the experimental period, the test was repeated again after 30min, 1h and 4h 
of hypoxia / normoxia. The partial oxygen pressure inside the medium (pO2) was calculated 
using dissolved oxygen concentrations in the following formula (Figure 2.3); the dissolved 
oxygen concentration in medium at 1atm under ambient conditions is considered as 6.00mg/L as 
previously described by Grant and Griffiths (2007). 
 
 
 
               Figure 2.3  Formula for partial gas pressure calculations  
                               (Mortimer, 1956; www. waterontheweb.org). 
 
 
2.3.5 Modification of cell culture plate lid 
The standard culture plate lids were modified before experimentation. The plate lid of each cell 
microtiter plate (24 and 96 well) was perforated with 2mm diameter holes using a heated (red-
hot) needle (2mm width x 4cm length). The holes were pierced in the centre of each culture well.  
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The holes in each plate lid were externally sealed by gas-impermeable adhesive strips (Appleton 
Wood, UK). Each hole can be opened by lifting the adhesive strip for addition of redox sensitive 
dyes or inhibitors/drugs. This technique was adapted to prevent the incorporation of external air 
into the culture medium when plates were removed from the chamber for manipulation (Figure 
2.4). 
 
 
Figure 2.4  Modification of culture plate lid 
Culture plates were modified with holes for probe additions. 
 
 
2.3.6 Determination of cell viability 
There are several methods available to determine cell viability. Most available methods are 
based either on metabolic activity or cell membrane integrity of viable cells. In general, 
metabolic activity is measured in terms of metabolically active mitochondrial reductases and 
their oxidation with tetrazolium salts which is cleaved into a coloured formazan product (e.g. 
MTT, MTS, XTT and WST-1 colorimetric assays). This method can therefore be used to 
measure cytotoxicity, proliferation or activation of cells or tissues. As previously explained the 
mitochondrion is strongly implicated in hypoxia-induced redox changes through the electron 
transport system. Therefore, the MTT (3- (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium) 
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assay was used to assess cell viability in terms of metabolically active mitochondria after 
exposure to hypoxia. The MTT assay is technically convenient, no washing steps are required 
and it is easy to apply in most experimental designs. The main advantages of the MTT assay are 
rapidity and precision, and the lack of any radioisotope use. The ATP levels of cells are also 
analyzed to estimate the cellular energy capacity and thus viability. Therefore, CellTiter-Glo 
luminescent assay (Promega, UK) was employed to assess cellular ATP levels during hypoxia. 
The CellTiter-Glo® Luminescent Cell Viability Assay is a homogeneous method to determine 
the quantitation of the ATP present in metabolically active cells. In principle, mono-oxygenation 
of luciferin is catalyzed by luciferase in the presence of Mg
2+
, ATP and molecular oxygen 
(Figure 2.5). Therefore, the generation of a luminescent signal is directly proportional to the 
amount of ATP present in metabolically active cells. The Cell-Titer-Glo luminescent assay is 
easy to use directly in experiments model as cell washing, removal of medium or multiple 
pipetting steps are not required. 
 
 
 
Figure 2.5  The luciferase reaction. Mono-oxygenation of luciferin is catalyzed by luciferase  
in the presence of Mg
2+,
 ATP and molecular oxygen, taken from www.promega.com. 
 
 
2.3.6.1 MTT assay 
Cardiomyoblast viability was determined using an MTT (3-[4, 5-dimethylthiazol-2-yl] - 2, 5 
diphenyltetrazolium) assay based on the reduction of 3-[4, 5-dimethylthiazol-2-yl] - 2, 5 
diphenyltetrazolium bromide by mitochondrial reductases [succinate dehydrogenase] in viable 
cells to insoluble violet formazan crystals, which are solubilised by the addition of a detergent 
solution.  
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Then, the colour can be quantified by a spectrophotometer (van de Loosdrecht et al., 1994). Cells 
were seeded at a density of 3 x 10
4
 cells/well (1ml) in DMEM in 24 well flat-bottomed 
microtiter plates. Cells were grown at 37 °C in a humidified atmosphere of 5% CO2 and 95% air 
until they reached to 80-90% confluence. One hour prior to the completion of each hypoxic 
and/or normoxic period, MTT solution (100µl of 5mg/ml in 0.01M PBS) was added to all wells.  
 
After completing hypoxia or normoxia, lysis buffer (100µl, 20% w/v SDS in 50% DMF, dH2O 
(50%), pH 4.7 adjusted with 2.5% of glacial acetic acid)  was added to each well and incubated 
for a further 16 hours at 37°C  in a humidified atmosphere of 5% CO2 and 95% air. After 
promptly agitating the content of each well, 250µl of the content of each well was transferred to 
a well in 96 well microtiter plate. The formation of formazan was assessed by measuring the 
optical density (OD) at 570nm in the microplate reader (Denley, UK). Cell viability was 
calculated by comparing results to normoxic cells which were considered as 100% viable. The 
MTT assay was employed to measure  hypoxia (2% and 10% O2 + balanced N2) - induced 
reduction in cell viability vs normoxia for 30min,1h, 4h and 24h and hypoxia/reperfusion 
studies. To measure the mitochondrial metabolic activity during hypoxia/reperfusion, MTT was 
added for 2h reperfusion period immediately after hypoxia (30min or 4h). 
 
2.3.6.2 Measurements of ATP 
Cells were seeded at a density of 3x10
4
 cells/well (24-well plate) and when cells reached 80% 
confluence, media was replaced with DMEM/HEPES under different oxygen tensions as 
previously explained. Five minutes prior to completion of hypoxia for 4h, plates were sealed and 
centrifuged at 1300rpm for 5min at room temperature. This step was important to avoid loss of 
any dead or partially dead cells floating in the media. Then, 900µl of media was removed from 
each well and loaded with 100µl of Cell Titer Glo reagent according to manufacturer’s 
instructions  (1:1 ratio for medium to Cell Titer Glo reagent) (Promega, UK).  
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Wells in the absence of cells were also loaded with same volume of Cell Titer Glo reagent for 
background luminescent measurements. The content of each plate was gently mixed to induce 
lysis and then incubated for another 10min to stabilize the luminescent signals. Finally, 
luminescence was recorded at room temperature in Spectramax GEMINI EM plate reader at 
emission: 542nm. 
 
2.3.7 Measurements of ROS/RNS generation 
ROS/RNS generation was measured using four different fluorescent probes, dihydroethidium 
(DHE), 2, 7-dichlorodihydrofluorescein diacetate (DCFH2-DA), dihydrorhodamine (DHR), and 
4, 5-diaminofluorescein diacetate (DAF-2-DA) according to their specificity for particular 
ROS/RNS.  
 
2.3.7.1 Fluorescent probes and preparation 
2.3.7.1.1 Dihydrodroethidium (DHE) 
Dihydroethidium is widely used as O2
•- 
detector in tissues and the assay system was recently 
reviewed (Fernandes et al., 2007; Zhao et al., 2005). This probe has unique specificity towards 
O2
•- 
radical over other radicals in the intracellular environment and oxidation results in a specific 
spectrum that can be measured by a fluorescence detector. Chemically and enzymatically 
generated O2
•- 
can react with DHE to form a fluorescent product that differs from ethidium (E
-
), 
which is a di-electron oxidised product of DHE (Zhao et al., 2005). In contrast, other ROS and 
RNS such as H2O2, 
•
OH, ONOO
-
, and OCl
-
 failed to oxidise DHE to the same product. 
Moreover, Zhao et al. (2005) showed that the reaction of DHE with O2
•- 
and its resultant DNA 
complex produce a different fluorescent spectrum. Zhao et al. (2003) demonstrated that O2
•-
 can 
oxidise with DHE to form 2-OH-DE
+
 as a specific product according their HPLC method 
(Figure 2.6). 
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Figure 2.6   Oxidation of DHE in the presence of O2
•-
, adapted from Zhao et al. (2005); 
Wardman et al. (2007). (+) indicate the inclusion of catalyst or peroxides. Blue colour indicates 
the non-oxidised compound of dye whereas yellow colour indicate the oxidised product of dye. 
 
Further studies suggest the formation of E+ in the presence of O2
•-
; but, this mechanism is not 
known (Zhao et al., 2003).   In contrast to above explanations, DHE can be oxidized by oxidants 
other than O2
•-
,
 
such as H2O2 in the presence of redox-active metal ion, peroxynitrite and 
cytochrome c; but these oxidants do not produce 2-OH-E
+
 (Zhao et al., 2005) and possibly result 
in products with different fluorescent spectra as well.   
DHE is a photosensitive reduced non-fluorescent compound. The photochemically oxidised form 
has a positive charge, so it cannot diffuse into cells. Therefore, DHE is suitable marker for 
intracellular O2
•-
 generation using specific wavelengths for detection that measure 2-OH-DE
+
. 
DHE is freely permeable into cells and rapidly oxidized to fluorescent ethidium in the presence 
of superoxide. Free unoxidised DHE emits blue fluorescence, however, it emits red fluorescence 
when the oxidised ethidium intercalates into cellular DNA. A stock solution (1mg/ml) of DHE 
was prepared in absolute ethanol. Before being stored at -20°C, the stock solution was purged in 
nitrogen to avoid air oxidation. Aliquots of 4mM working solutions were made in ethanol and 
purged in nitrogen again before storage at -20°C. 
     Oxidation 
Non-fluorescent 
O2-• 
Fluorescent 
Excitation; 488 nm Emission; 570nm 
DHE 
Dihydroethidium 
2-OH-DE
+ 
2-hydroxyethidium 
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2.3.7.1.2   2, 7- dichlorofluorescein diacetate (DCFH2-DA) 
DCFH2-DA is the most common probe in in vitro biological research. The oxidation of the probe 
is described below (Figure 2.7). DCFH2-DA has a very low reactivity toward superoxide 
radicals and hydrogen peroxide. However, in the presence of a catalyst, reaction of H2O2 can be 
achieved in the cytosol. Recent reports suggest that DCFH2-DA fluorescence is much more 
likely due to cytosolic redox change as it cannot get into mitochondria (Abramov et al., 2007). 
DCFH2-DA can exhibit subject background fluorescence due to metal impurities in culture 
media. DCFH2-DA can also be oxidised by peroxyradicals in the presence of catalyst and can be 
directly oxidized by ONOO
- 
without the catalyst (Figure 2.7). 
 
                                        
Figure: 2.7  Oxidation of DCFH2-DA in the presence of H2O2 and ONOO
-
. (+) indicate the 
inclusion of catalyst or peroxides. Blue colour indicates the non-oxidised compound of dye 
whereas yellow colour indicate the oxidised product of dye (Wardman et al., 2007; Tarpey et al., 
2004). 
 
DCFH2-DA is oxidised in the presence of intracellular reactive oxygen species such as H2O2, 
peroxy radicals and peroxynitrite (Royall and Ischiropoulos, 1993a). DCFH2-DA is used to 
assess cytosolic based ROS/RNS.  
DCFH2-DA 
2, 7-dichlorodihydrofluorescein 
non-fluorescent 
DCF  
2, 7-dichlorofluorescein  
fluorescent 
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       Oxidation   
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H 
COO
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CATALYST 
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A stock solution (1mg/ml) of DCFH2-DA was prepared in dimethylsulfoxide (DMSO) and 
stored at -20°C after purging with nitrogen. Aliquots of 4mM working solutions were made in 
DMSO and stored at -20°C. Aliquots were purged in nitrogen in the dark to avoid air oxidation. 
 
2.3.7.1.3 Dihydrorhodamine 123 (DHR) 
Dihydrorhodamine (DHR) is cell–membrane permeant, mitochondrially retained-fluorescent 
(Tarpey et al., 2004) and lipophilic (Crow, 1997), uncharged (Royall and Ischiropoulos, 1993a) 
probe that is often used to detect ROS and RNS in cells via oxidation to the respective 
fluorescent product. The oxidised fluorescence can be easily determined or typically monitored 
in a continuous assay system using a fluorometer at emission fluorescence; 525nm following 
excitation; 488nm (Henderson and Chappell, 1993). It has been widely used as a stain for 
mitochondria (Royall and Ischiropoulos, 1993) and possesses the aforementioned properties with 
intracellular fluorescence stability up to 1h. However, it is not mono-specific. DHR has an 
ability to enter mitochondria and be oxidised to fluorescent rhodamine in the presence of 
ROS/RNS (Frantseva et al., 2001; Henderson and Chappell, 1993). The oxidised rhodamine 
partitions over time to mitochondria due to their large inside-negative transmembrane potentials 
(Emaus et al., 1986).  
 
DHR is not oxidised by superoxide or H2O2 alone requiring a cofactor such as heme containing 
peroxidase (HRP) or cellular peroxidases (Hempel et al, 1999; Henderson and Chapell et al., 
1999) but can react directly with ONOO
-
 (Henderson and Chappell, 1993) (Figure 2.8). 
Therefore the quantitative estimation of intracellular H2O2 is questionable as it is mediated 
through secondary reactions. However, qualitative conclusions may be made. Several other cell 
derived oxidants such as ONOO
-
, but not 
•
NO or OCl
-
 can directly oxidise DHR. The spectrum 
of oxidised rhodamine is the same, regardless of the oxidizing agent (Tarpey and Fridovich, 
2001). 
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Figure 2.8  The oxidation of DHR in the presence of H2O2 and ONOO
-
, adapted from  
Wardman et al. (2007) and Royall and Ischiropoulos et al. (1993). (+) indicate the inclusion 
of catalyst or peroxides. Blue colour indicates the non-oxidised compound of dye whereas 
yellow colour indicate the oxidised product of dye. 
 
DHR is a cell-membrane permeant, mitochondrially retained-fluorescent and lipophilic dye; the  
uncharged (Kooy et al., 1994) probe is also used to detect ROS/RNS such as H2O2, HOCl and 
peroxynitrite in cells and after oxidation is converted to a highly fluorescent form of rhodamine 
(Royall and Ischiropoulos, 1993a). However, it is used to assess mitochondrial based ROS/RNS. 
A stock solution (1mg/ml) of DHR was prepared in DMSO in the dark and stored in -20°C after 
purging with nitrogen. Aliquots of 4mM working solutions were prepared in DMSO and stored 
in -20°C. Aliquots were purged in nitrogen to avoid air oxidation. 
 
2.3.7.1.4   4, 5 - Diaminofluorescein diacetate (DAF-2-DA) 
The quantification of 
•
NO generation during hypoxia/reperfusion either by mitochondrial NOS 
or by constitutive cytosolic isoforms is challenging due to low levels of accumulation at early 
stages.  
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The ideal method for 
•
NO detection in hypoxia-reperfusion should be able to detect low levels of 
intracellular 
•
NO and with minimum autoxidation in a cellular system (Kojima et al. 1998) 
reported NO-specific oxidation of DAF-2-DA. DAF-2-DA is a non-fluorescent cell permeable 
reagent that can measure intracellular 
•
NO and nitric oxide synthase (NOS) activity in tissues 
and assay systems. When the probe enters into the cytosol, diacetate groups on the DAF-2-DA 
reagent are hydrolyzed by cytoplasmic esterases and released DAF-2 is sequestered inside the 
cell. 
•
NO oxidises the non-fluorescent dye (DAF-2) to a triazole fluorescent derivative (DAF-2T) 
in the presence of O2 which can be maximally detected at ex: 491nm and em: 513nm (Figure 
2.9). A 4mM solution of DAF-2-DA was prepared in 0.01M NaOH solution and purged with 
nitrogen to avoid air oxidation. Aliquots of 4mM working solutions were stored in the dark at 
room temperature. 
Figure 2.9 The oxidation of DAF-2-DA in the presence of 
•
NO, adapted from Kojima et al. 
(1998); Wardman et al. (2007). (+) indicate the inclusion of catalyst or peroxides. Blue colour 
indicates the non-oxidised compound of dye whereas yellow colour indicate the oxidised product 
of dye. 
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2.3.8   Optimisation of incubation time points for fluorescent probes 
H9C2 rat myoblasts were seeded at 3x10
4
cells/well (1ml) in 24 well plates and cultured for 48h 
in DMEM, 10% FBS, 4mM L-glutamine and 1% penicillin / streptomycin  at 37°C in 5% CO2 
humidified atmosphere. Then, cells were briefly washed three times with PBS and loaded with 
DMEM (25mM HEPES, 1% penicillin, 1% streptomycin, phenol red free), preincubated for 24h 
at 21% oxygen + 79% N2. For time-dependent measurements of probe oxidation (15min, 20min, 
45min and 1h), cells were treated with fluorescent probes at time t=0 and incubated further for 
15min, 30min, 45min and 1h. The media in the wells was replaced with fresh preincubated 
DMEM (at 21% O2 for 24h). At t=60min, the fluorescence was measured at 37˚C in preheated 
Spectramax GEMINI EM fluorescence plate reader at particular excitation and emission 
wavelengths (Table: 2.1). 
 
 
Fluorescent probe 
 
Excitation 
 
Emission 
 
Cut off filter 
DHE 
1,2,4
 488nm 570nm 560nm 
DCFDA 
4,5,6
 488nm 520nm 515nm 
DHR 
4,5,6
 488nm 520nm 515nm 
DAF-2-DA
3,5
 491nm 513nm 495nm 
 
Table 2.1  Excitation, and emission maxima of fluorescent probes.  
(
1
Zhou et al., 2002; 
2
Zhou et al., 2005; 
3
Kojima et al., 1998; 
4
Royall and Ischiropoulos, 1993a; 
5
Tarpey and Fridovich, 2001; 
6
Tarpey et al., 2004). 
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2.3.9 Using the hypoxia chamber to induce and measure ROS/RNS  
H9C2 rat myoblasts were seeded at 3x10
4
cells/well (1ml) in 24 well plates and cultured for 48h 
in DMEM, 10% FBS, 4mM L-glutamine and 1% penicillin / streptomycin  at 37°C in 5% CO2 
humidified atmosphere. Then, cells at 80% confluence were washed three times with PBS 
solution and loaded with preincubated DMEM (phenol red-free, 25mM HEPES, 10% FBS, 1% 
penicillin / streptomycin, pH 7.4). 
 
In the experimental cells, severe hypoxia ( 2% O2 ) was induced by removing any existing media 
and replacing it with DMEM, preincubated for 24h at 2% oxygen + 98% nitrogen whereas mild 
hypoxia (10% O2) was induced by removing any existing media and replacing it with DMEM, 
preincubated for 24h at 10% oxygen + 90% nitrogen. Control cells were exposed to normoxia by 
adding DMEM preincubated for 24h at 21% oxygen +79% nitrogen. Before cells were loaded 
with preincubated medium at specific oxygen tensions, the dissolved oxygen level was measured 
using the Winkler test to verify the extent of hypoxia or normoxia in the medium.  The pH value 
of each preincubated medium was also determined to ensure physiological homeostasis (pH 7.4).
           
(+) pre-equilibrated medium                                                   Fluorescent measurement             
 Preincubation (24h)                                                                         (-) medium   
                3min                                 24min                                   3min 
   (+)  
Medium        Cells ± probe          (+) pre-equilibrated  
Gas f low rate 25ml/min                                                                                               Fresh medium and 
                                     Gas flow rate 2L/min          without probe 
               Gas flow rate 25ml/min 
Figure 2.10  Schematic diagram showing experimental design for fluorescent 
                                  measurements; acute hypoxia (30min). 
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After loading hypoxic medium, the plate was briefly flushed with premixed, sterile-filtered gas 
of specific O2 tension before it was covered with a lid. Plates were then transferred into a pre-
equilibrated hypoxic/normoxic chamber. To flush out any entrapped air inside the chamber, the 
airspace was perfused with premixed gas at a higher flow rate (2000ml/min) for 5min. During 
this procedure, the chamber’s gas outlet was fully unscrewed to prevent the build up of pressure. 
This technique was applied for all experimental treatments and controls. All four ROS/RNS-
sensitive probes were studied in a single culture plate for each experiment and control. 
 
2.3.9.1 ROS/RNS generation measured during hypoxia for 30min, 1h and 4h 
H9C2 rat myoblasts were seeded at 3x10
4
cells/well (1ml)  in 24 well plates and cultured for 48h 
in DMEM, 10% FBS, 4mM L-glutamine and 1% penicillin / streptomycin  at 37ºC in 5% CO2 
humidified atmosphere. Then, cells were washed three times with PBS and replaced with 
DMEM (1ml/well) which was preincubated at 2% or 10% O2 + balanced with nitrogen for 24h. 
Control cells were treated with DMEM preincubated at 21% O2 + balanced with N2. Then, the 
plate surface was briefly flushed with the gas at the appropriate O2 tension and immediately 
placed in the chamber shown in figure 2.1 at specific O2 tension. The fluorescent probes (5µl, 
4mM DHE or 2mM DAF-2-DA) were immediately added into wells through the holes in the lid 
by lifting the adhesive strips and gently mixed. Then, the plate was placed inside pre-equilibrated 
(hypoxia/normoxia) chamber and the plate sealant strip (Appletonwood, UK) was removed. The 
chamber was flushed with premixed gas at a higher flow rate (2000ml/min) for 3min. Then, the 
flow rate was immediately reduced to 25ml/min.  
 
The plate was taken out and medium was replaced gently with DMEM (preincubated at specific 
O2 tension) at t=27min before completing the 30min hypoxia. This step minimised the 
fluorescence due to spontaneous oxidation of the probe in the medium. At t=30min, fluorescence 
in each well was read in a preheated (37ºC) Spectramax fluorescence plate reader (Molecular 
Devices, USA) at specific excitation and emission wavelengths shown in table 2.1.  
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To measure the ROS/RNS generation in 30min normoxia (control), the same procedure was 
followed using premixed normoxic gas (21% oxygen balanced with nitrogen) (Figure 2.10). For 
1h or 4h experiments, the procedure of cell exposure and equilibration at specific oxygen tension 
was  repeated as described previously except that probes were added at t=30min for 1h 
experiment and t=3h 15min for 4h experiment, and then extracellular dye removed at 3min 
before the completion of the hypoxic period and replaced with fresh medium. 
 
2.3.9.2 Measurement of ROS/RNS generation during hypoxia/reperfusion  
For 2h reperfusion studies after hypoxia for 4h, plates were sealed and taken out at t=3h and 
57min and centrifuged at 1000rpm for 3min to avoid any loss of hypoxia induced dead cells. 
Then, existing medium was gently removed and replaced with pre-equilibrated reoxygenated 
medium (21% O2 for 24h). Then, at 45min before measurement (5h 15min) fluorescent probe 
(5μl of DHE or DAF-2-DA) was added into wells through the holes in the plate lid without 
incorporating air as previously explained. Immediately after that, the plate was returned to the 
pre-equilibrated normoxic chamber whilst removing the sealer gently.  
 
The chamber was again flushed with premixed normoxic gas at a higher flow rate (2000ml/min) 
for 3min and immediately decreased to 25ml/min. Reoxygenation was allowed for 2h. After 1h 
and 57min of reoxygenation, or at t= 5h and 57 min of total experiment duration, cell culture 
plates were taken out and the medium replaced with preincubated normoxic medium and the 
fluorescence was read at 37ºC, in a preheated fluorescence reader. For 30min hypoxia and 1h 
reperfusion studies, the same procedure was employed with media replacement after hypoxia 
and again at 3 min prior to termination of the experiment. After each experiment of hypoxia-
reoxygenation, cell number was estimated by protein quantification. After fluorescent 
measurements, cell plates were centrifuged at 400g for 5min and then supernatant was carefully 
discarded without dislodging the pellet. Then, cells were lysed using 2% Triton and used for 
protein quantification by BCA assay.  
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Fluorescence in each well was calculated in arbitrary fluorescent units per 1mg of total protein in 
order to minimise the effect of cell density on fluorescence after hypoxia and reoxygenation. 
 
2.3.10 Live imaging of O2
-•
 or 
•
NO generating cells under confocal microscopy 
Superoxide production by H9C2 cells during hypoxia was assayed using DHE (Molecular 
Probes, UK), a red fluorescent probe for in vivo superoxide detection, and imaged with a Carl 
Zeiss LSM 700 confocal microscope (Germany). At t=0min and t=3h15min for 30min and 4h 
experiments respectively, 20µM DHE was added to cells cultured in microscopic chambers and 
previously exposed to control (21% O2), mild (10% O2) and severe (2% O2) hypoxia for 30min 
and 4h in the hypobaric chamber at 37 ºC. Hypoxic conditions were maintained at the time of 
imaging, by keeping chambers sealed from ambient air.  
 
The 488nm argon laser line was used to excite DHE, which was measured by fluorescence 
emission using a band pass filter from 570-590nm (Zhao et al, 2005). Same procedure was 
applied for intracellular 
•
NO detection during hypoxia using DAF-2-DA fluorescent probe 
(Excitation: 480-490nm and emission: 510-520nm). Illumination intensity was set up at a 
minimum (0.1-0.2% of laser output) to avoid photooxidation and the pinhole set to give the 
optical beam at 2nm. Each experiment was undertaken using by at least 3 independent chamber 
wells. 
 
2.3.11 Inhibitor effects on ROS/RNS generation and cell death 
Inhibitors/antioxidants were used to assess ROS generation in H9C2 cardiomyoblasts during 
hypoxia/reoxygenation and the effects on cell viability. Inhibitors used were rotenone 
(C23H22O6), FCCP (carbonyl
 
cyanide p-(trifluoromethoxy)-phenylhydrazone), apocynin (4'-
hydroxy-3'-methoxy-acetophenone), allopurinoland L-NAME(N
G
-nitro-L-arginine methylester).  
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2.3.11.1 Rotenone  
Rotenone is a potent mitochondrial complex I inhibitor which specifically inhibits the NADH 
dehydrogenase. Rotenone at higher concentrations is also widely utilised as an insecticide or 
pesticide in the agriculture industry. It is a naturally occurring compound extracted from the root 
of Derris sp. A stock solution of rotenone (4mM) was prepared in DMSO and stored in the dark 
at room temperature (Dawson et al., 1986). 
 
2.3.11.2 Apocynin  
Apocynin is a selective, potent inhibitor of phagocyte NADPH oxidase, preventing production of 
superoxide by blocking the migration of p47 phox to membrane which is required for formation 
of a functional NADPH complex (Touyz, 2008; Stolk et al., 1994b). However, apocynin is 
widely considered as a more specific NADPH oxidase inhibitor than DPI, a potent flavoprotein 
inhibitor or a non-specific inhibitor for NADPH oxidase, but commonly used as a NOX inhibitor 
(Bedard and Krause, 2007). Apocynin is a naturally occurring botanical compound which 
isolated from Picrorhiza kurroa (Stolk et al., 1994a). A stock solution of apocynin (4mM) was 
prepared dissolving in DMSO and stored at room temperature in dark. 
 
2.3.11.3 FCCP  
FCCP, a potent uncoupler of oxidative phosphorylation, was
 
selected for these studies because it 
has been used extensively to induce uncoupling of mitochondrial oxidative phosphorylation
 
in 
many cell types, including cardiac myocytes (Hool and Arthur, 2002). It is a hydrophobic weak 
acid and it can readily diffuse across the mitochondrial membrane. The mode of action of FCCP 
in the inner mitochondrial membrane is unknown. The stock solution of FCCP (4mM) was 
prepared in DMSO and stored at 4˚C in the dark. The 200µM diluted aliquots (100µl) were 
employed as working solutions in experiments. 
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2.3.11.4 L-NAME 
L-NAME is known as potent NO synthase inhibitor. Its function is not selective between 
different types of 
•
NO synthases. A stock solution (40mM) of L-NAME was prepared freshly in 
Milli Q (MQ) water and used each day.  
 
2.3.12 Cell treatment with inhibitors 
Cells at 3x10
4
/well (1ml) were seeded into 24 well plates and allowed to grow to 80% 
confluence over 2-3 days under standard conditions (section: 2.3.1.2). Hypoxia was induced for 
varying times (30min-4h) by replacing medium with fresh medium which had been pre-
incubated for 24h at 2%, 10% or 21% oxygen and then transferring cells to hypoxic chambers 
flushed with gas (5ml/min) of the same oxygen tension (section: 2.3.9.1). 
 
In order to determine the generation and effects of specific ROS/RNS, before initiation of 
hypoxia for 30min or 4h duration and before initiation of reperfusion for 2h after 4h hypoxia, 
cells were treated with an appropriate inhibitor; 20µM rotenone, 20µM apocynin, 1µM FCCP 
and 200µM L-NAME at t=-2min before induction of hypoxia or hypoxia/reperfusion and 
inhibitors remained throughout the hypoxic/normoxic/reperfusion period. Control cells received 
an equal volume of vehicle and were exposed to hypoxia or normoxia for 30min and 4h as 
appropriate. 
 
2.3.13 Nuclear morphology of necrotic and apoptotic cell death 
Nuclear morphological changes were assessed in H9C2 cells after exposure to hypoxia using the 
fluorescent nuclear binding dye Hoechst 33342 (Calbiochem,UK) which binds to the minor 
groove and stains DNA blue after entering into damaged or viable H9C2 cells. Therefore, 
Hoechst 33342 stains the condensed chromatin of apoptotic cells more brightly than the 
chromatin in normal viable cells.  
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PI or 7-AAD can be used to discriminate late apoptotic or necrotic cells which have lost 
membrane integrity from early apoptotic cells which still have intact membranes by dye 
exclusion. Therefore, propidium iodide (Sigma-Aldrich, UK) was used and it binds and stains 
DNA red only in necrotic and late apoptotic cell where PI cannot enter into cells with preserved 
membrane integrity. Necrotic cells have round nuclei with red fluorescence, whereas round 
nuclei of viable cells are stained only with Hoechst 33342 blue fluorescence (Shimizu et al., 
1996) (Table 2.2). 
 
 
Conditions 
 
PI staining 
 
Hoescht 33342 staining 
 
Viable 
 
Nuclei not stained 
 
Round nuclei 
 
Necrosis 
 
Round nuclei stained 
 
Round nuclei 
 
Early apoptosis 
 
Nuclei not stained 
 
Fragmented nuclei 
 
Late apoptosis (secondary 
necrosis) 
 
Fragmented nuclei stained 
 
Fragmented nuclei 
 
Table 2.2  Mode of cell death defined by fluorescence staining (Shimizu et al., 1996). 
 
2.3.13.1 Method of staining apoptotic or necrotic cells 
Immediately after hypoxia or control treatments (30min and 4h) in the presence or absence of 
ROS scavengers/inhibitors, cells grown on cover slips were washed with PBS and treated with 
PI + Hoechst (10ng/ml, 20min). After 3x washing cells with PBS, they were then fixed in 4% 
paraformaldehyde. Following further 2x washing with PBS, nuclear/DNA morphology was 
visualised under a ZEISS (Carl Zeiss, Germany) fluorescence microscope according to 
manufacturer’s instructions.  
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Late apoptotic cells were detected by chromatin condensation and nuclear fragmentation 
(positive PI) but not early apoptotic cells (negative PI), whereas necrotic cells were detected as 
intact round nuclei (positive PI) (Levrand et al., 2006; Shimizu et al., 1996) (Table 2.2). 
 
2.3.14 Quantification of necrotic cells 
Quantitative necrotic cell death was measured as a ratio of PI to Hoechst staining considering the 
uptake of PI into necrotic dead cell DNA and Hoechst 33342 (Calbiochem, UK) uptakes into 
DNA of dead cells and viable cells. Cells were grown in 24-well culture plates until 80-95% 
confluency. Then cells were washed with 3x PBS and exposed to different hypoxia conditions 
and time periods. After hypoxia exposure, culture medium and cells were removed and 
centrifuged to make a pellet at 400g for 3min at room temperature. Then cells were suspended in 
10µg/ml PI for 20min at 4ºC and after 3xPBS washing, exposed to 10µg/ml Hoechst 33342 for 
20min at 4ºC. Finally, cells were suspended in PBS and dual-fluorescence was measured by 
excitation at 535nm/emission at 617nm for PI and excitation at 346nm/emission at 460nm for 
Hoechst 33342. 
 
2.3.15 Protein carbonyl ELISA 
Protein carbonyl formation during hypoxia is an indicative measure of protein oxidation induced 
by hypoxia. The quantity of protein carbonyls can be determined by derivatising with 
dinitrophenylhydrazine (DNPH) and quantifying bound DNP using a colorimetric or 
immunological method. The ELISA method is more sensitive and discriminatory than 
colorimetric methods and also can be used with microgram quantities of protein lysate.  
The quantity of protein carbonyls in each protein sample is determined by comparing its 
absorbance with that of a known reduced/oxidized BSA standard curve.Proteins are non-
specifically adsorbed to the plate wells. Proteins are then derivatised with DNPH. During the 
washing step, unconjugated DNPH is washed away.  
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Then adsorbed proteins are probed with anti-DNP primary antibody followed by HRP-
conjugated secondary antibody. Proteins for the standard curve are prepared by oxidising serum 
albumin samples with and calibrating their carbonyl content by the colorimetric method (Carty et 
al., 2000). 
 
2.3.15.1 Method 
H9C2 cells were grown at 95% confluence were washed with 3xPBS and loaded with pre 
equilibrated medium at 2% O2, 10% O2 and 21% O2. Then, culture flasks were exposed to 
hypoxia or normoxia for 30min and 4h. After each experiment, cells were incubated with 
protease cocktail inhibitor for 30min at -20ºC prior to lysis in Laemmli buffer. Both carbonyl 
standards and experimental samples were diluted in 50mM sodium carbonate buffer (1.59 g/L 
Na2CO3, 2.93 g/L NaHCO3 and pH 9.2).  
 
Samples (50µl/well) were plated in 96 well plates (Maxisorb, NUNC) and incubated for 1h at 37 
ºC.  Then, wells were washed 3x washing buffer (Tween-20 0.05% v/v in PBS) and with 1mM 
DNPH (2, 4- dinitrophenylhydrazine, 2M HCl) except blank wells and incubated for 1h at room 
temperature in the dark. After that, wells were washed and incubated with blocking agent 
(Tween-20 1% v/v in PBS) overnight at 4 ºC. The following day, sample wells were washed and 
incubated with anti-DNP primary antibody (1:2000 in Tween-20 1% v/v in PBS)   for 2h at 37 
ºC. Samples well were then washed gently and incubated with HRP conjugated-secondary 
antibody (1:5000 in Tween-20 1% v/v in PBS) for 1h. To remove excess secondary antibodies, 
wells were washed gently and loaded with substrate (50µl/well) solution (0.15M sodium citrate 
phosphate, pH5, 2g/L O-Phenylenediamine, 4.4mM H2O2). Following incubation (15min) at 
room temperature in the dark, the colour development reaction was terminated by adding 2M 
H2SO4. Absorbances were finally recorded at 490nm in the microplate reader (Biotek EL800). 
Total protein carbonyl content (nmol/mg) in each sample was quantified against the known 
concentration of standards. 
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2.3.16 Evaluation of apoptosis on the base of cleavage of procaspase-3 
There are several methods available to determine caspase-3 activation during apoptosis. Initially, 
a fluorimetric caspase-3 assay was performed to quantify active caspase-3, but results were poor 
compared to control samples due to low caspase-3 activity under experimental conditions (data 
not shown). However, detection of the cleavage of procaspase-3 was more sensitive to determine 
induction of apoptosis under the conditions used. Therefore, to investigate apoptotic cell death 
during hypoxia, western blot analysis was performed to visualise the cleavage of procaspase-3. 
 
2.3.16.1 Method 
After each period of hypoxia in the presence or absence of inhibitors, cells were trypsinised. 
After 3 x PBS washes, cells were treated with protease inhibitor cocktail (1µl/mg of total 
protein) (P8340, Sigma, UK) for 30min at -20ºC. Then cells were lysed in 2x Laemmli sample 
buffer (5% SDS) and aliquots (100µl) of lysates stored in -20 ºC for subsequent analysis.  
Proteins (20µg) were resolved by 15% Tricine-SDS-PAGE and transferred to polyvinylidene 
fluoride (PVDF) membrane (GE Healthcare, Buckinghamshire, UK) in transfer buffer with an 
ice-pack at 115V, 240mA for 2h prior to blocking overnight at 4 ºC with 5% non-fat dried milk 
powder in Tris-buffered saline containing 0.1% Tween 20 (0.1% TTBS, pH 7.5). The membrane 
was incubated overnight at 4 ºC with an appropriate dilution of anti-procaspase-3 (33kDa for 
complete fragment; Millipore) and anti-cleaved caspase-3 (17- to 19-kDa fragments) (Cell 
Signalling, UK) primary antibodies (1:1000).  
The following day, membranes were washed with 25ml of washing buffer 0.1% TTBS for 8 x 
15min at room temperature. Blots were then incubated for 1h with a 1:20,000 dilution of the 
appropriate horseradish peroxidase-conjugated secondary antibody (Cell Signalling, UK) at 
room temperature and followed by 8 x 15min washes with 0.1% TTBS at room temperature.  
The immunoblot signal was visualized by incubating PVDF membranes using enhanced 
chemiluminescence (GE Healthcare, Buckinghamshire, UK) mixed solution according 
manufacturer’s instructions and then exposed to X-ray film (GE Healthcare, Buckinghamshire, 
UK) for 45 seconds in a dark room.  
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The film was developed and fixed gently using developer and fixer solutions (Kodak Chemicals, 
Japan). Finally, films were washed with copious amounts of water for 3min and air dried. 
 
2.3.17 Quantification of total protein content in cell lysate 
2.3.17.1 RC-DC assay 
The RC-DC (Bio Rad, USA) protein assay was used to quantify total protein content of samples 
after cells are lysed into Laemmli buffer. The RC-DC assay is a colorimetric assay which is 
compatible with complex mixtures such as Laemmli buffer which contain both reducing agents 
and detergents. Also this assay is sensitive for wide range (0.2-1.5mg/ml) of protein 
concentrations. This assay is based on a modification of Lowry method of protein estimation. 
Peptide bonds in protein sample initially form complexes with Cu
2+
 ions and then reduce to Cu
1+
 
ions under alkaline conditions. Then this Cu
1+
 ion reacts with tyrosine, tryptophan and cysteine 
amino groups in the presence of Folin reagent to produce an unstable product. This unstable 
product is then reduced to tungsten blue and detected at 630nm using spectrophotometer (Lowry 
et al., 1951). 
 
2.3.17.1.1 Method 
H9C2 cardiomyoblasts were seeded at a density of 3 x10
4
 cells/well and cultured at 37°C in a 
5% CO2 humidified atmosphere in DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin mixtures. At 80-90% confluence, hypoxia was induced for varying times 
(30min-4h) in the presence or absence of inhibitors by replacing medium with fresh medium 
which had been pre-incubated for 24h at 2%, 10% or 21% oxygen and then transferring cells to 
hypoxic chambers flushed with gas (5ml/min) of the same oxygen tension. After the hypoxic 
period was completed, cell metabolism was inhibited by incubation on ice for 20min and cells 
were washed twice in ice cold 0.15M PBS. Cells were harvested by scraping. 1ml of boiled 2 x 
Laemmli buffer (63mM Tris HCl, 4mM Na2P2O7, 5mM EDTA, 41% Glycerol v/v, 2% SDS w/v, 
0.007% bromophenol blue, pH 6.8) and 100µl of protease inhibitor cocktail (P8340, Sigma, UK) 
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was added to minimize proteolysis. Genomic DNA was sheared using a 21G needle. The total 
protein extracts were transferred into a microfuge tube. Some aliquots were taken for protein 
estimation, others were diluted in 2 x Laemmli buffer and stored at -20°C for western blot 
analysis. Protein samples (5µl of 2 and 1 fold dilutions) and BSA standards (0, 0.2, 0.4, 0.6, 0.8, 
1.0, 1.2, 1.4 and 1.5 mg/ml in Laemlli buffer) were pipetted into clean, dry microfuge tubes in 
triplicate and 25µl of RC reagent I was added. Samples were vortexed and incubated for 1min at 
room temperature.  
Then, 25µl of RC reagent II was added and samples were vortexed and centrifuged at 15,000xg 
for 5min. The supernatant was discarded by inverting the tubes on clean, absorbent tissue paper 
until the liquid was completely drained. Then, 25µl of reagent A’ (1:50 v/v, DC reagent S to DC 
reagent A) was added to each microfuge tube and samples vortexed and incubated for 5min at 
room temperature or until the precipitate was completely dissolved. After vortexing the samples 
again, each tube was added with 200µl of RC reagent B and vortexed immediately. After 15min 
incubation of samples, the content of each tube (200µl) was transferred to 96 well plates and the 
absorbance detected at 630nm. Protein concentrations were determined by comparison to the 
standard curve. 
 
2.3.17.2 Bicinchoninic acid (BCA) protein assay 
The BCA protein assay was employed to quantify total protein content of samples when cells are 
lysed in culture medium or PBS with 2% Triton. The BCA assay was also adapted from the 
Lowry method (1951) and is based on reduction of Cu
2+
 to Cu
1+
 by proteins under alkaline 
conditions. Then, colorimetric detection of Cu
1+
 is achieved with bicinchoninic (BCA) acid. 
When the assay is performed, initially, Cu
2+ 
chelates with proteins in alkaline sodium potassium 
tartate solution to produce a light blue complex with Cu
1+
.  Second, BCA reacts with the Cu
1+ 
and produces an intense purple-coloured product. Two molecules of BCA react with one 
molecule of Cu
1+
. The coloured BCA/copper complexes are water-soluble and show a sharp 
linear absorbance at 562 nm that is directly proportional to protein concentration in samples.  
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The reaction that leads to BCA/copper colour formation strongly depends on the four different 
amino acid residues; cysteine or cystine, tyrosine, and tryptophan in the protein. Whenever 
required, the BCA assay was used to estimate protein concentrations in the samples as it is 
highly sensitive colorimetric technique. 
 
2.3.17.2.1 Method 
Protein samples (10µl) and bovine serum albumin (BSA) standards (0, 2, 4, 6, 8 and 10 µl of 
BSA diluted with 10, 8, 6, 4, 0 µl of deionised water) were aliquotted into independent wells in 
triplicate. Then, to each well was added 200µl copper sulphate-bicinchoninic acid mix solution 
(1:50 v/v) and the plate was incubated for 30min at 37°C. The absorbances were read at 570nm 
and protein concentrations were determined by comparison to the standard curve. 
 
2.3.18 Cloning of Bacterial Plasmids 
2.3.18.1 Preparation of Luria Bertani (LB) agar plates and LB broth for selection of Clones   
              in E. coli 
LB agar solution (15g/L) was prepared by dissolving 10g of tryptone, 5g of yeast extract, 5g of 
NaCl, (Sigma, UK) in 1000ml of deionised H2O and then transferring the content into a flask 
which contains 15g of LB agar. The solution was autoclaved for 30min at 121°C. Petri dishes 
(15mm) were labelled for each of the three different bacterial plasmids DNA; pGL 3 
[3enh/conA/luc]; pGL 3 [nqo1/luc] and pGL4.74 [hRluc/TK] (Promega, UK); pGL 3 
[3enh/conA/luc] and pGL 3 [nqo1/luc]. Plasmid pGL 3 [3enh/conA/luc] was kindly donated by 
Dr Ann Vernallis (Aston University, UK) and plasmids; pGL4.74 [hRluc/TK] and pGL 3 
[nqo1/luc] were kindly donated by Dr Melissa Grant (University of Birmingham, UK) (plasmid 
maps are shown in Appendix). After autoclaving, LB agar solution was cooled down to 45°C 
and was supplemented with the sterile ampicillin sodium salt (Sigma, UK) solution (100µg/ml).  
Agar plates were prepared by pouring LB agar solution (25ml) into Petri dishes under aseptic 
sterile conditions and any air bubbles were burst if necessary by flaming with a Bunsen burner. 
Plates were allowed to cool and solidify.  
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When plates were completely hardened, they were inverted and stored at 4°C until needed. LB 
broth solution (25g/L) was prepared by mixing 15g of LB agar in 600ml of deionised H2O in a 
sterile Erlenmeyer flask and autoclaved for 30min. After autoclaving and cooling to 45°C, LB 
agar solution was supplemented with the sterile ampicillin sodium salt (Sigma, UK) solution 
(100µg/ml). LB broth solution was stored sterile at 4-8°C. 
 
2.3.18.2 Transformation of E. coli (DH5α) with recombinant plasmids: pGL 3       
               [3enh/conA/luc], pGL 3 [nqo1/luc] and pGL4.74 [hRluc/TK] 
 
Polypropylene culture tubes were chilled on ice, one per single transformation. Frozen DH5α E. 
coli competent cells (Invitrogen, UK) were removed from -70°C and placed on ice for 5min. 
After gently mixing the thawed competent cells by flicking, competent cells (50µl) were 
transferred to each chilled tube and dilutions of cells prepared at 1:10 and 1:100 ratio in LB agar 
solution supplemented with ampicillin. Three transformation reactions; undiluted, 1:10 and 
1:100 were conducted for each plasmid.  
 
Then, 2µl of plasmid DNA was added to each tube and flicked quickly several times. 
Immediately, tubes were equilibrated on ice for 10min. A heat block (Thermo Scientific, UK) 
was set up at 42°C. The cells were heat shocked for 45sec at 42°C exactly and immediately 
placed on ice for 2min. Each tube of transformed cells was diluted with cold sterile LB broth 
(950 µl) and incubated for 1h at 37°C with shaking (9g). After the incubation period, the 
contents of each tube were  transferred into a microfuge tube and centrifuged at 5000g for 3min. 
Cells were plated with undiluted cells, 1:10 and 1:100 diluted cells on independent ampicillin 
treated LB agar plates. Then, plates were inverted and incubated at 37°C for 14-16 hours. 
Throughout the protocol, sterile aseptic conditions were employed to avoid any contamination. 
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2.3.18.3 Starting culture for DNA preparation by Maxiprep 
In order to prepare a starter culture for Maxiprep DNA extraction, a single colony of E. coli 
(DH5α) was carefully selected from a freshly grown (14-16h) selective culture using a sterile 
pipette tip. The LB broth medium (5ml, 100µg/ml ampicillin) was inoculated with one selected 
bacterial colony and incubated overnight with shaking (~16g) at 37°C. The following day, 
bacterial suspensions (1.5ml) were transferred to sterile 1.5ml eppendorf tubes and centrifuged at 
13,000xg for 5min to harvest the bacteria. After discarding the supernatant, the bacterial cell 
pellet was resuspended in fresh LB broth (1ml). For Maxipreps, a large flask of LB broth 
(400ml, 100µg/ml ampicillin) was inoculated with LB broth (1ml) containing bacterial cells and 
incubated overnight with shaking at 37°C. 
 
2.3.18.4 Maxiprep of bacterial plasmid DNA 
Large scale purification of plasmid DNA was performed by using a Marligen Maxiprep Kit 
(Marligen, USA) according to the manufacturer’s instructions. The column was equilibrated by 
adding 30ml of equilibration buffer and solution to the column and it was allowed to run through 
by gravity flow. Meanwhile, bacterial cells from 400ml of an overnight culture were harvested 
by centrifugation at 4480g for 10min at room temperature. The cell pellets were resuspended in 
cell suspension buffer (10ml) containing RNase A until the cell pellet was homogeneous. Cell 
suspension was added to cell lysis buffer (10ml) and mixed gently by inverting the capped tube 
five times and incubating at room temperature for exactly 5min. 
To the mixture, neutralization buffer was added (10ml) and mixed immediately by inverting until 
the solution was homogeneous. The mixture was centrifuged at 15,000g at room temperature for 
10min. Then, the equilibrated column was loaded with supernatant and the eluent/buffer in the 
column was allowed to drain by gravity. The column was washed with wash buffer (60ml). In all 
steps, column flowthrough was discarded. DNA was eluted by adding 15ml of elution buffer to 
the column and flowthrough was collected into clean polypropylene tubes. Isopropanol 10.5ml 
was added to the evaluate and mixed, then, centrifuged at 15,000g at 4°C for 30min.  
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Supernatant was discarded and the plasmid DNA pellet was washed with 5ml of 70% ethanol 
and again centrifuged at 15,000g at 4°C for 5min. The ethanol wash was carefully pipetted off 
and the precipitate was air dried for 10-15min.  
Finally, the precipitated DNA was dissolved in 500µl of TE buffer and transferred into fresh 
tubes. All purified plasmid DNA solutions were aliquoted (10µl) and stored at -80ºC. 
 
2.3.18.5 Determination of Plasmid DNA concentrations and purity 
Total plasmid DNA concentration and the purity of each sample was determined using a 
NanoDrop™ 8000 Spectrophotometer (Thermo Scientific, UK) according manufacturer’s 
instructions. The upper and lower measurement pedestals were cleaned first with 70% ethanol 
and then by Milli Q water on lint free wipe (Kimwipes, UK). The instrument was initialized 
using 2µl of deionised water and ―Nucleic acid application module‖ was selected. The 
instrument was blanked using 2µl of TE buffer. Then, each plasmid DNA sample (2µl) was 
pipette onto the lower measurement pedestal. The sampling arm was closed and OD reading was 
initiated automatically at A260nm and A280nm.  
 
When the measurement was complete, both the upper and lower pedestals were wiped clean 
using lint free wipes before pipetting the second sample. This step prevents the sample carryover 
in successive measurements for samples varying by more than 1000 fold in concentration. The 
readings of samples at A260nm were accepted as DNA concentrations and the ratio of 
A260/A280 was used to assess the purity. A ratio of ~1.8 was accepted as pure sample of DNA. 
 
2.3.18.6 Restriction analysis of purified plasmid DNA 
To reassess the presence of sequences (promoter, enhancer and reporter gene) of DNA inserts in 
purified plasmids, restriction analysis was performed using single enzyme digestions according 
to manufacturer’s instructions.  
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Plasmid DNA maps were referred to identify particular restriction sites in all three different 
purified plasmids (Plasmid maps in appendix). Following restriction-digestion, fragments were 
separated on 1% agarose gel as described below.  
 
2.3.18.6.1 Restriction endonuclease digestion of purified plasmid DNA  
Plasmid DNA (1μg-1.5μg) was mixed with 2μl of 10X reaction buffer, 1μl of appropriate 
restriction endonuclease (Fermentas, USA) and the  volume made up to 20μl with deionized 
H2O. The digests were incubated in a water bath set to 37°C for 4h. Genomic DNA was digested 
as above except that digests were incubated at 37°C overnight to allow for complete digestion of 
genomic DNA. Finally, restriction enzymes were heat-inactivated at 80ºC in 20min according to 
manufacturer’s instructions. 
 
2.3.18.6.2 Agarose gel electrophoresis of digested plasmid DNA fragments 
1 % agarose gel was prepared by boiling an appropriate mass of agarose powder in Tris-borate 
EDTA buffer (89mM Tris; pH 7.6, 89mM boric acid and 2mM EDTA) (TBE) buffer until 
dissolved and 0.5µg/ml ethidium bromide (Fisher Scientific) was added. Then, agarose solution 
was gently poured into a horizontal mini-gel tank (10cm x 15cm) (Bio Rad, USA) and gel was 
allowed to set at room temperature for 10min with 12 well comb.  
DNA samples (volumes ranged from 2-50μl) were mixed with one-sixth volume of loading 
buffer (12% glycerol v/v, 60mM Na2EDTA, 0.6% SDS w/v, 0.003% bromophenol blue w/v, 
0.003% xylene cyanol w/v) and loaded onto the gel. Standard DNA ladder (New England Bio 
labs, UK) was run adjacent to DNA samples. They comprised of 1Kbp or 100bp DNA fragments 
and were diluted in loading buffer as before. Electrophoresis was carried out in 1X TBE at 150V, 
250mA for 1h. Gels were visualized using UV light on a transilluminator and images were 
captured by Polaroid camera (Kodak, Japan) (Figure 2.11). 
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2.3.19 Primer designing 
Primer sequences were designed  using ―Invitrogen Oligo design‖ on line software (Invitrogen, 
UK) referring to recommended sequences for pGL 3 (GL primer 2) and pGL 4 (RV primer 3) 
basic plasmids (Promega, UK) and the primer sequence for pGL 3 [nqo1/luc] designed according 
to the 5’-upstream region of NQO1 ( genomic walking) as described by Nio1 et al. (2003). All 
primers were synthesized by Invitrogen, UK and stored frozen as 100µM in 1xTE (10mM Tris 
base, 1mM EDTA, pH 8.0) buffer at -20°C until use. Annealing conditions were computed using 
the Wallace formula (Tm= [4(G+C) +2(A+T)] -5°C (Suggs et al., 1981) according to the 
recommended temperature range of Functional Genomic Labs, University of Birmingham, UK 
(Table 2.3).    
 
2.3.20 Sequencing of plasmid DNA 
In order to reassess further the presence of DNA consensus sequences; promoter region, 
enhancer and reporter in purified plasmid DNA samples. DNA sequence analysis was performed 
using 250ng of purified plasmid DNA in an ABI3730 DNA analyser (Applied Biosystems, USA) 
at the Functional Genomic Labs, University of Birmingham, UK. The DNA Reaction mixture 
was prepared as follows for each purified plasmid DNA sample (Table: 2.4). 
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Plasmid DNA 
Types 
 
Primer sequence 
(5’ to 3’) 
 
Annealing 
temperature 
(Tm) 
 
% 
GC 
 
Molecular 
Weight 
pGL3 
[nqo1/luc] 
CGCCTCGAGGCCCTC 
TGAATACTTTCAACAA 
      
      59°C 
 
    51 
 
        9401.2 
pGL3 
[3enh/coA/luc] 
CTTTATGTTTTTGGCG 
TCTTCCA 
 
      47°C 
 
     39 
 
        6978.6 
pGL4.74 
[hRluc/TK] 
GACGATAGTCATGCC 
CCGCG 
 
       53°C 
 
     53 
 
        6104.0 
 
Table 2.3  DNA sequencing specific primer. Single primers were designed as described in 
methods and were based on sequence information of plasmid manufacture and Genbank (NCBI, 
USA). 
 
 
 
Reagent 
 
Quantity 
    
pGL 3 [nqo1/luc] 
 
(1188.2ng/µl) 
 
pGL 3 [3enh/conA/luc] 
 
(1693.7ng/µl) 
   
pGL4.74 [hRluc/TK] 
 
(663.9ng/µl) 
 
    Plasmid DNA 
 
2.10µl (250ng) 
 
1.47µl (250ng) 
 
3.76µl (250ng) 
 
         Primer 
 
3.2µl 
 
3.2µl 
 
3.2µl 
 
   Deionised water 
 
4.7µl 
 
5.33µl 
 
3.04µl 
 
    Total Volume 
 
10µl 
 
10µl 
 
10µl 
 
Table 2.4  Composition of plasmid DNA reaction mixture. The reaction mixture for each 
purified plasmid was prepared according to the Functional Genomic Lab’s instructions. 
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Samples were loaded onto a 96 well plate and run in the automated process of ABI3730 DNA 
analyser. Big Dye terminator V3.1 (10µl) (Applied Biosystem) was added into each sample 
(10µl) by the ABI3730 analyser robot and the labelling reaction, PCR cycle sequencing cycles 
(Sanger sequencing method (Ramp at 96ºC for 10cycles/Ramp at 50ºC for 5cycles/Ramp at 60ºC 
for 240cycles and repeat further 24 and then total x 25 cycles) and purification of samples was  
performed Qiagen DyeEx plates (Qiagen, USA) according to size-exclusion principle to remove 
unincorporated dye and reagents from samples initially. Finally samples were analysed on the 
capillary sequencer ABI 3730 to produce the plasmid DNA sequence. The sequence of purified 
plasmids is shown in the appendix. 
 
2.3.21 Transient transfection of plasmid DNA into H9C2 myoblasts  
2.3.21.1 Optimisation of plasmid DNA transfection with Lipofectamine 2000 (Lipofection) 
One day before transfection, H9C2 myoblasts were seeded at 1.5 x 10
5
 cells/well in 1ml of 
culture medium (DMEM, 10% FBS and 4mM L-glutamine) without antibiotics in 24 well plates 
and the cells were incubated at 37°C in a humidified atmosphere of 5% CO2 and 95% air. After 
24h, H9C2 cells at 90% confluence were transfected with pGL 3 [nqo1/luc] plasmid for 
determination of Nrf2 activation or pGL 3 [3enh/conA/luc] for NF-κB  activation and control 
plasmid pGL4.74 [hRluc/TK] for thymidine kinase using Lipofectamine 2000 (Invitrogen, UK). 
The manufacturer’s standard protocol was modified in some steps to achieve optimum 
transfection efficiency. 
 
Initially, the total DNA to Lipofectamine 2000 ratio for each transfection was optimised using 
total DNA to Lipofectamine 2000 ratios of 1:2, 1:3 and 1:4 according manufacturer’s 
instructions. The total amount of DNA was held constant with varying amount of lipofectamine. 
Similarly, control plasmid DNA to experimental plasmid DNA ratio was optimised using 1:9, 
1:10 and 1:11 ratios as previously described elsewhere.  
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The amount of control plasmid DNA; pGL4.74 [hRluc/TK] was held constant with varying 
amounts of experimental plasmids; pGL 3 [nqo1/luc] or pGL 3 [3enh/conA/luc]. For each 
transfection, DNA/Lipofectamine complexes were prepared as follows. Each sample was diluted 
and gently mixed in 50µl of Opti-MEM I reduced serum medium (Invitrogen, UK) in 1.5ml 
polypropylene tubes.  
 
Then, an appropriate amount of Lipofectamine 2000 was diluted and gently mixed with 50µl of 
Opti-MEM I reduced serum medium and incubated for 25min (Dalby et al., 2004). After the 
25min incubation, the diluted DNA samples (1:10) were combined with diluted Lipofectamine 
2000 (Total volume=100ul) and incubated for 25min at room temperature to achieve the optimal 
complex formation as previously reported (Dalby et al., 2004). Meanwhile, cells were washed 
with PBS and Opti-MEM I reduced-serum medium and the medium in each well was replaced 
with 400µl of fresh Opti-MEM I reduced-serum medium. After a 25min incubation period, 
100µl of DNA and Lipofectamine 2000 complex was added to each well containing cells with 
400µl of medium and then the contents in each well were gently mixed by rocking the plate back 
and forth. Cells were incubated for a 24h period at 37°C in a humidified atmosphere of 5% CO2 
and 95% air. After the first 6h of transfection, wells were loaded with 500µl of culture medium 
containing 20% FBS and 8mM L-Glutamine to all transfected and non-transfected cells.  
 
Non-transfected cells served as controls for background luminescent measurements in luciferase 
assay. To test for transgene expression, cells were gently washed 2xPBS and loaded with phenol 
red-free medium (1ml/well) containing 2µM LPS and incubated for 4h period. It has been 
reported that LPS can induce NF-κB (Tsao et al., 1996) and Nrf2 (Rushworth et al., 2008) 
activation. Therefore, 10ng/ml LPS treatment was employed to activate these transcription 
factors as a positive control in luciferase assay. 
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2.3.21.2 Luciferase reporter gene assay 
To measure the luciferase reporter activity in transfected cells after exposure to hypoxia, a Dual 
Glo luciferase assay (Promega, UK) was performed according to an in-house modified protocol. 
Before conducting the luciferase reporter assay, plates were centrifuged at 300g for 3min to 
avoid loss of dying cells due to exposure to hypoxia or LPS treatment. Then, medium in each 
well was completely discarded and loaded with 100µl of serum and phenol red-free DMEM. To 
measure the Firefly luciferase activity, each transfected or non-transfected cell treatment was 
incubated with 100µl Dual Glo luciferase reagent and mixed gently to induce cell lysis on a 
rocker for 2min. Then, plates were incubated for another 8min at room temperature and Firefly 
luminescence was measured in a Spectramax luminometer (Molecular Devices, USA) at 
emission: 542nm and at room temperature.  
 
To measure the Renila luciferase activity for control gene expression and transfection efficiency, 
both transfected and non-transfected cells were incubated with 100µl of Dual Glo Stop and Go 
reagent and gently mixed for 2min on a rocker. After 6min incubation at room temperature, the 
Renilla luminescence was measured in a luminometer at room temperature, in the same order as 
the firefly luminescence measurement. In order to obtain optimal and consistent results avoiding 
inconsistencies with transfection efficiency, the ratio of luminescence of experimental reporter to 
control reporter was calculated as follows according manufacturer’s instructions.  
 
                Ratio of control firefly luminescence/Renilla luminescence=X 
Ratio of Experimental well firefly luminescence/Renilla luminescence=Y 
                Relative ratios; control = X/X=1 and experimental well=X/Y 
 
 
 
104 
 
2.3.22 Visualisation of transfection efficiency using cytochemical staining of β-galactosidase  
The transfection efficiency was determined using cytochemical staining of β-galactosidase 
expression. One day before lipofection, H9C2 cells at 90% confluence were seeded on 60-mm 
tissue culture dishes at a density of 1.5x10
5
 cells/dish and loaded with 5ml of culture medium 
(phenol-red free DMEM, 10% FBS, 4mM L-glutamine) without antibiotics and incubated for 
24h at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Then, β-galactosidase plasmid 
DNA Lipofectamine 2000 complexes were prepared at 1:4 ratio in 0.5 ml Opti-MEM I reduced 
serum medium as previously described (Section 2.3.21.1). The β-galactosidase plasmid DNA 
was kindly donated by Dr Ann Vernallis (Aston University, UK).   
 
After 24h, the cell culture dish was washed with 2x PBS and 1x Opti-MEM I reduced serum 
medium and loaded with 2ml  Opti-MEM I reduced serum medium and return to 37°C 
humidified incubator with of 5% CO2 and 95% air. Once the DNA/Lipofectamine 2000 
complexes were ready, β-galactosidase plasmid DNA/Lipofectamine solutions were added 
evenly to culture dishes as appropriate and incubated for another 24-48h at 37°C in a humidified 
atmosphere of 5% CO2 and 95% air. After 6h of transfection, each dish was loaded with 2.5ml of 
culture medium containing 20% FBS and 8mM L-Glutamine and re-incubated for 48h.  
 
Cells were then washed with 2x PBS at room temperature and loaded with 5ml of cell fixative 
solution (2% v/v formaldehyde, 0.2% v/v glutaraldehyde, 1x PBS). After 2min, cells were 
washed with 1x PBS and loaded with 5ml of histochemical staining solution (5mM Fe3Fe[CN]6, 
5mM Fe4Fe[CN]6, 2mM MgCl2, 1x PBS, 1mg/ml X-gal (5-bromo-4-chloro-3-indolyl-β-
galactoside) and incubated for 24h at 37°C. Finally, cells were washed gently with 4x PBS and 
covered with 1ml of PBS to examine under a light microscope. The transfection efficiency was 
estimated by counting the relative numbers of stained and unstained cells. Mean transfection 
efficiency ~30% was estimated from three independent studies (Figure 2.12A and 2.12B).  
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 (A)  
 
(B)                                            
 
Figure 2.12  β-Galactosidase expression in H9C2 cells after 48h. H9C2 cell transfected with 
plasmid DNA harbouring β-Galactosidase. Cell monolayers were   histochemically stained with 
X-gal. (A) Transfected cells at 20x magnification (B) Transfected cells at 40x magnification.  
 
2.3.23 Statistical Analysis 
Results are presented as sample mean ± SEM. Statistical analysis was performed using Graphpad 
Prism TM software and tested by one-way ANOVA (nonparametric) using Tukey’s post-hoc 
test. All results are means of three independent experiments. P< (0.05)* was considered as 
significantly different from controls and P< (0.05) was considered as significantly different from 
treatments. 
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CHAPTER 3 
OPTIMISATION OF CONDITIONS FOR 
USE OF FLUORESCENT PROBES TO 
DETECT ROS/RNS 
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3.1 Preface 
This chapter describes the optimisation of conditions for use of various fluorescent probes in 
measuring intracellular ROS/RNS during hypoxia and hypoxia/reperfusion, and the validation 
and optimisation of the hypobaric chamber. Initial studies determined the optimum incubation 
time for detecting probe oxidation with ROS/RNS during normoxia, in respect of their 
fluorescent intensity and kinetics of formation. Subsequent experiments were conducted to verify 
whether the hypoxic system can render cells hypoxic without affecting the pH in culture medium 
over the period of hypoxia. The optimised protocol of fluorescence dye applications was used to 
measure intracellular ROS/RNS generation in in vitro cell culture system.  
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3.2 Introduction  
3.2.1 Fluorescent probes 
The production of ROS/RNS is associated with deleterious changes to biomolecules and/or 
changes in biochemical functions in cells (sections 4.2 and 5.2). ROS/RNS generation during 
hypoxia alone or hypoxia/reperfusion has been established in neuronal cells from the use of free 
radical scavengers (Abramov et al., 2007). Their detection by a validated probe is critically 
important to understand their associated role in cardiac cell toxicity during hypoxia ± 
reperfusion. It is hard to characterise ROS/RNS due to their short half-lives, the action of in vivo 
antioxidant defence and their high reactivity with a variety of substrates (Gomes et al., 2005; 
Tarpey et al., 2004; Tarpey and Fridovich, 2001).  
 
The use of probes in situ is an excellent approach to measure ROS/RNS due to their potential for 
sensitivity, simplicity in application and high resolution of images under the microscope. The 
development of reliable techniques for detecting ROS/RNS is vitally important to understand 
deleterious effects of hypoxia or hypoxia/reperfusion.  
The number of readily available direct and indirect methods may under- or over-estimate the 
level of ROS/RNS at an intracellular level as high background fluorescence may be due to probe 
leakage from the cell system; photoxidation of probe, their non-specific oxidation by other 
catalytic/redox cycling chemicals and therefore an increase in noise (Gomes et al., 2005).  
 
Recent reports have shown leakage of DCF fluorescent probes from skeletal muscle fibres and 
their extracellular photooxidation that increases background fluorescence (McArdle et al., 2005). 
However, Murrant et al. (1999) have suggested the ways of minimising background fluorescence 
and photo oxidation in experimental systems. Previously published work has described the use of 
probes over variable periods during hypoxia or ischaemia to assess ROS/RNS generation 
(Duranteau et al., 1998; Chandel et al., 2000; Chandel and Schumacker, 1999).  
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The presence of probe over longer time points may lead to increased autooxidation, time-
dependent decay of fluorescence and saturation/insufficient amount of probe for oxidation 
thereby this approach may not indicate an accurate estimation of ROS/RNS produced over 
period. Therefore, it is important to determine optimum oxidation time point(s) as measured by 
fluorescence spectrometry which gives minimum background noise with high signals. This 
chapter describes the quantitative optimisation of fluorescent probe oxidation conditions to 
minimise photo/autooxidation and fluorescent decay.  
 
It has been reported that mitochondria generate O2
-•
 as a by-product of oxidative 
phosphorylation. Approximately 1–3% of mitochondrial O2 consumed may produce O2
-•
 by 
interaction with "leaked" electrons at mitochondrial complex I, II and III (Hool and Arthur, 
2002; Guzy et al., 2005; Chandel et al., 2000). O2
-•
 is the primary ROS produced and can 
undergo further reactions to produce subsequent radical species. Therefore, a panel of probes has 
been selected for optimisation that has specificity for ROS/RNS and sources e.g. mitochondrial 
and non mitochondrial based-ROS/RNS.  
 
3.2.2   Hypobaric oxygen chamber 
Hypoxic chambers are widely used to achieve a hypoxic environment in in vitro or in vivo 
experiments. In such systems, reduced O2 tensions are perfused with continuous flow. 
Alternatively, hypoxic-mimic agents such as Co or Ni can be used to mimic cellular hypoxic 
events chemically (Chachami et al., 2004; Chandel et al., 1998). However, those studies are 
difficult due to metal toxicity induced cell death (Wang et al., 2000). Cell cultures can be made 
hypoxic by bubbling nitrogen gas through the medium; the gas should be sterile to avoid 
contamination (Killilea et al., 2000). Sample manipulations are also difficult during hypoxia; 
when cells are removed from hypoxia to normoxia, reoxygenation can cause additional stress 
and metabolic changes in the cells, leading to complications in the interpretation of results.  
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In kinetic studies of ROS generation during hypoxia, addition of fluorescent probes or inhibitors 
into cell culture plates or taking sample for dissolved gas analysis is a challenge in wet 
laboratory practice whilst maintaining stable hypoxic conditions inside the chamber without 
incorporation of ambient air into experimental samples. The maintenance of stable pH conditions 
in the culture medium during both hypoxia or normoxia and also stable dissolved O2 level are 
critical. It is difficult to achieve this without monitoring the changes by advanced instruments 
such as oxygen sensors and micro pH electrodes. Therefore, a closed environmental system with 
continuous perfusion of gas mixtures such as Sykes-Moor chambers or Billups-Rothenbergs 
advanced chambers are often preferred. In the methods section of this thesis, the invention of a 
simple and economical gas flow system is described to initiate hypobaric hypoxia in cell cultures 
while allowing simultaneous addition of experimental reagents without incorporation of ambient 
air.  
 
3.3 Results 
3.3.1 Optimisation of fluorescent probes 
To investigate the optimum incubation time to detect oxidation of each fluorescent probe with 
reactivity of intracellular ROS/RNS generated during inhibition of mitochondrial respiration (as 
might be expected during hypoxia), fluorescence was measured for various periods: 15min, 
30min, 45min and 60min after loading the probe into cells in the presence or absence of 
mitochondrial complex I inhibitor; rotenone (40µM) as described in section: 2.3.8.  
 
3.3.1.1 Superoxide detection by DHE  
H9C2 cells at 70-80% confluence were briefly washed with PBS and loaded with phenol red-free 
DMEM prior to addition of 20µM DHE in the presence or absence of mitochondrial complex I 
inhibitor; rotenone (40µM). Cells were incubated in the dark and fluorescence was determined 
after 15min, 30min, 45min and 60min under normoxia.  
111 
 
In order to minimise background fluorescence, existing culture medium was replaced gently with 
fresh medium 3min before the fluorescence measurements at optimal wavelengths for detection 
of 2-hydroxy ethidium (excitation at 488nm and emission at 570nm) as previously reported 
(Zhao et al., 2005; Zhao et al., 2003).  
 
As illustrated in figure 3.1, DHE fluorescence increased time-dependently and maximum 
oxidation was achieved at t=60min. There was a trend for lower DHE fluorescence after 30min 
in the presence of rotenone, but this was not significant compared to untreated cells. Therefore, 
incubation time; 45min was selected as an optimum oxidation period of DHE due to the stability 
of the oxidised products.  
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Figure 3.1 DHE oxidation at different incubation times. H9C2 cells were seeded at 
3x10
4
/well and grown until 70-80% confluence at 37ºC in 5% CO2 in humidified atmospheric 
conditions. Then cells were washed with PBS and loaded with phenol red-free DMEM. In the 
presence or absence of 40µM rotenone, the fluorescence was measured  after 60min, 45min, 
30min and 15min incubations with 20µM DHE in dark in a preheated (37°C) GEMNI 
fluorescence reader at Excitation: 488nm, Emission: 570nm, cut off filter: 560nm. Data 
represents the mean±SEM fluorescence of three independent experiments conducted in 
triplicates.  
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3.3.1.2 Kinetics of DCFH2-DA and DHR123 oxidation 
The optimum oxidation periods of DCFH2-DA and DHR123 were assessed in respect to 
cytosolic and mitochondrial ROS/RNS respectively. H9C2 cells at 70-80% confluence were 
briefly washed with PBS and loaded with phenol red-free DMEM. To show the sensitivity of 
DHR123 towards peroxide radicals; 20µM H2O2 + horse radish peroxidase (HRP) solution was 
employed as a positive control. Peroxynitrite solution (60µM) was also employed to demonstrate 
the sensitivity of DCFH2-DA for peroxynitrite anion radical. Cells were treated with 20µM 
DCFH2-DA or 20µM DHR123 in the absence or presence of 40µM rotenone and incubated for 
15min, 30min, 45min, and 60min. Then, fluorescence was measured after replacing the existing 
medium with fresh phenol red-free DMEM at 3min before the completion of incubation period. 
Both DCFH2-DA and DHR123 showed time-dependent increases in fluorescence with rotenone 
treatment. In the presence of rotenone, both probes achieved optimum oxidation at t=45min 
(Figure 3.2 A and 3.2B).  
 
In the positive control, DCFH2-DA showed sensitivity for ONOO
-
 with increase in fluorescence 
by 780±83% compared to controls (100±9%). DHR123 showed sensitivity for H2O2 with 
increase in fluorescence by 541±44% compared to controls (100±9%) in the presence of HRP 
only, confirming the requirement of the cofactor; HRP to reduce H2O2 (Hempel et al., 1999; 
Henderson and Chappell, 1993; Kooy et al., 1994; Royall and Ischiropoulos, 1993a). 
 
3.3.1.3 Optimisation of conditions for the nitric oxide detector; DAF-2-DA 
 H9C2 cells were cultured in DMEM, 10% FBS under basal conditions. At 70-80% confluence, 
cells were briefly washed with PBS and loaded with phenol red-free DMEM.  To determine the 
optimum oxidation period of DAF-2-DA, fluorescence was measured in the presence or absence 
of 40µM rotenone after incubating cells with 10µM DAF-2-DA for 60min, 45min, 30min, and 
15min. 
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Figure 3.2  Optimisation of conditions for (A) DCFH2-DA and (B) DHR123 oxidation at 
different incubation times. H9C2 cells were seeded at 3x10
4
/well and grown until 70-80% 
confluence at 37ºC in 5% CO2 in humidified atmospheric conditions. Then, cells were washed 
with PBS, loaded with phenol red-free DMEM, and experimental cells were treated with 40µM 
rotenone. The fluorescence was measured after 60min, 45min, 30min and 15min incubations 
with 20µM DCFH2-DA (A) or 20µM DHR123 (B) at 37ºC in a preheated GEMNI fluorescence 
reader at Excitation: 488nm, Emission: 520nm, cut off filter: 515nm. Data represents the 
mean±SEM fluorescence of three independent experiments conducted in triplicates. *** 
represent P < 0.0001, cells+DCF or DHR vs. cells+Rotenone+DCF or DHR (one-way ANOVA), 
Tukey’s post-hoc test. 
 
To minimise the background fluorescence, existing culture medium was replaced with fresh 
DMEM and plates were read after 3min before the completion of incubation period. A solution 
of 100µM spermine nonoate was employed as positive control to determine the DAF-2-DA 
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sensitivity for 
•
NO. The DAF fluorescence was increased by 210±18% compared to control cells 
(100±8%) in the presence of spermine nonoate (100mM); 
•
NO donor. As illustrated in figure 
3.3, DAF-2-DA oxidation showed a time-dependent increase in fluorescence from t=0 min to 
45min, but was not further increased at t=60min.  
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Figure 3.3  DAF-2-DA oxidation at different incubation periods. H9C2 cells were seeded at 3 
x10
4
/well and grown until 70-80% confluence at 37ºC in 5% CO2 in humidified atmospheric 
conditions. Then, cells were washed with PBS and loaded with phenol red-free DMEM and 
experimental cells were treated with 40µM rotenone. The fluorescence was measured after 
60min, 45min, 30min and 15min incubations with 20µM DAF-2-DA at 37ºC in a preheated 
GEMNI fluorescence reader at Excitation: 491nm, Emission: 513nm, cut off filter: 495nm. Data 
represents the mean±SEM fluorescence of three independent experiments conducted in 
triplicates.  
 
3.3.2 Validation and optimisation of hypoxia chamber  
Initial studies were performed to determine the stability of the hypoxic system i.e. whether it can 
maintain a stable hypoxic or normoxic environment. Therefore, dissolved O2 level was 
determined after pre-equilibrating the medium (HEPES-buffered, phenol red-free) for 18h at 2% 
O2 + 98 % N2 and/or 10% O2 + 90 % N2 using premixed gas in the chamber. Control medium 
was preequilibrated at 21% O2 + 79% N2. Following equilibration, the dissolved O2 level was 
routinely measured using the Winkler assay as previously described (Winkler, 1888; Grant & 
Griffiths, 2007) (Section 2.3.4.2).  
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After 18h, the dissolved O2 concentration in the medium was 0.23±0.04mg/L (pO2; 14.5 mmHg) 
at 2% O2 + 98% N2 which was a 26-fold decrease compared to O2 concentration in the medium 
equilibrated under normoxia. The equilibration at 10% O2 + 90% N2 resulted in a 2-fold decrease 
in O2 concentration compared to normoxic medium. The dissolved O2 concentration in the 
medium at 10% O2 was 2.78±0.77mg/L (pO2; 72.4 mmHg). The dissolved O2 concentration in 
control medium (normoxia at 21% O2) was measured as 5.93±0.23mg/L (pO2; 152.2 mmHg) 
(Figure 3.4). As shown in figure 3.4, the dissolved O2 level in the medium depleted dose-
dependently with decreasing O2 tension.  
 
To assess the stability of pH value, pH was measured before and after hypoxia. The pH of the 
medium was stable during both normoxic (pH 7.4 ± 0.30) and hypoxic exposures (severe 
hypoxia; pH 7.5 ± 0.21 and mild hypoxia; pH 7.5 ± 0.23) up to 24h period. The results suggest 
that this system could render cells hypoxia by depleting dissolved O2 concentration in the 
medium. This hypobaric chamber was adapted in subsequent experiments to induce hypoxia or 
normoxia. 
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Figure 3.4  The effect of hypobaric hypoxia on dissolved O2 level in the medium. HEPES 
buffered, phenol red-free DMEM were preequilibrated for 24h at different O2 tensions; 2% O2 + 
98% N2, 10% O2 + 90% N2 and 21% O2 + 79% N2 in the chamber. The dissolved O2 level in the 
medium (1ml) was then measured by the Winkler assay. Data represents the mean±S.E.M of 
three independent experiments conducted in triplicate.  
116 
 
3.4 Discussion 
3.4.1 Optimisation of fluorescent probes 
Fluorescent probes are important for in vivo and in vitro biological research as they can provide 
unique spatial and temporal information about ROS/RNS molecules. The quantitative oxidation 
of a non-fluorescent probe to a fluorescent product reflects the amount of ROS/RNS oxidized 
intracellularly as previously explained (Tarpey and Fridovich, 2001; Tarpey et al., 2004). 
Therefore, the intensity of fluorescence is proportional to the amount of ROS/RNS generated in 
the cell (Gomes et al., 2005). However, this may reflect an over estimate of ROS/RNS produced 
intracellularly as probes can undergo autooxidation outside the cell (McArdle et al., 2005; 
Murrant et al., 1999). To minimise contribution of artefactual oxidation, experiments were 
conducted in the dark and old culture medium was always replaced with fresh medium to 
minimise background fluorescence prior to analysis (Murrant et al., 1999).  
 
The methodology outlined in this thesis has avoided monitoring time-dependent kinetics of 
fluorescence as oxidised fluorescent products are susceptible to further excitation by the light 
intensity in the instrument (McArdle et al., 2005) and this results in poor fluorescent signal to 
noise ratio (Fennell and Baker, 2005). Therefore, the current protocol has been developed so that 
it uses a single exposure to light (under optimal excitation conditions) after completing the 
incubation periods; 15min, 30min, 45min and 60min at high signals to minimum fluorescent 
noise.  Killilea et al. (2000) reported the influence of pH on the oxidation of fluorescent probe in 
the culture medium, therefore, HEPES-treated medium was employed to maintain a stable pH 
over incubation periods (Killilea et al., 2000).  
According to other investigators, background fluorescence may reflect metal impurities in the 
medium (Wardman, 2007). The impurities in medium represents trace ions or catalyst, which can 
catalyse probe oxidation via Fenton reaction (Wardman, 2007). Principally, the mitochondrion is 
the major ROS/RNS generation site in many tissues and particular in muscle cells in respiration 
during normoxia (Jackson et al., 2002; Chandel et al., 1998 and 1997).  
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To evaluate the contribution of the mitochondrial electron transport system to produce ROS/RNS 
during normoxia, cells were treated with the mitochondrial complex I inhibitor; rotenone before 
adding the fluorescent detector probe. This method was adapted from Chandel et al. (1998). The 
pre-treatment of cells with rotenone mimics the hypoxic response under normoxia (Chandel et 
al., 1998). The optimal incubation time for a particular probe was assessed by considering 
stability of fluorescence and retention time of oxidised products in the cell before fluorescence 
decay in the presence or absence of rotenone.  
 
The fluorescence probes that were examined showed an optimal oxidation either at 45min or 
30min and subsequent experiments were applied accordingly. Zha et al. (2005) and (2003) 
suggested that DHE can only react with cellular O2
-•
 forming 2-hydroxyethidium (2-OH-E
+
), 
which has a distinct fluorescence spectrum of excitation at 490nm and emission at 570nm. 
Therefore, DHE fluorescence measurements were conducted according Zhao et al. (2005) and 
(2003). Dose response studies of DHE suggest that it does not react with singlet oxygen, 
hydroxyl radical, H2O2, 
•
NO and peroxynitrite (Fennell and Baker, 2005). There are other non-
superoxide-dependent ways of oxidizing DHE into E
+
 which is distinct from the fluorescence 
spectrum of 2-OH-E
+
 and intercalates into nucleic acids (Zhao et al., 2005; Zhao et al., 2003). 
This study suggests that the decrease in DHE fluorescence after rotenone pre-treatment is an 
indication of decreased production of O2
-•
 from mitochondrial complex I. It may be due to 
blockage of formation of ubisemiquinone by rotenone under normoxia (Duranteau et al., 1998). 
The decrease in DHE fluorescence after rotenone pre-treatment during normoxia is consistent 
with some, but not all previous reports (Chandel et al., 1998; Chandel and Schumacker, 1999).  
 
It has been reported that O2
-•
 and DHE reacts at a 1:1 molar ratio (Fennell and Baker, 2005). The 
total cellular fluorescence of DHE after incubation with cells for 45min may indicate not only 
O2
-•
 production from the mitochondria, but also from other sources such as NADPH oxidase, 
xanthine oxidase and NOS system (Pagano et al., 1998; Souza et al., 2002; Pou et al., 1999).  
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DCF fluorescence at 45 min in normoxia assesses the cytosolic basal ROS and RNS production, 
whereas the fluorescence of DHR123 at 45min reports mitochondrial basal ROS/RNS 
production during normoxia. DCFH2-DA and DHR123 showed their relative sensitivity for 
positive controls; ONOO
-
 and H2O2 + HRP respectively and suggest the generation of those 
radicals during basal normoxic respiration. The increase in both DHR123 and DCFH2-DA 
fluorescence in rotenone-treated cells suggests that overproduction of ROS/RNS is due to 
electron leak from mitochondria. The DCF fluorescence reflects the generation of ONOO
-
 and 
probably, peroxy radicals via Fenton-type reaction in the presence of peroxidase enzymes in 
cytosol or/and readily available HOCl (Killilea et al., 2000; Hempel et al., 1999). In contrast, the 
increase in DHR123 fluorescence supports a change in mitochondrial redox state and/or 
increased production of ROS/RNS of mitochondrial origin. 
 
 It has been reported that rotenone increases the mitochondrial ROS generation by blocking 
complex I. When complex I is inhibited with rotenone, electrons may leak into the matrix and 
may be reduced chemically to form ROS/RNS resulting in the increase in DHR123 fluorescence 
(Chandel et al., 1998).  
•
NO generation during normoxia was demonstrated by using the DAF-2-
DA probe under basal conditions.  
 
The sensitivity of this probe for 
•
NO was confirmed by its reactivity towards the positive control; 
spermine nonoate, confirming previous reports (Gomes et al., 2005; Tarpey et al., 2004; Kojima 
et al., 1998). Total DAF fluorescence represents the cellular 
•
NO production during normal 
physiological conditions by mitochondria or/and cytosolic reactions (Kojima et al., 1998; 
Strijdom et al., 2006; Nakatsubo et al., 1998). The cell membrane and mitochondrial membrane 
are permeable to DAF-2-DA, and the probe can only be reactive with 
•
NO after it is hydrolysed 
to a reactive form; DAF-2, by intracellular esterases (Nakatsubo et al., 1998; Kojima et al., 
1998). Extracellular probe cannot be oxidized by 
•
NO, however it may subject to background 
fluorescence due to autooxidation of the probe.  
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Previous studies have adopted the variable incubation periods including 30min, 2h and 6h of 
fluorescent probes in cell systems (Abramov et al., 2007; Chandel et al., 1998), but the present 
system indicates the oxidation of fluorescent probe at its optimum level, precluding non-specific 
and autooxidation.  
 
Fluorescent probes are often employed in fluorescence microscopy to monitor time dependent 
increase in fluorescence in specific cells or subcellular organelles with respect to ROS/RNS. 
Recently, it has been reported that laser exposure in fluorescence microscopy can induce photo-
toxicity or affect quantitative fluorescent assessments due to photooxidation as previously 
reported by Abramov et al. (2007) and McArdle et al. (2005). Therefore, the quantification of 
ROS/RNS by microscopy may need reliable methods under low light excitation. Supporting this 
suggestion, in the present method, replacement of old medium with fresh medium has avoided 
detection of any leftover photoxidised/autoxidised dye in the extracellular medium, resulting in 
minimum background fluorescence.  
 
Most investigators have omitted the method of minimising background fluorescence; instead 
they have followed continuous monitoring and kinetics of fluorescence (Abramov et al., 2007; 
Chandel et al., 1998; Chandel and Schumacker, 1999; Duranteau et al., 1998). In the present 
study, levels of fluorescence are not directly proportional between dyes, though; the 
stoichiometry of the reaction may be the same. This is evident with greater increase in 
fluorescence of some dyes more than another dye that has been exposed to same ROS/RNS. 
Cells respond to different probes in various ways and probes can leak by passive diffusion or 
rapidly by active efflux. The doses of probes employed in this thesis have been used by previous 
investigators (Becker et al., 1999; Zhao et al., 2003; Strijdom et al., 2006; Henderson and 
Chappell, 1993; Crow, 1997) and were found to be non-toxic.  
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This study has confirmed the generation of various ROS/RNS including O2
-•
 and 
•
NO under 
normal physiological state as consistent with previous authors (Coral and Michael, 2001; Kudin 
et al., 2005; Ramachandran et al., 2002; Robinson et al., 2006).  
The optimum incubation periods for each probe with H9C2 cells have been applied to the study 
of the time-dependent increase in ROS/RNS generation during hypoxia and hypoxia-reperfusion. 
The present study was aimed to adapt and optimise the use of probes to detect and quantify 
radicals in interest; O2
-•
 or 
•
NO production in subsequent experiments during hypoxia and 
reperfusion in H9C2 cardiomyoblasts. 
 
3.4.2 Hypoxic chamber 
Hypoxic chambers should provide a continuous flow of a perfusing gas mixture in order to 
achieve a stable hypoxic environment (Killilea et al., 2000). The chamber developed in this 
study is highly versatile, cost-effective and simple to use. The gas exposure system can be used 
with different compositions of mixed gases (e.g. hyperoxia, anoxia and tobacco smoke) in 
addition to the gas mixtures used in this thesis. This system allows a convenient approach of 
simulating a variety of environmental conditions. The suitability of the gas exposure chamber 
was demonstrated by determining the different dissolved O2 levels in hypoxic or normoxic 
culture medium during mild (10% O2) and severe (2% O2) hypoxia.  
 
The main advantages of this hypoxic chamber are; (a) minimal gas consumption compared to 
larger glove box or hypoxic incubators; (b) maximum culture space for 2-4 tissue culture plates 
or two T75 cell culture flasks in a single chamber; (c) fast recovery time and easy manual 
operation for conducting an experiment; (d) easy disassembly for cleaning; (e) an ability to resist 
high gas flow rates. The present study has determined the dissolved O2 concentration in hypoxic 
or normoxic-culture medium using the Winkler assay which has been modified to minimise 
incorporation of air.  
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Further validation studies proved the maintenance of a stable pH range (7.5±0.21) as measured 
by pH electrode (Appleton Woods, UK) under hypoxic or normoxic incubation periods; 30min 
and 4h. Therefore, these data confirm that changes in fluorescence were not affected by pH 
gradients established during hypoxia or normoxia and they are due to different O2 tensions 
established in culture medium. Since the completion of these studies, more advanced and 
accurate methods to monitor dissolved O2 and pH at the same time have become available such 
as the hydrogel micro array system, and such systems could have advantage for future studies to 
provide real time measurements (Lee et al., 2008). In summary, the present study describes a 
system that could permit convenient evaluation of ROS/RNS under a variety of environmental 
conditions using premixed gases, including hypoxia and reperfusion, in H9C2 cardiomyoblasts 
without a substantial investment of resources compared with other commercial chambers. 
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CHAPTER 4 
HYPOXIA-INDUCED ROS/RNS 
GENERATION 
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4.1 Preface 
This chapter examines ROS/RNS generation from cardiomyoblasts during hypoxia compared to 
basal ROS production. The hypoxia-induced ROS generation depends on the amount of O2
-•
 
produced from various sources. Therefore, global O2
-•
 generation was assessed by DHE 
fluorescent probe and visualised in live cells under confocal microscopy. The selective oxidation 
of DHE probe and basal O2
-•
 level were determined in the presence of superoxide dismutase 
mimetic; MnTBAP. During chronic, severe hypoxia, the contribution of mitochondria, NADPH 
oxidase complex, xanthine oxidase and NOS isoforms as O2
-•
 producers were assessed in the 
presence of inhibitors and uncouplers.  
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4.2 Introduction 
4.2.1 The production of O2
-•
 during hypoxia 
O2
•- 
generation during hypoxia alone and hypoxia-reperfusion or ischaemia-reperfusion have 
been widely studied, however, associated mechanisms of toxicity or survival in cardiac cells 
have not been clearly established. The O2
-•
 is an important precursor signalling molecule which 
can dismutate to H2O2 in the presence of SOD or spontaneously at a slower rate at physiological 
pH or reacts with 
•
NO to produce ONOO
-
. Both ONOO
- 
and H2O2 are signal transduction 
molecules and play a vital role in the maintenance of vascular homeostasis and pathogenesis. 
According to Griendling et al. (2000), O2
-•
 and H2O2 are the most important signalling molecules 
in the cardiovascular system. However, the large scale accumulation of O2
-•
 during hypoxia can 
have deleterious effects, leading to irreversible cardiac damage. Hypoxia can enhance O2
•-
 
generation in muscle cells, especially cardiac myocytes (Vanden Hoek et al., 1997; Becker et al., 
1999). An increase in ROS generation from cardiomyocytes during ischaemia appears to be 
paradoxical as the molecular O2 needed to be reduced is in low abundance and this can reduce 
ATP production. It is evident that ischaemia alone can trigger cardiac cell injury without 
reperfusion as described in previous reports (Vanden Hoek et al., 1997), but can also afford 
benefit, if the ischaemic period is short, i.e. ischaemic preconditioning. Therefore, understanding 
the role of O2
•-
 production during severe hypoxia is vitally important and may have clinical 
implications for design of interventions that improve cell survival during and after ischaemia 
(Becker et al., 1999).   
 
The antioxidants 2-mercaptopropionyl glycine and 1.10-phenanthroline added to culture medium 
during the ischaemia in cardiomyocytes attenuated oxidant generation, increased cell viability, 
and improved return of contraction after ischaemia or reperfusion (Vanden Hoek et al., 1997). 
Abramov et al. (2007) described an increase in ROS generation under the condition of reversed 
electron flow with less available O2 that depends on mitochondrial membrane potential 
differences (∆Ψm). The electron flux through the ETS, coupled to proton pumps from the matrix 
normally maintains the mitochondrial membrane potentials (Murphy, 2009).  
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Therefore, an inhibition of electron transport system should decrease the proton pumps, resulting 
in depolarization of the mitochondrial inner membrane. During hypoxia, NADH in complex I 
becomes increasingly reduced, driving electrons to O2, and leading to loss of ∆Ψm (Levraut et al., 
2003). Mitochondrial uncouplers can decrease membrane potentials and reduce O2
•-
 production 
as a protective measure.  
To support this hypothesis, partial mitochondrial uncoupling with a low dose of FCCP (Carbonyl 
cyanide 4 - (trifluoromethoxy) phenylhydrazone) significantly improved post-ischaemic 
recovery of rat hearts via a ROS-dependent pathway (Brennan et al., 2006b; Brennan et al., 
2006a).  Within the hypoxic heart, mitochondria are likely to be the main source of ROS in 
muscle cells (Vassilopoulos and Papazafiri, 2005; Turrens, 1997; Suleiman et al., 2001). Other 
sources such as the NADPH oxidase complex in vascular cells (Souza et al., 2002) or xanthine 
oxidase in endothelial cells, pulmonary cells and neuronal cells can generate O2
•-
 (Pearlstein et 
al., 2002; Abramov et al., 2007; Becker et al., 1999; Becker, 2004a). Moreover, NOS isoforms 
also can produce O2
•-
 and H2O2 when L-arginine substrate is limited in supply (Pou et al., 1999).  
However, the relative contribution of aforementioned sources for O2
•-
 production during hypoxia 
alone in cardiomyocytes has not been clearly established.  
 
4.2.2 The production of RNS during hypoxia 
Nitric oxide (
•
NO) is a unique biological messenger molecule with various effects in cells and 
cellular organelles such as mitochondria, including maintenance of mitochondrial integrity and 
defence during hypoxia. It has been reported that formation of ONOO
-
 in the presence of 
•
NO 
and O2
-•
, can activate protein kinase C (PKC), down regulate KATP channels and induce release 
of cytochrome c from mitochondrial complex IV, thereby  inducing caspase-3 activation. During 
hypoxia, 
•
NO generation is dependent on the degree of activity of NOS isoforms present in 
cytosol and mitochondria. Three isoforms of NOS are present in most cell types; the constitutive 
endothelial (eNOS) and neuronal (nNOS) isoforms, and the inducible (iNOS) isoform (Beckman 
and Koppenol, 1996; Pou et al., 1999; Porasuphatana et al., 2003).  
 
126 
 
Zanella et al. (2002) reported the presence of the three isoforms of mtNOS ( eNOS, nNOS and 
iNOS) in mitochondria of H9C2 rat myoblasts. It has been reported that mitochondrial NOS are 
constitutively expressed and they can be functionally up-regulated when cells are exposed to 
hypoxia (Lacza et al., 2001; Lacza et al., 2006). During hypoxia, an increase in [Ca
2+
] in the 
cytoplasm or mitochondria can activate eNOS to produce 
•
NO (Lacaza et al., 2001). Therefore, 
the increase in 
•
NO production is likely to be associated with eNOS activation in both cytosol 
and mitochondria. During normoxia, a low level of NOS activity was suggested to be a 
constitutive feature in mitochondria (Lacza et al., 2001). However, the expression of NOS 
isoforms in mitochondria is still under debate (Lacza et al., 2006).  
 
The baseline 
•
NO production in cardiac microvascular endothelial cells is eNOS-dependent and 
endothelial cells produce more 
•
NO than ventricular cardiomyocytes during normoxic 
respiration, demonstrating that eNOS activity is different between cardiac microvascular 
endothelial cells and ventricular cardiomyocytes (Strijdom et al., 2006). In contrast, Strijdom et 
al. (2006) demonstrated iNOS induction occurs in ventricular cardiomyocytes to produce 
•
NO, 
but not in microvascular endothelial cells during hypoxia. Hypoxia pre-exposure increases iNOS 
mRNA expression in myocardial cells and protects against subsequent damage from a second 
prolonged hypoxia. Lacaza et al. (2006) have suggested that rat heart mitochondria produce RNS 
via the respiratory chain rather than through an arginine-dependent mtNOS. 
  
This supports earlier findings of Zweier et al. (1999) who reported the generation of 
•
NO from a 
non-enzymatic pathway. Overall, the impact of 
•
NO accumulation during hypoxia is not yet 
clearly established. Therefore, the effect of 
•
NO on cell viability after exposure to hypoxia has 
been investigated using specific and non-specific NOS inhibitors and other metabolic inhibitors 
alone and with the RNS-sensitive fluorescent probe, DAF-2-DA.  
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4.3 Results 
4.3.1 Chronic, severe hypoxia significantly increased O2
-•
 production in H9C2 
cardiomyoblasts. 
H9C2 cells were cultured in DMEM, 10% FBS under basal conditions and at 70-80% 
confluence, cells were washed briefly with PBS and loaded with O2 preequilibrated (2% O2, 10% 
O2 and 21% O2 in independent experiments), HEPES buffered, phenol red-free DMEM.  
To determine O2
-•
 generation during 30min and 4h under severe (2% O2 + 98% N2) and mild 
hypoxic (10%O2 + 90% N2) conditions, cells were treated with 20µM DHE and incubated in the 
hypoxic chamber as described in methods (Sections :  2.3.9.1).  
 
DHE oxidation was determined at different times (30min or 4h) and O2 tension (2%, 10% and 
21% O2) to characterise O2
-•
 production during hypoxia. As illustrated in figure 4.1A, there was 
no significant increase in O2
-•
 production during acute, severe or mild hypoxia compared to 
normoxia. However, the increase in DHE oxidation (123.47±5.84% of normoxia control, 
P<0.001, 4h) during chronic, severe hypoxia compared to normoxia (100±3.66%; 4h) or mild 
hypoxia suggests a significant increase in O2
-•
 production during chronic, severe hypoxia (see 
Table 4.1 for summary of results). 
 
To find out the specificity of DHE fluorescence for O2
-•
 detection during hypoxia, cells were 
treated with 50µM MnTBAP prior to adding 20µM DHE. As shown in figure 4.1B, MnTBAP 
significantly reduced DHE fluorescence in hypoxia and normoxia cultured cells. The 
fluorescence of DHE in cells treated with MnTBAP was not different between hypoxia and 
normoxia indicating the selective oxidation of DHE probe with O2
-•
 during hypoxia. MnTBAP 
treatment significantly reduced the DHE fluorescence in normoxic controls indicating a basal 
level of O2
-•
 production under normoxia. 
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Figure 4.1  O2
-• 
production during mild and severe hypoxia for 30min and 4h. Cells were 
cultured for 48h in culture medium and were loaded with O2 equilibrated HEPES buffered-
phenol red-free DMEM (2% or 10% or 21% O2) after 3 x PBS washes. Experimental cells were 
exposed to hypoxia after treating cells with 20µM DHE, 45min prior to completion of 4h 
hypoxia and adding probe at t=0 for 30min hypoxia studies (A). Controls were maintained at 
normoxia (21% O2). Negative control cells were treated with 50µM MnTBAP 45min prior to 
complete 4h hypoxia or normoxia (B). After replacing the culture medium, fluorescence was 
measured at 37°C in Spectramax GEMINI EM fluorescence reader at Excitation: 488nm, 
Emission: 570nm and cut off filter: 560nm. Data represent the mean±SEM fluorescence of three 
independent experiments conducted in triplicates. ** represent P < 0.001 and *** represent P 
<0.0001 (one-way ANOVA), Tukey’s post-hoc test. 
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4.3.1.2 Live cell imaging of O2
-•
 generation during acute and chronic, severe hypoxia 
In order to confirm that O2
-• 
production is intracellular, real-time imaging of cardiomyocytes was 
undertaken under varying degrees of hypoxia and time (Section: 2.3.10). As visualized in figure 
4.2B, confocal microscopy images show stronger signals of DHE fluorescence during chronic, 
severe hypoxia compared to chronic, mild hypoxia and normoxia (Figure 4.2D & 4.2F). The 
intensity of DHE fluorescence signals was weaker in confocal images obtained during acute, 
severe or mild hypoxia compared to normoxia (Figure 4.2A, 4.2C and 4.2E) and is consistent 
with quantitative fluorescent measurements (Figure 4.1A).  
 
4.3.1.3 Effects of respiratory chain inhibition, uncoupling and inhibition of NADPH 
oxidase complex during mild and severe hypoxia 
To identify whether mitochondrial O2
-• 
is generated during hypoxia, the effects of H9C2 
incubation with mitochondrial complex I inhibitor; rotenone and the respiratory chain uncoupler; 
FCCP during chronic, severe hypoxia were investigated. Cardiacmyoblasts are reported to 
generate O2
-• 
via NOX and to investigate any possible contribution of the NOX-dependent 
respiratory burst to O2
-• 
generation during chronic, severe hypoxia, the inhibitor apocynin was 
included. Then fluorescence was measured after adding 20µM DHE in the presence of inhibitors 
during hypoxia as previously explained in section 2.3.12.  
 
In the presence of FCCP, DHE oxidation was increased significantly during acute, severe 
hypoxia and acute, mild hypoxia compared to untreated cells (Figure 4.3A and 4.3B). However, 
in the presence of rotenone, DHE fluorescence was significantly increased during acute, severe 
hypoxia (30min; 2% O2), but not acute, mild hypoxia (Figure 4.3A and 4.3B). The presence of 
either rotenone or FCCP reduced DHE oxidation significantly (~10% decrease) due to chronic, 
severe hypoxia (Figure 4.3D), suggesting the involvement of mitochondrial complex I in O2
-• 
production during severe hypoxia. However, only rotenone, but not FCCP or apocynin was able 
to attenuate DHE fluorescence significantly during chronic, mild hypoxia (Figure 4.3E). 
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The mitochondrial uncoupler, FCCP, the inhibitor of the respiratory chain (rotenone) and apocynin 
had no effect on DHE oxidation under normoxic conditions after 4h of treatment (Figure 4.3F) 
(see Table 4.1 for summary of results). 
 
4.3.2 Chronic, mild and severe hypoxia significantly increased 
•
NO production 
H9C2 cells were cultured in DMEM, 10% FBS under basal conditions and at 70-80% 
confluence, cells were washed briefly with PBS and loaded with O2 preequilibrated (2% O2 and 
10% O2), HEPES buffered, phenol red-free DMEM. To determine 
•
NO generation during 30min 
and 4h under severe (2% O2 + 98% N2) and mild hypoxic (10% O2 + 90% N2) conditions, cells 
were treated with 10µM DAF-2-DA at t=0min and incubated for 30min for acute hypoxia 
(severe and mild) and 4h for chronic hypoxia (severe and mild) in the chamber (See section: 
2.3.91).  
 
The same procedure was applied to normoxic controls at 21% O2 + 79% N2. Before 
measurement of the fluorescence, the old culture medium was replaced with O2-preequilibrated 
DMEM at t=27min for acute hypoxic cultures and t=3h and 57min for chronic hypoxic cultures. 
Then, fluorescence was measured at t=30min (for acute hypoxia) and t=4h (for chronic hypoxia).  
 
As illustrated in figure 4.4, there was no significant increase in 
•
NO production during acute, 
mild or severe hypoxia compared to normoxia. However, the DAF fluorescence was 
significantly increased during chronic, mild, (132.12±25.64% vs. 100% control, P<0.0001) and 
severe hypoxia (183.75±27.33% vs. 100% control, P<0.0001), compared to normoxia (see Table 
4.1 for summary of results). 
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Figure 4.3  Effects of mitochondrial uncouplers and inhibitors of the respiratory chain and 
respiratory burst on O2
-• 
generation during chronic hypoxia in cardiomyoblasts. H9C2 cells 
(3 x 10
4
/well) were cultured to 80% confluence, were washed three times with PBS and loaded 
with oxygen equilibrated HEPES buffered-phenol red-free DMEM (2%, 10% or 2% O2). Cells 
were treated with and without 20µM rotenone, 100 µM apocynin, 1µM FCCP, 100µM L-
NAME, 20µM Oxypurinol or vehicle control at t= -2min. DHE (20µM) was added at t= 0min for 
acute hypoxia; 2% O2 (A),10% O2 (B) and 21% O2 (C), whereas for chronic, severe hypoxia; 2% 
O2 (A),10% O2 (B) and 21% O2 (C), DHE (20µM) was added at t=3h 15min. At 30min or 4h, 
fluorescence was measured at 37°C using a microplate reader determining fluorescence at 
Excitation: 488nm, Emission: 570nm, cut off filter: 560nm and data are expressed in arbitrary 
units. Data represent the mean ± SEM fluorescence of three independent experiments conducted 
in triplicates. * represents P < 0.05, *** for P<0.0001 (one-way ANOVA), Tukey’s post-hoc 
test.  
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Figure 4.4  
•
NO production during mild and severe hypoxia for acute (30min) and chronic 
(4h). Cells were cultured for 48h in culture medium and were loaded with O2 equilibrated 
HEPES buffered-phenol red-free DMEM (2% or 10% or 21% O2) after 3 x PBS washes. Then, 
experimental cells were exposed to hypoxia whereas controls were maintained at normoxia (21% 
O2). Cells were treated with 10µM DAF-2-DA, 45min prior to completion of 4h hypoxia and 
probe was added at t= 0 for 30min hypoxia studies. After replacing the culture medium, 
fluorescence was measured at 37°C in Spectramax GEMINI EM fluorescence reader at 
Excitation: 491nm, Emission: 513nm. Data represent the mean±SEM fluorescence of three 
independent experiments conducted in triplicates. *** represent hypoxia vs. controls represent P 
< 0.0001 (one-way ANOVA), Tukey’s post-hoc test. 
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Figure 4.5  Effects of mitochondrial uncouplers and inhibitors of the respiratory chain on 
•
NO generation during severe hypoxia in cardiomyoblasts. H9C2 cells (3 x 10
4
/well) were 
cultured to 80% confluence, were washed three times with PBS and loaded with O2 equilibrated 
HEPES buffered-phenol red-free DMEM. Cells were treated with or without 20µM rotenone, 
1µM FCCP, 100 µM L-NAME, or vehicle control at t= -2min for all time points and DAF-2-DA 
(10µM) was added at t=0 min for 30min hypoxia; 21% (A) 10% (B) or 2% O2 (C) whereas dye 
was added at t= 3h.15min for 4h hypoxia; 21% (D), 10% (E) or 2% (F) O2. At 30min and 4h, 
fluorescence was measured at 37°C using a microplate reader determining fluorescence at 
Excitation: 491nm, Emission: 513nm, cut off filter; 495nm and data are expressed in arbitrary 
units. Data represent the mean ± SEM fluorescence of three independent experiments conducted 
in triplicates. * represents P < 0.05 and ** represent P<0.001 (one-way ANOVA), Tukey’s post-
hoc test.  
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4.3.2.1 The effect of respiratory uncoupler, L-NAME and inhibition of NADPH oxidase 
complex on 
•
NO production during mild or severe hypoxia 
To identify whether NOS-dependent 
•
NO generation occurs during hypoxia, the effect of H9C2 
incubation with the non-selective NOS inhibitor; L-NAME on DAF-2-DA oxidation, was 
examined during acute and chronic hypoxia (Section 2.3.12). Cardiac myoblasts are reported to 
generate O2
-•
 and 
•
NO, therefore may form ONOO
-
 after reaction with O2
-•
 and 
•
NO at 1: 1 ratio 
(Jiao et al., 2009). Therefore, the contribution of O2
-•
 production from NADPH oxidase to 
modulate DAF fluorescence was investigated during hypoxia, by inhibiting NADPH oxidase 
complex with 100µM apocynin. 
 
Similarly, the contribution of mitochondrial based O2
-•
 to form DAF fluorescence during hypoxia 
was assessed by uncoupling respiratory chain with 1µM FCCP. In the presence of L-NAME, 
FCCP or apocynin, DAF-2-DA oxidation was not changed significantly during acute, severe or 
mild hypoxia or normoxia compared to untreated cells (Figure 4.5A, 4.5B and 4.5C). However, 
in the presence of L-NAME, DAF-2-DA oxidation was significantly reduced during chronic, 
mild hypoxia (79.9±1.8%, P<0.0001) and chronic, severe hypoxia (81.8%±2.5%, P<0.0001) 
compared to untreated cells of control, but not with FCCP or apocynin treatment (Figure 4.5D, 
E and F) (see Table 4.1 for summary of results). 
 
4.3.2.2 Live cell imaging of 
•
NO generation during acute and chronic, severe hypoxia 
In order to confirm that DAF-2 oxidation is intracellular, real time imaging of cardiomyoblasts 
was undertaken under chronic, severe hypoxia and normoxia as described in section 2.3.10. As 
visualised in figure 4.6A, confocal microscopy images show stronger signals of DAF 
fluorescence during chronic, severe hypoxia compared to normoxia (Figure 4.6B). Moreover, 
single cell imaging with DAF showed a concentrated fluorescence at the centre of the cell as 
visualised in figure 4.6C.  
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Figure 4.6 Live fluorescence images showing 
•
NO generation during chronic, severe 
hypoxia vs. normoxia. Cells were cultured in slide chambers for 48h in culture medium and 
then loaded with O2 equilibrated HEPES buffered-phenol red-free DMEM (2% or 21% O2) after 
3 x PBS washes. The experimental cells were exposed to chronic, severe hypoxia (2% O2) 
whereas controls were maintained at normoxia (21% O2). Cells were treated with 10µM DAF-2-
DA, 45min prior to completion of 4h hypoxia. After completing hypoxic incubations, sealed 
chambers were mounted on the platform of the confocal microscope and cell images were taken 
at the fluorescence excitation at 480-490nm and emission at 510-520nm. (A) Chronic, severe 
hypoxia at 2% O2, magnification 20x (B) normoxia at 21% O2, magnification 10x and (C) DAF 
fluorescence from a single cell (Colour palette - glow yellow for DAF fluorescence). 
 
 
137 
 
4.4 Discussion 
4.4.1 Superoxide generation during hypoxia 
In summary, the present study demonstrates that mitochondria are the main site of O2
-•
 
generation in hypoxic cardiomyocytes. Other potential sources of ROS generation sites such as 
NADPH oxidase, NOS isoforms and xanthine oxidase do not contribute to global O2
-•
 production 
during both acute and severe hypoxia. In the current cellular model, the respiratory chain can 
function optimal at 10% O2 compared to hyperoxic stress-induced cells at 21% O2. Severe 
hypoxic stress (2% O2) in cardiomyocytes causes O2
-•
 production (see Figure 4.7 and Table 
4.1).  
 
The physiology of cells exposed to low levels of O2 (1-3% O2 hypoxia) is different from that of 
cells exposed to 0% O2 (anoxia) and 21% O2 (normoxia) (Chandel et al., 2005). ROS are 
important signalling molecules for adaptive response in cardiomyocytes as previously 
documented (Duranteau et al., 1998). Increased levels of ROS production during hypoxia, but 
not anoxia stabilise the transcription factor, HIF-1α (Chandel et al., 1998; Chandel and 
Schumacker, 1999). To confirm the production of O2
-•
 in H9C2 cells during 2% O2 hypoxia in 
the present model system, this study describes the systematic, time and dose-dependent kinetics 
of O2
-•
 generation as DHE oxidation during hypoxia in rat cardiomyoblasts. The cell culture 
system established in this study mimics a physiological ischaemic period through pre-incubation 
of media (in the absence of FBS and L-glutamine) for 18h under reduced partial O2 pressure and 
results in 14.5 mmHg in media under 2% O2. 
 
This work confirms that hypoxia causes significant changes in O2
-•
 generation from 
mitochondria in cardiomyoblasts during severe, chronic hypoxia as measured by DHE oxidation. 
In the presence of the superoxide dismutate mimetic, MnTBAP O2
-• 
production was significantly 
decreased which suggests the selective oxidation of DHE by O2
-•
 (Figure 4.1B). However, it is 
not clear why endogenous SOD in cardiomyoblasts does not completely scavenge O2
-•
 to 
dismutate it to H2O2 during normoxia.  
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This may indicate either that; (1) endogenous SOD is removed from the site of ROS production 
but DHE is available; and/or (2) that cells can tolerate lower O2
-•
 production due to respiratory 
chain leakage without upregulation of SOD at the given level. Other investigators have 
suggested that an increase in O2
-•
 during hypoxia is associated with loss of membrane potentials 
(∆Ψm) in mitochondria and results in the further leak of electrons to reduce O2 (Abramov et al., 
2007; Millar et al., 2007). However, the data obtained in cardiomyocytes reported here suggests 
only limited generation of O2
-•
  during acute, severe hypoxia and agrees with previous authors, 
possibly reflecting the sudden drop of O2 supply at early time points (Vanden Hoek et al., 1997). 
This could be due to loss of ∆Ψm and accumulation of O2
-•
 in the mitochondrial compartments 
that makes DHE less oxidized during early time points (Hool et al., 2005) as further observed in 
confocal images (Figure 4.2A) of acute hypoxia. Moreover, during hypoxia, a decrease in O2 
availability may reduce the rate of electron flow through the system, resulting in a slower rate of 
O2
-•
 production, even than the normoxic cells.  
 
Waypa and Schumacker, (2005) observed a decrease in O2
-•
 generation during severe hypoxia in 
pulmonary vasoconstriction and suggested this was due to the availability of O2 substrate in the 
medium. However, in Waypa and Schumacker’s, system of in vivo pulmonary vasoconstriction, 
partial O2 pressure (pO2) is less than 60mmHg in arteries (Longmore et al., 2001) where the 
system tested here is much more hypoxic with pO2 at 14.5mmHg. Hool et al. (2005) reported a 
40% significant decrease in DHE fluorescence in ventricular cardiomyocytes during hypoxia at 
pO2 of 15mmHg compared to normoxia (100%, 30min). This is very similar, except Hool et al. 
(2005) used HEPES treated-hypoxic buffer system where the present system used HEPES 
treated-DMEM medium. Other sources of ROS generation such as NADPH oxidase, xanthine 
oxidase and NOS isoforms have been reported in the intact heart (Porasuphatana et al., 2003; 
Souza et al., 2002; Li and Jackson, 2002). Xanthine oxidase (XO) is active in neurones 
(Abramov et al., 2007) and endothelial cells during ischaemia or hypoxia respectively and 
produces ROS, but the importance of this enzyme in cardiomyocytes, is unclear, and some 
workers have reported absence of xanthine oxidase in chick cardiomyocytes (Becker et al., 
1999).  
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Preliminary studies with oxypurinol, an XO inhibitor did not reduce hypoxia induced DHE 
oxidation (data not shown) and this suggests that XO is unlikely to generate ROS. Generation of 
O2
-•
 from NADPH oxidase complex has been reported (Touyz, 2008; Ushio-Fukai et al., 2002). 
However, the present study with apocynin did not cause a significant reduction in DHE 
oxidation in cardiomyoblasts, implying a lack of NADPH oxidase-dependent O2
-•
 production 
during chronic, severe or mild hypoxia (Figures 4.5D, 4.5E and Table 4.1).  
Nevertheless, such sources may contribute to produce O2
-•
 during reperfusion period (Abramov 
et al., 2007; Dodd-O and Pearse, 2000; Becker et al., 1999; Elisabetta et al., 2008). Three distinct 
isoforms of NOS (eNOS, iNOS and nNOS) are reported in rat myoblasts (Zanella et al., 2002). 
The inhibition of NOS isoforms with L-NAME did not reduce DHE oxidation as a measure of 
O2
-•
 production, suggesting that NOS isoforms are not participating in O2
-•
 production during 
hypoxia. The effect of FCCP on the ETS is not clear; however, it is assumed that the 
hydrophobicity of FCCP may allow diffusion into the mitochondrial matrix where disassociation 
of protons into the matrix would dissipate the proton gradient and would result in the collapse of 
∆Ψm.  
 
Rotenone inhibits the NADH dehydrogenase enzyme present in mitochondrial complex I, 
resulting in a decrease in NADH reduction which leads to loss of membrane potential in the 
absence of electron flux through ETS. An increase in mitochondrial O2
-•
 generation during acute, 
severe hypoxia is associated with the collapse of mitochondrial membrane potentials in the 
presence of FCCP or blockage of NADH oxidation at complex I in the presence of rotenone. 
Though, the similar effects could occur in normoxia, those effects may have led to a change in 
the oxidation state (NADH: NAD
+
 ratio) during acute, severe hypoxia and resulted in increase of 
O2
-•
 production (Abramov et al., 2007; Millar et al., 2007; Tahara et al., 2009). Moreover, 
uncoupling of mitochondria during acute, severe hypoxia allows the reducing equivalents that 
have been accumulated through the compromised respiratory chain to be discharged via electron 
leakage. Collectively, this enables the dissipation of reducing equivalents more readily 
(Abramov et al., 2007) (Figure 4.7).  
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Increased DHE fluorescence in the presence of apocynin indicates the activation of NOX 
complex via an unknown mechanism as H9C2 cardiomyoblasts are non-phagocytic cells as 
reported (Vejrazka et al., 2005; Touyz, 2008). Chronic, severe hypoxia caused a significant 
increase in O2
-•
 confirming many other reports (Li and Jackson, 2002; Vanden Hoek et al., 1998; 
Abramov et al., 2007), but this was not observed in chronic, mild hypoxia.  
When the cells were exposed to severe hypoxia, electron flow may be reversed through the ETS 
whilst the membranes are being depolarised under limiting O2 supply facilitating electron loss 
through complex I. When the mitochondrion is at rest during normoxic respiration, ∆Ψm 
provides the driving force for ATP synthesis and is generated by electron flow through the ETS 
from NADH or FADH2 (Figure 4.7). The mitochondrial membrane potential depends on the 
protons being pumped into mitochondrial intermembrane space. This is dissipated by the protons 
flowing back to couple with the membrane bound ATP synthase (complex V) along with pH 
gradients between intermembrane space and matrix. Therefore, the membrane potential reflects 
the balance between the rate of electron transport and the rate of ATP synthesis by the 
mitochondrion. Therefore, a loss of membrane potential in chronic, severe hypoxia would 
reduced the oxidation of NADH in complex I and FADH2 in complex II and result accumulation 
of more reducing equivalents. To support this hypothesis, Abramov et al. (2007) explained the 
reverse flow of electrons through the mitochondrial ETS with the accumulation of reducing 
equivalents during ischaemia. Reverse flow of electron in mitochondrial electron transport 
system may indicate as an adaptive response to recover mitochondrial membrane potentials 
during severe hypoxia.  
 
However, during low O2 tension, reverse electron flow may have led to greater electron leak to 
produce O2
-•
 within the mitochondrial matrix, offering an explanation for the data in current 
study. Moreover, mitochondrial ROS generation depends on the ratio of NADH/NAD
+
. 
Therefore, accumulation of more reducing equivalents, especially, more NADH may result in an 
increase in the NADH/NAD
+
 ratio. In support of this hypothesis, other investigators reported the 
significant increase in NADH concentrations in cells under severe hypoxia may create a more 
reductive environment in the mitochondria (Schumacker et al., 1993; Murphy, 2009).  
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The increase in NADH concentration is suggested to be an enzymatic adaptation when cells are 
exposed to prolonged hypoxia for 1-2h (Chandel et al., 1995). Therefore, accumulation of 
reduced intermediates in the mitochondrial electron transport system (ETS) would potentially 
support the leaking of electrons for O2
-•
 generation. The major site of O2
-•
 generation during 
severe hypoxia is the mitochondrion according to the current study.  
Mitochondrial complex I inhibition (rotenone) significantly attenuated DHE oxidation, 
indicating mitochondrial electron transport significantly contributes to O2
-•
 production during 
chronic, severe hypoxia (Figure 4.7). An increase in O2
-•
 in the presence of complex I inhibitor 
during acute, severe hypoxia may reflect the rapid leak of electrons to produce O2
-•
, though there 
is no apparent increase in O2
-•
 production in control cells under acute, severe hypoxia. During 
chronic, severe hypoxia, loss of voltage potentials of cytochrome oxidase should increase the 
reduction state of mitochondrial electron carriers upstream of cytochrome oxidase including the 
ubisemiquinone site of complex III. Therefore, this may increase the lifetime of reduced electron 
carriers (i.e: ubisemiquinone) and thereby, would increase the generation of O2
-•
 via univalent 
electron transfer to O2 in the mitochondria (Chandel and Schumacker, 2000; Chandel et al., 
2000). The mitochondrial complex I inhibition is upstream to the ubisemiquinone site; 
suggesting that complex I is the chief site where the ETS is blocked during hypoxia, causing 
significant increase in O2
-•
 production. This is consistent with previous authors who carried out 
studies with site-specific inhibitors (Duranteau et al., 1998; Chandel et al., 1998; Chandel et al., 
2000).   
 
It is difficult to understand how mitochondria can alter its redox state due to changes in 
extracellular O2 tensions. ―Peri-mitochondrial‖ pO2 can be much lower than the extracellular O2 
tension due to the difference in O2 concentration gradient between the plasma membrane and 
mitochondrial membrane (Chandel et al., 2000). The H9C2 cultured cells used in this 
investigation have been maintained and adapted to 21% O2 during routine culture over many 
passages (cells were used between 14-18 passages for this study) and are therefore expected to 
have adapted to living under high O2 tension.  
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This may have some impact on the levels of antioxidant enzymes (i.e.; Mn-SOD and GSH) 
present and therefore the cells ability to withstand ROS. Cells studied under 10% O2 do not 
exhibit any significant change in O2
-•
 production compared to 21% O2 (Figures 4.2B, 4.2E and 
4.1A), suggesting the optimal level of respiration at 10% O2. 
 
The presence of MnTBAP significantly decreased DHE oxidation as a measure of O2
-•
 
production during normoxia. Interestingly, MnTBAP treatment did not take DHE fluorescence to 
zero, suggesting autofluorescence was elicited under the conditions employed at 2% and 21%O2. 
Co-incubation of cells with FCCP during acute, mild hypoxia (10%; 30min) did increase the 
steady state level of O2
-•
 as seen with cells exposed to acute, severe hypoxia. This may reflect the 
fact that the respiratory chain is optimal at 10% O2 and disruption of a highly efficient metabolic 
process has catastrophic effects on the cells by increasing O2
-•
. Since the completion of these 
studies, highly selective and mitochondrial specific probes are available for detecting O2
-•
 in the 
cells or solution based systems and could have an advantage for future studies to provide real 
time measurements in mitochondrial-specific O2
-•
 generation. The characterisation of 
mitochondrial O2
-•
 production using fluorescence microscopy has clear advantages over cell-
based system with inhibitors such as they are less time consuming with exquisite precision and 
minimal impact on cell viability and function (Mukhopadhyay et al., 2007). 
 
4.4.2 
•
NO generation during hypoxia 
In summary, the significant increase in DAF fluorescence during chronic normoxia indicates 
•
NO production partly dependent on NOS, but also probably from non-enzymatic sources 
(Figure 4.7).  
It has been widely accepted that hypoxia can trigger 
•
NO generation intracellularly in various 
cell lines and in vivo models. 
•
NO has been implicated as a signalling molecule which may 
modulate cardiomyocyte death during ischaemia/reperfusion with the dysfunction of 
mitochondrial respiration (Beckman and Koppenol, 1996; Brown, 1999; Borutaite and Brown, 
2005).  
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Moreover, 
•
NO has been associated with the protection against ischaemic cell death (Rakhit et 
al., 2000). Therefore, the majority of reports suggest that 
•
NO may play a role between cell death 
and survival, that may be dependent on level of 
•
NO production and duration of exposure. 
 
The present study outlines how the duration and severity of hypoxia contributes to generation of 
•
NO. Many authors have reported an increase in 
•
NO production during hypoxia or ischaemia for 
30min and 3h in various cell lines, including cardiac myocytes (Zweier et al., 1995; Strijdom et 
al., 2006). The present data did not indicate the significant production of 
•
NO during acute, mild 
or severe hypoxia. Intracellular 
•
NO is produced by NOS isoforms through oxidation of L-
arginine to L-citrulline in the presence of available O2 and by non-enzymatic sources (Zweier et 
al., 1999). Two moles of O2 and 1.5mol of NADPH are required to produce one mole of 
•
NO 
(Lepore, 2000; Von Bohlen und Halbach, 2003). Both, chronic, mild and severe hypoxia 
significantly increased 
•
NO production as shown by an increase in DAF fluorescence. However, 
in the presence of L-NAME, the decrease in DAF fluorescence (~20%) during chronic, mild and 
severe hypoxia suggests that 
•
NO generation is at least partly NOS-dependent via the L-arginine 
pathway.  
 
Supporting this evidence, Strijdom et al. (2006) showed a significant decrease in 
•
NO production 
during hypoxia for 3h, when cardiac microvessel endothelial cells and ventricular 
cardiomyocytes rat were pre-treated with L-NAME.  In contrast, there are reports that suggest 
the generation of 
•
NO from non-enzymatic sources such as nitrites in rat hearts during ischaemia 
(Zweier et al., 1999) using EPR spectroscopy, to measure 
•
NO generation from rat hearts 
perfused with ischaemic bicarbonate buffer solution. Therefore, it is presumed that non-
enzymatic sources such as cellular nitrite stores or ETS are available or activated during hypoxia 
to generate 
•
NO/RNS and their contribution is greater than NOS-dependent 
•
NO generation. In 
support of this hypothesis, arbitrary value ~300 for 
•
NO during normoxia (4h) indicates the 
oxidation of DAF with 
•
NO generated from cellular nitrite stores under unstimulated conditions. 
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Lacza et al. (2001) and Zenebe et al. (2007) reported an increased activity of mtNOS to produce 
•
NO during hypoxia or hypoxia/reperfusion. Lacza, et al. (2001) demonstrated increased 
expression of eNOS in rats exposed to chronic hypoxia, whereas Zenebe et al. (2007) reported 
increased mtNOS activity to generate 
•
NO when cardiomyocytes were exposed to anoxia; 100% 
N2. It is evident in the present study that; the 
•
NO production during chronic, severe or mild 
hypoxia is partly NOS-dependent. However, it is difficult to explain the involvement of mt-NOS 
to produce 
•
NO in the current hypoxic model. Failure of apocynin treatment to curtail DAF 
fluorescence during chronic, severe hypoxia indicates that intracellular ONOO
-
 production is 
independent of NOX-dependent superoxide production.  
 
The uncoupling of mitochondrial ETS and mitochondrial depolarization with FCCP did not have 
any effect on 
•
NO generation during acute or chronic mild hypoxia, suggesting that 
•
NO 
generation is independent from the mitochondrial uncoupling and depolarization. DAF-2-DA 
was developed as a 
•
NO-detection probe (Kojima et al., 1998; Nakatsubo et al., 1998), and its 
specificity for 
•
NO has since been confirmed in a variety of cell types (Leikert et al., 2001; 
Lebuffe et al., 2003; Tiscornia et al., 2009) by validating results with other widely used 
indicators of 
•
NO production (Failli et al., 2001; Havenga et al., 2001).  
 
However, there are other reports, which describe selectivity of DAF-2-DA for ONOO
-
 
(Jourd'heuil, 2002; Peyrot and Ducrocq, 2007). Therefore, it is hard to exclude the possibility 
that ONOO
–
 contributed to changes in DAF-2-DA fluorescence in the present study, although 
the relative contribution of ONOO
-
 cannot be determined under current experimental conditions. 
There are a number of unresolved questions regarding the performance of these probes in 
biological systems that affect their utility in culture systems and targets of 
•
NO at intracellular 
level. The present study aimed to adapt and optimize the use of DAF-2-DA to detect and 
quantify 
•
NO production in hypoxia and reperfusion systems in which H9C2 cardiomyoblasts are 
grown in HEPES-treated culture medium.  
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(A) 
Condition Acute, severe hypoxia  
(2% O2, 30min) 
Acute, mild hypoxia 
(10% O2, 30min) 
Acute normoxia 
(21% O2, 30min) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
O2
-· Χ ↑ ↑ ↑ Χ Χ Χ ↑ Χ Χ Χ Χ Χ Χ Χ 
•NO Χ - Χ Χ Χ Χ - Χ Χ Χ Χ - Χ Χ Χ 
 
(B) 
Condition Chronic, severe hypoxia  
(2% O2, 4h) 
Chronic, mild hypoxia  
(10% O2 ,4h) 
Chronic normoxia  
(21% O2, 4h) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
       O2
-· ↑* ↓ ↓ Χ Χ Χ* Χ Χ Χ Χ Χ Χ Χ Χ Χ 
•NO ↑* Χ Χ Χ ↓ ↑* Χ Χ Χ ↓ Χ Χ Χ Χ Χ 
 
 
Table 4.1  Summary of results in acute (A) and chronic (B) hypoxia. 
Key:  Ctl - control, ROT-rotenone, FCP- FCCP, APO- apocynin and LNM- L-NAME. 
          ↑*  - Significant increase in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↓*  - Significant decrease in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↑    - Significant increase in treated cells vs. control cells at same O2 tension. 
          ↓    - Significant decrease in treated cells vs. control cells at same O2 tension. 
         Χ    - In treated cells, no significant difference vs. control cells at same O2 tension or if in  
                  control cells (2% O2 or 10% O2), no significant difference vs. normoxic cells or in  
                  normoxic cell shows the basal effect. 
          -      Not available. 
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Figure 4.7  Schematic diagram to represent effect of rotenone and FCCP on O2
-•      
production   during chronic, severe hypoxia.    - increase  or     - decrease. 
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CHAPTER 5 
HYPOXIA-INDUCED CELL DEATH 
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5.1 Preface 
The overproduction of O2
-•
 during hypoxia may contribute to cell death via necrosis or apoptosis. 
This chapter examines hypoxia-induced cell death during acute and chronic, mild and severe 
hypoxia compared to normoxic cell viability with respect to mitochondrial metabolic activity, 
necrosis and apoptosis. Quantitative necrotic cell death was assessed as PI uptake by damaged 
cells and nuclear morphology of necrotic or late apoptotic cells was further characterised by 
fluorescence microscopy. Apoptosis is initiated by proteolytic cleavage of procaspase-3 during 
hypoxia.  The quantitative measurement of procaspase-3 cleavage (the large fragment of cleaved 
caspase-3) was normalised to loading control; α-tubulin and assessed as the ratio between 
cleaved caspase-3 and procaspase-3. Mitochondrial metabolic activity during hypoxia was 
assessed as mitochondrial SDH activity. The contribution of ROS/RNS from mitochondria, 
NADPH oxidase and NOS isoforms, and Ca
2+
 flux to cell death via necrosis or apoptosis and the 
role of NF-κB activation in these processes were investigated.  The kinetics of hypoxia-induced 
protein carbonylation and ATP depletion and their association with cell death were analysed.   
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 5.2 Introduction 
5.2.1 Hypoxia-induced cell death 
ROS and RNS generation and associated oxidative/nitrosative stress leads to irreversible cell 
damage during hypoxia (Murphy, 2009; Brown and Borutaite, 2007). It has been reported that 
exposure of hypoxic cells to reoxygenation may result in exacerbated cell death compared to that 
seen with than hypoxia alone in many cells (Abramov et al., 2007; Kawahara et al., 2006; Chen 
et al., 1998). The amount of irreversible or reversible cell damage induced by hypoxia may 
depend on the severity, type of tissue and duration of hypoxia. There are at least two major 
forms of cell death, apoptosis and necrosis that are linked to over production of ROS during 
hypoxia (Crompton, 1999). Cellular necrosis is associated with prolonged anoxia or severe 
hypoxia; however, this is dependent on the type of cells in the myocardium, their cellular 
metabolic rate and the intrinsic adaptive mechanism of the tissues (Adrain and Martin, 2001; 
Bialik et al., 1999; Bromme and Holtz, 1996; Crow et al., 2004). 
 
Previous investigators have reported the appearance of apoptosis as caspase-3 activation at 
30min and DNA fragmentation at 60min in the ischaemic myocardium after a coronary 
occlusion without reperfusion in rat heart (Borutaite and Brown, 2003). Levrand et al. (2006) 
reported an increase in apoptosis and necrosis in ventricular cardiomyocytes due to increased 
production of ONOO
-
 during 2h reperfusion after 2h coronary occlusion. Cellular necrosis 
inevitably follows prolonged anoxia/ischaemia or chronic, severe hypoxia in which O2 supply is 
decreased relative to metabolic demand for ATP production in many tissues including 
cardiomyocytes (McCord, 1985). Cells undergo necrosis instead of apoptosis in the absence of 
ATP that is required for the activation of proapototic factors (Zhao., 2004; Eguchi et al., 1997; 
Tatsumi et al., 2003; Lieberthal et al., 1998). Several studies have shown that mitochondria play 
an important role in apoptosis during hypoxia (Chen et al., 2002; Bonavita et al., 2003). 
However, the interplay between mitochondrial reactive species; 
•
NO, ROS, ONOO
-
, and 
apoptosis during hypoxia is not well understood.  
150 
 
Overproduction of ROS and increased [Ca
2+
] is known to trigger cell death cascades in 
cardiomyocytes (Hajnóczky et al., 2006; Yamawaki et al., 2004; Chen et al., 2002).  Moreover, 
both intracellular Ca
2+
 overload and ROS play a role in modulation of contractility of 
cardiomyocytes through phosphorylation of PKC, which may then involve in ischaemic 
contractile dysfunction (Wang et al., 2001; Liao et al., 2002). An increase in mitochondrial Ca
2+
 
overload, depletion of ATP in cardiomyocytes and activation of glutamate receptors in neurons 
trigger cell injury during ischaemia and ischaemia/reperfusion (Crow et al., 2004; Tsujimoto and 
Shimizu, 2007; Eguchi et al., 1997; Crompton, 1999; Abramov et al., 2007).  
 
It has been reported that over-production of ROS during hypoxia or ischaemia/reperfusion leads 
to depolarisation and loss of mitochondrial membrane potentials (Crompton, 1999; Levraut et 
al., 2003; Banki et al., 1999; Yamawaki et al., 2004).  Also an increase in intracellular [Ca
2+
] has 
been reported in cardiomyocytes during hypoxia (Crompton, 1999; Levraut et al., 2003; Li and 
Jackson, 2002). It has been reported that an imbalance exists between Ca
2+
 influx by passive 
diffusion and Ca
2+
 efflux to the cytosol from the mitochondria through the mitochondrial 
permeability transition pores (MPTP), which results in an increase in [Ca
2+
] in the cytoplasm. 
Ca
2+
 concentration becomes high in the mitochondrial matrix. Eventually, opening of the MPTP 
causes mitochondrial swelling due to water influx as a result of the imbalance between solute 
concentrations in the mitochondrial matrix and the cytosol (Gottleb, 2003; Crompton, 1999). 
Consequently, this swelling in turn causes the rupture of mitochondrial membranes and release 
of pro-apoptotic factors such as cytochrome c and apoptosis-inducing factor (AIF) (Crompton, 
1999).  
Activation of procaspase-3 is necessary to induce the apoptotic cascade. The inactive form of 
caspase-3 is known as procaspase-3 (35kDa) and consists of larger fragment (17-24kDa) and 
smaller (10-12kDa) fragment. The cleavage of caspase-3 requires the aspartic acid at position 
175 (Nicholson et al., 1995). Then, cleaved caspase-3 cleaves the inhibitor of caspase-3-
activated DNase (ICAD) into 24-and 12-kDa fragments, releasing CAD. Subsequently, CAD 
translocates to the nucleus and cleaves genomic DNA which is an essential evidence of apoptosis 
(Crow et al., 2004; Enari et al., 1998; Sakahira et al., 1998; Sabol et al., 1998).  
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Mechanisms involved in triggering apoptosis or necrosis during hypoxia are not known in detail, 
but it is generally believed that the release and/or activation of various bioactive substances such 
as reactive oxygen species are important. Levraut et al. (2003) showed that the use of 
antioxidants throughout ischaemia seemed to be more protective against reperfusion injury than 
if applied only at reperfusion. Pharmacological agents used to inhibit mitochondrial complexes I 
and II reversibly are cardiac protective (Solaini et al., 2005). Some researchers have suggested 
that use of uncouplers such as FCCP, dinitrophenol (DNP) (Elz and Nayler, 1988; Brennan et al., 
2006a) and 3-NP (Turan et al., 2006) to inhibit complex II are cardioprotective. However, the 
use of antioxidants, metabolic inhibitors or mitochondrial inhibitors/ uncouplers to protect cells 
against hypoxia has not been studied thoroughly. Therefore, re-investigation of those inhibitory 
effects or uncoupler effects are important to understand the mechanism and the nature of cell 
damage during hypoxia.  
 
5.3 Results 
5.3.1 The effect of oxygen tension on metabolic activity and viability of cardiomyoblasts 
Following mild or severe hypoxia, MTT activity was determined relative to cells maintained 
under normoxia as described in sections 2.3.6.1.1. As illustrated in figure 5.1A and 5.1B, the 
exposure of cells to acute (30min) or chronic (4h), mild hypoxic conditions did not result in a 
changed metabolic activity of cells when compared to cells grown under normoxic conditions for 
the same time periods. However, cells grown in severe hypoxia showed a significant loss of 
metabolic activity after both acute (83±0.2%; 30min) and chronic exposures (65±1%; 4h) 
(Figure 5.1A and 5.1B). PI uptake was significant during acute, severe hypoxia (127.2±6.7% vs 
100.0±5.2%, P<0.05) and chronic, severe hypoxia (136.6±16% vs 100.00±13.6%, P<0.05) 
compared to normoxia, but not in acute or chronic, mild hypoxia (Figure 5.1C and 5.1D). A 
time-dependent reduction of cell metabolic activity was observed; 83.2±0.2% of control 
(100±4.2%) after 30min severe hypoxia (P<0.001) and 74.3±3% of control (100±1%) after 1h 
(P<0.001) with metabolic activity further reduced to 34±4% of control (100±3.7%) cells after 
24h hypoxia (P<0.0001) (Figure 5.2) (see Table 5.1 for summary of results). 
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Figure 5.1 Hypoxia reduces the metabolic activity and increases necrotic cell death of 
cardiomyoblasts. At the start of each experiment, the growth media of cells (80% confluent) 
was changed to HEPES buffered, phenol red-free DMEM (pre-equilibrated under 2% or 10% or 
21% O2 for 24h). Cells were immediately transferred to incubators pre-equilibrated to the same 
O2 tension. MTT was added 30mins (A: 30min, acute hypoxia) or 2h (B: 4h, chronic hypoxia) 
prior to the end of each experiment and then cells were lysed at the end of each experiment prior 
to analysis at 570nm. To assess necrotic cell death (C: 30min acute hypoxia and D: 4h, chronic 
hypoxia), following hypoxia the culture medium was removed and any detached cells were 
recovered by centrifugation. Attached and detached cells were suspended for 10µg/ml PI for 
20min at 4ºC and after 3xPBS washes, cells were resuspended in 10µg/ml Hoechst 33342 for a 
further 20min at 4ºC. Finally, cells were washed in 3 x PBS and resuspended in PBS. The dual-
fluorescence was measured at excitation 535nm/emission 617nm for PI and at excitation 
346nm/emission and 460nm for Hoechst 33342. * represents P < 0.05 and *** P<0.001 versus 
21% O2 control (one-way ANOVA), Tukey’s post-hoc test.  
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Figure 5.2 Hypoxia induced a time-dependent decrease in metabolic activity. H9C2 cells 
were seeded at 3x10
4
/well in 24-well plate and cultured until 80% confluence in DMEM, 10% 
FBS at 37°C in 5% CO2 humidified atmosphere. At 70-80% confluence, cells were washed three 
times with PBS solution and 2% O2 equilibrated, HEPES-buffered, phenol red-free DMEM was 
added and cells were exposed for hypoxia in a chamber at 2% O2 for 30min, 1h, 4h and 24h. 
MTT was added to cells at t=0min for 30min, t=0 for 1h, t=2h for 4h and t=22h for 24 hypoxia. 
After completing hypoxic incubation, cells were lysed and re-incubated for further 16h at 37° C 
in 5% CO2 humidified atmospheric conditions. An optical density was measured at 570nm. Data 
represents the mean±S.E.M of three independent experiments conducted in triplicates. *** 
represents P < 0.001 and ** represent P<0.001 (one-way ANOVA) Tukey’s post-hoc test. 
 
To further investigate whether the effect of hypoxia on MTT reduction was attributable to 
necrotic cell death or apoptosis, further analysis was undertaken using dual staining with 
Hoechst/PI. The assessment of cell death was undertaken as quantitative relative fluorescence 
measured by fluorescence spectrophotometer as described in methods (section 2.3.14). 
Microscopic analysis of apoptotic cell death was performed under Zeiss fluorescence 
microscopy as described in the methods (section 2.3.13.1).   
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(A)                       Acute hypoxia 
     
                              2% O2 - Hoechst                               2% O2 - PI 
(B) 
     
                              10% O2 - Hoechst        10% O2 - PI 
(C) 
      
         21% O2 - Hoechst                   21% O2 - PI 
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(D)                      Chronic hypoxia                                                                                                   
             
                           2% O2 - Hoechst                                  2% O2 - PI  
(E) 
            
                          10% O2 - Hoechst                                  10% O2- PI   
(F) 
            
                             21% O2 - Hoechst                                  21% O2 – PI 
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Figure 5.3  Hypoxia-induced necrotic cell death as visualized by propidium iodide and 
Hoechst 33342 stains. Cells were grown on cover slips in 24-well culture plates in DMEM for 
30min (A, B and C) and 4h (D, E and F) at 21% O2, 10% O2 and 2% O2. Immediately after 
hypoxia, cells were washed 3x with PBS and stained with PI (10µg/ml) and Hoechst 33342 
(10µg/ml) on ice for 10min in the dark. Cells were washed a further 3 x in PBS and necrosis 
visualised as PI positive staining nuclei relative to total nuclei (Hoechst stained) under a Zeiss 
fluorescence microscope at the following emissions; 460nm for Hoechst 33342 and 570-590nm 
for PI following excitation with a 405nm UV lamp.  
 
 
Necrotic cell death was increased significantly after 30min severe hypoxia and was further 
increased after 4h severe hypoxia compared to control cells incubated under normoxia for the 
same duration (Figure 5.1C and 5.1D). There was no significant increase in cell death under 
mild hypoxic conditions compared to normoxia at either time point studied. No significant 
effects on viability measured as PI uptake were observed in cells under normoxia after 30mins 
and after 4h (Figures 5.3C and 5.3F). Figures 5.3A and 5.1C illustrate the increased uptake of 
PI by cells maintained under 2% O2 for 30mins or 4h (Figures 5.3D and 5.1D) compared to 
cells maintained under 21% O2 for the same times. In addition, fewer cells remained attached to 
the microscope cover slip at lower O2 tension. Qualitative increases in PI uptake by cells 
occurred under severe hypoxia, visualised in figure 5.3, are confirmed by quantitative 
microplate fluorimetry in figures 5.1(see Table 5.1 for summary of results).   
 
5.3.2 Chronic, severe and mild hypoxia induce apoptosis  
It has been reported that hypoxia can elicit apoptosis in primary cardiomyocytes (Todor et al., 
2002). The proteolytic cleavage of caspases from precursor procaspase-3 is an early, sensitive 
indicator of caspase activation (Niquet et al., 2003; Levrand et al., 2006). In non-apoptotic 
cardiomyoblasts, procaspase-3 is detected as a single band (32kDa); during apoptosis caspase-3 
is cleaved into large (17-24 kDa) and small (10-12kDa) fragments (Todor et al., 2002).  
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Figure 5.4  Chronic, severe and mild hypoxia induce cleavage of procaspases-3. Whole cell 
lysates from cells exposed to hypoxia (30min and 4h) or normoxia-treated controls were 
resolved using 15% Tricine-SDS-PAGE and transferred to PVDF membranes. Lysate from cells 
exposed to 200µM H2O2 for 8h was employed as a positive control. Western blot analysis was 
performed using; anti-cleaved caspase-3 and anti-procaspase-3 (A). Immunoreactive bands were 
revealed by enhanced chemiluminescence. Densitometric analysis was performed as the ratio of 
cleaved caspase-3 to procaspase-3 (B). Integral data are expressed as mean±SE of three 
independent experiments. ** and * (control vs treatment) represent p<0.001 and p<0.05 
respectively (one way ANOVA), Tukey’s post-hoc test. 
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Following treatment (2% O2 severe hypoxia and 10% O2 mild hypoxia for 30min and 4h or 
normoxia) total cell lysates (20µg) were resolved by SDS-PAGE and transferred to PVDF 
membranes for immunoblotting against procaspase 3 and cleaved caspase 3. The larger cleaved 
fragment (18kDa) of procaspase-3 was detected in cardiomyoblasts exposed to chronic, severe or 
mild hypoxia. However, no cleavage band was detected in cells exposed to acute, hypoxia or 
normoxia at any time of the investigation (Figure 5.4). Lysates from H9C2 cells exposed to 
200µM of H2O2 (8h) were employed as a positive control as previously described (Park et al., 
2003). Chronic, severe hypoxia induced activation of caspase-3 as indicated by the increased 
ratio of cleaved caspase-3 to procaspase-3 (P<0.01; Figure 5.4B). Similarly, chronic, mild 
hypoxia induced procaspase-3 cleavage as illustrated by the increase in cleaved caspase-3 to 
procaspase-3 (P<0.01, Figure 5.4B) (see Table 5.1 for summary of results). 
 
 
5.3.4 The effect of metabolic inhibitors on viability and metabolic activity during mild and 
severe hypoxia 
To identify the contribution of different metabolic sources of O2
-•
 production to the toxicity of 
hypoxia, the effects of incubation with mitochondrial complex I inhibitor; rotenone (20µM), the 
respiratory chain uncoupler; 1µM FCCP, NADPH oxidase complex inhibitor; 50µM apocynin 
and the non-selective NOS inhibitor; 100µM L-NAME were examined during hypoxia (see 
section 2.3.12).  
Control cells received an equal volume of vehicle and were exposed to hypoxia or normoxia for 
30min and 4h. The mitochondrial uncoupler; FCCP, and the inhibitors of the respiratory chain 
(rotenone) and respiratory burst (apocynin) had no effects on metabolic activity (MTT reduction) 
or cell viability (PI/Hoechst assay) under normoxic conditions after either 30min (Figures 5.5C 
and 5.6C) or 4h (Figure 5.5F and 5.6F) of treatment. The presence of FCCP enhanced 
metabolic activity of cells in mild and severe hypoxia at 30mins (Figures 5.5B and 5.5A) 
compared to control cells maintained under normoxia (Figure 5.5C).  
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Similarly, non-selective inhibition of NOS isoforms with L-NAME showed a significantly 
increased metabolic activity compared to normoxia in cells incubated under 2% O2 for 4h 
(Figure 5.5D), although it did not have an effect on O2
-•
 production as determined by 
quantitative oxidation of DHE (Figure 4.3D). Other inhibitors did not show any significant 
effects on MTT reductive capacity at 30mins. During chronic hypoxia, the presence of the 
mitochondrial uncoupling agent, FCCP or the NOX inhibitor apocynin significantly reduced 
metabolic activity in H9C2 cells during mild, but not severe hypoxia (Figure 5.5E & 5.5D).  
 
In contrast, the presence of rotenone during chronic, severe hypoxia was associated with an 
increase in metabolic activity compared to untreated hypoxic control cells (Figure 5.5D), which 
was not significantly different from the MTT reductive activity of cells growing under normoxic 
conditions for 4h (Figure 5.5F). The inhibition of NADPH oxidase complex with apocynin and 
the uncoupling of the mitochondrial electron transport chain with FCCP failed to protect against 
severe hypoxia-induced loss of metabolic activity during chronic hypoxia (Figures 5.5D).  
 
To further investigate whether the effects of metabolic inhibitors during hypoxia on MTT 
reduction were attributable to perturbation of the respiratory chain or cell death, further analysis 
was undertaken using dual staining with Hoechst/PI. In the presence of metabolic inhibitors; 
mitochondrial complex I inhibitor; rotenone (20µM), the uncoupler 1µM FCCP, NADPH 
oxidase complex inhibitor; 50mM apocynin and non-selective NOS inhibitor; 100µM L-NAME 
an assessment of cell death was undertaken as quantitative relative fluorescence and by 
fluorescence microscopic analysis as previously described in sections 2.3.12, 2.3.13 and 
2.3.13.1.  
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Figure 5.5 Hypoxia-induced changes to cardiomyoblast metabolic activity are mitigated by 
modulators of mitochondrial metabolism. H9C2 cells were loaded with O2 equilibrated 
HEPES buffered-phenol red-free DMEM at 21% (C & F), 10% (B & E) or 2% (A & D) O2 with 
and without 20µM rotenone, 100 µM apocynin, 1µM FCCP or vehicle control at t=-2min. MTT 
was added at t=0min (for acute hypoxia) or 2h prior to completion of 4h hypoxia. MTT 
reduction was determined at 570nm in a microplate reader. Cell viability was analysed with 
respect to control cells maintained at the same O2 tension for the same time period. * represent P 
< 0.05, ** for P<0.01 (one-way ANOVA), Tukey’s post-hoc test. 
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Figure 5.6 Quantitative effects of mitochondrial uncoupling and metabolic inhibition on 
hypoxia-induced necrotic cell death, determined by propidium iodide (PI) and Hoechst 
33342 fluorescence. Cells were grown to 90% confluence on coverslips, washed with PBS and 
exposed to 2% O2, 10% O2 and 21% O2 for 30mins (A-C) and 4h (D-F) in the presence of 
ROS/RNS inhibitors. Following hypoxia, cells were harvested into 10µg/ml PI for 20min at 4ºC 
and after 3xPBS washing, were resuspended in 10µg/ml Hoechst 33342 for further 20min at 4ºC. 
Finally, cells were washed in PBS and dual-fluorescence was measured by excitation at 
535nm/emission at 617nm for PI and excitation at 346nm/emission at 460nm for Hoechst 33342. 
Data is expressed as a relative fluorescence ratio. * represent P < 0.05 (one-way ANOVA), 
Tukey’s post-hoc test. 
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In the presence of the complex I respiratory chain inhibitor rotenone, PI uptake was reduced 
significantly during acute, severe hypoxia (30min, 2% O2) (Figures 5.6A) and chronic, severe 
hypoxia (4h, 2% O2) (Figure 5.6D and 5.8A) by 16% and 26% respectively (p<0.05) compared 
to hypoxia treatment alone (Figure 5.3D). This effect was associated with normalised MTT 
reductive capacity (Figure 5.5D) and less DHE oxidation (Figure 4.3D) under severe, chronic 
hypoxia in the presence of rotenone. The NADPH oxidase inhibitor apocynin, prevented severe 
hypoxia-induced PI uptake by 25% after 4h (p<0.05) (Figure 5.6D and Figure 5.8B). This 
associated with a small reduction in DHE oxidation (Figure 4.3D) but no effect on MTT 
reductive activity (Figure 5.5D).  
 
Co-incubation of H9C2 cells with the mitochondrial uncoupler FCCP, had a profound effect on 
PI uptake in acute, mild hypoxia conditions, but not chronic hypoxia as visualised by 
fluorescence microscopy and by independent analysis using spectrofluorimetry (Figure 5.6B).  
FCCP increased cell death by 18% (p<0.05) over 30min at 10% O2 but this effect was no longer 
evident after 4h (Figure 5.6E). Fewer cells were analysed after FCCP treatment for 4h under 
mild hypoxia compared to 30min mild hypoxia, possibly reflecting lysis of dead cells and 
analysis of resistant cells only. The effects of acute, mild hypoxia on PI uptake paralleled 
previous observations on MTT reductive capacity (Figure 5.5B vs 5.6C) of H9C2 cells, which 
increased significantly in the presence of FCCP under acute, mild hypoxia and acute, severe 
hypoxia. Severe hypoxia induced cell death was not prevented by the presence of FCCP after 
30mins as observed in 4h hypoxia (Figures 5.6D and 5.8C) (see Table 5.1 for summary of 
results). 
 
5.3.5 Chronic, severe hypoxia causes ATP depletion 
It has been reported that depletion of ATP during hypoxia can contribute to cell death via 
necrosis or/and apoptosis (Lieberthal et al., 1998).  
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To test whether loss of ATP associated with cell death under the time and severity of hypoxia 
studies, ATP production was assessed under different hypoxic conditions using an ATP 
luminescent assay as previously described in section: 2.3.6.1.2.  
 
Cellular ATP was reduced significantly during chronic, severe hypoxia by 52% compared to 
normoxia control cells (786±15 vs 1656±29, P<0.05) and by 28% during mild hypoxia 
(1192±69) (Figure 5.7A). ATP production during hypoxia was also assessed in the presence of 
the mitochondrial complex I inhibitor; rotenone (20µM) and uncoupler; FCCP (1µM), which 
inhibit cell death during severe hypoxia. Under normoxic conditions (4h), ATP production was 
significantly reduced by 22% in the presence of rotenone (P<0.0001) and 12% in the presence of 
FCCP (P<0.0001) compared to untreated normoxic controls (Figure 5.7B) in the absence of any 
cytotoxicity. In the presence of FCCP, ATP production was significantly reduced by 43% during 
both chronic, severe (443±21 versus 786±15, P<0.0001) and mild hypoxia (673±28 versus 
1192±69, P<0.0001) compared to non-inhibited, hypoxia-exposed controls (Figure 5.7D).  
Similarly, in the presence of rotenone, ATP production was markedly reduced by 48% during 
chronic, mild hypoxia (P<0.0001) (Figure 5.7C) and 38% during chronic, severe hypoxia 
(P<0.0001) (Figure 5.7D) (see Table 5.1 for summary of results).   
 
5.3.6 Mitochondrial complex-I inhibition protects cells against chronic, severe hypoxia 
induced apoptosis 
It has been reported that increased intracellular O2
-• 
levels can activate the apoptotic cell death 
pathway (Lièvre et al., 2000). However, the relative contribution of O2
-• 
produced from different 
metabolic sources during hypoxia to induction of apoptosis is unknown. Therefore, the effects of 
incubation with the mitochondrial complex I inhibitor; rotenone, the uncoupler; FCCP, NADPH 
oxidase inhibitor; apocynin and the non-selective NOS inhibitor; L-NAME were examined  by 
western blotting for cleavage of procaspase-3 as previously described in section 2.3.12, 2.3.16 
and 2.3.16.1.  
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(B)                   Normoxia                      (D) Chronic, severe hypoxia 
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Figure 5.7 Hypoxia and metabolic inhibition causes depletion of ATP in H9C2 cells. 
Confluent (80%) H9C2 cells were pre-incubated with 20µM rotenone or 1µM FCCP for 30min 
prior to loading with O2 equilibrated HEPES buffered-phenol red-free DMEM (21% (A, B); 10% 
(A, C); or 2% (A, D) O2). After incubation for 4h, total ATP content was assessed in each lysate 
using the ATP luminescent assay. Luminescence was measured at 37°C in Spectramax GEMINI 
EM plate reader at 542nm. Data represent the mean ± SEM luminescence of three independent 
experiments conducted in triplicates. *** represents P < 0.0001 (one-way ANOVA), Tukey’s 
post-hoc test. 
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Figure 5.8  The effect of inhibitors on cleavage of procaspase–3 during severe hypoxia Total 
protein lysate (20µg) from cells exposed to severe hypoxia (4h) was resolved using 15% Tricine-
SDS-PAGE and transferred to PVDF membrane. Western blot analysis was performed using the 
primary antibodies; anti-cleaved caspase-3, procaspase-3 and loading control; anti-α-tubulin (A). 
Immunoreactive bands were revealed by enhanced chemiluminescence. Densitometry analysis 
was performed and results are expressed as the ratio of cleaved caspase-3 to procaspase-3 (B) 
and the ratio between cleaved caspase-3 to α-tubulin (C). Total protein lysate from cells exposed 
to 200µM of H2O2 for 8h was employed as a positive control. Results are expressed as mean±SE 
where n=3.  *, ** and *** represent p<0.05, p<0.001 and p<0.0001 respectively (one way 
ANOVA), Tukey’s post-hoc test. 
 
As illustrated in figure 5.8A, rotenone treatment suppressed the cleavage of procaspase-3 during 
chronic, severe hypoxia when compared to untreated and treated control cells. In the presence of 
rotenone, caspase-3 activation was suppressed as indicated by a 15-fold decrease (P<0.0001, 
0.047±0.014 vs 0.687±0.141) in the ratio of cleaved caspase-3 to loading control to α-tubulin 
(Figure 5.8B) and a 17-fold decrease (P<0.001, 0.051±0.01 vs 0.863±0.263) of the ratio between 
cleaved caspase-3 and procaspase-3. In contrast, apocynin treatment was not able to suppress the 
procaspase-3 cleavage (Figure 5.8A) induced by severe, chronic hypoxia (P<0.0001, 
0.594±0.091 vs hypoxia alone control). However, FCCP and L-NAME treatment afford some 
significant protection against procaspase 3 cleavage when analysed relative to α-tubulin 
expression but not caspase-3 content (FCCP; 0.186±0.002 and L-NAME; 0.309±0.044) (Figure 
5.8A).  
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The positive control showed a 7-fold increase in the ratio between cleaved caspase-3 to 
procaspase-3 (0.258±0.047 vs 0.030±0.005) (Figure 5.8B and 5.8C) (see Table 5.1 for 
summary of results). 
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Figure 5.9 The effect of inhibitors on cleavage of procaspase-3 during chronic, mild 
hypoxia. Total protein lysate (20µg) from cells exposed to chronic, mild hypoxia in the presence 
of inhibitors (4h) was resolved using 15% Tricine-SDS-PAGE and transferred to PVDF 
membrane. Western blot analysis was performed using the primary antibodies; anti-cleaved 
caspase-3, anti-procaspase-3 and loading control; anti-α-tubulin (A). Immunoreactive bands 
were revealed by enhanced chemiluminescence. Densitometry analysis was performed as 
previously described (B and C). Mean±SE and n=3. ** and *** (control vs. treatment) represents 
p<0.001 and p<0.0001 respectively (one-way ANOVA), Tukey’s post-hoc test. 
 
Several studies indicate that cleavage of procaspase-3 in cells can be stimulated by short term 
exposure to O2
-• 
(Madesh and Hajnoczky, 2001). In contrast, figure 5.9 shows that chronic, mild 
hypoxia induced procaspase-3 cleavage even in the absence of a detectable increase in O2
-• 
production. To investigate whether O2
-• 
preferentially activates caspase-3 compared to reaction 
with DHE or whether other radical species may be important, the effects of inhibiting different 
metabolic sources of O2
-• 
and 
•
NO generation were studied.  
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5.3.7 The inhibition of NADPH oxidase complex and NOS isoforms significantly protect 
cell against chronic, mild hypoxia-induced apoptosis 
To identify any roles for ROS/RNS as inducers of apoptosis and to suppress the execution phase 
of apoptosis during chronic, mild hypoxia, cells were treated with rotenone (20µM), FCCP (1 
µM), apocynin (100 µM) and L-NAME (100 µM) prior to exposing cells to chronic, mild 
hypoxia. Apoptosis was examined by western blotting for cleavage of procaspase-3. 
 
As illustrated in figure 5.9A, apocynin (100µM) treatment completely suppressed the cleavage 
of procaspase-3 during chronic, mild hypoxia. In control cells exposed to hypoxia alone, the 
ratio between cleaved caspase-3 and procaspase-3 (P<0.0001, 0.403±0.038 vs. 0.024±0.014) 
(Figure 5.9B) and the ratio of cleaved caspase-3 to α-tubulin (P<0.0001, 0.214±0.014 vs. 
0.002±0.002) (Figure 5.9C) were significantly increased compared to normoxia.  
 
In the presence of rotenone, chronic, mild hypoxia-induced procaspase-3 cleavage was 
suppressed but apoptosis was not completely suppressed as indicated by a 10-fold higher 
(P<0.0001, 0.109±0.021 vs. 0.002±0.002) ratio of cleaved caspase-3 to loading control; α-
tubulin and also the 8-fold higher (P<0.001, 0.2001±0.061 vs. 0.024±0.014) ratio between 
cleaved caspase-3 and procaspase-3 when compared to control cells maintained under normoxia 
(Figure 5.9A, B and C). In the presence of FCCP and L-NAME, the collapse of mitochondrial 
membrane potentials (Ψ) or inhibition of NOS isoforms respectively suppressed the cleavage of 
procaspase-3 partially during hypoxia (Figure 5.9C), though  the rotenone treatment failed to 
suppress procaspase-3 cleavage during chronic, mild hypoxia (see Table 5.1 for summary of 
results).  
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Figure 5.10  Metabolic inhibitors do not induce procaspase-3 cleavage during normoxia 
Total protein lysate (20µg) from cells exposed to normoxia in the presence of inhibitors (4h) was 
resolved using 15% Tricine-SDS-PAGE and transferred to PVDF membrane. Western blot 
analysis was performed using the primary antibodies; anti-cleaved caspase-3, anti-procaspase-3 
and loading control; anti-α-tubulin (A). Immunoreactive bands were revealed by enhanced 
chemiluminescence. Whole cell lysate from cells exposed to 200µM of H2O2 for 8h was 
employed as a positive control. Densitometry analysis was performed as the ratio of cleaved 
caspase-3 to procaspase-3 and α-tubulin (B and C). Mean±SE and n=3. *** (control vs. 
treatment) represent p<0.0001 (one way ANOVA), Tukey’s post-hoc test. 
 
 
Lysates from cells exposed to 200µM H2O2 for 8h at 21% O2 were employed as a positive 
control and showed at least 20-fold increase in procaspases-3 cleavage ((Figure 5.10A, 5.10B 
and 5.10C)). As illustrsted, all inhibitors and metabolic uncoupler did not activate significantly 
the cleavage of procaspase-3 during normoxia (Figure 5.10A, 5.10B and 5.10C). 
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Figure 5.11   Hypoxia-induced protein carbonylation during 30min but not 4h. H9C2 lysate 
was analysed for protein carbonyl content by ELISA after hypoxia and normoxia. Data are 
expressed as mean±SE and n=7. * represents p<0.05 (one way ANOVA), Tukey’s post-hoc test. 
 
 
5.3.8 Acute, but not chronic, severe hypoxia induced protein carbonylation in H9C2 
myoblasts 
Increased levels of carbonylated proteins are associated with the early stages of apoptosis or 
necrosis (England et al., 2003). However, the effects of severity and duration of hypoxia on 
protein carbonyls remains unknown and therefore, carbonyl levels were examined for any 
relationship to cell death. Total amount of protein carbonylation (nmol/mg) was assessed using 
whole cell lysate extracted from H9C2 cells after exposing to hypoxia and normoxia. As shown 
in figure 5.11, there was a significant increase in protein carbonylation during acute, severe 
hypoxia (P<0.05, 0.767±0.216nmol/mg, 30min) compared to normoxic controls 
(0.110±0.216nmol/mg, 30min). A 40% decrease in protein carbonylation was observed during 
chronic, severe hypoxia (0.506±0.131nmol/mg) compared to acute hypoxia. Acute or chronic, 
mild hypoxia did not elicit a substantial difference in protein carbonylation compared to 
normoxic controls (Figure 5.11) (see Table 5.1 for summary of results). 
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5.3.9 Effect of NF-κB inhibition and preventing extracellular Ca2+ uptake during hypoxia-
induced cell death     
It has been reported that NF-κB activation and modulation of intracellular and/or mitochondrial 
Ca
2+
 mediate cellular defence mechanism against hypoxia-induced cell death (Lu et al., 2009; 
Regula et al., 2004; Bolli,2000; Talukder et al., 2009; Persson-Rothert et al., 1994; Zhou et al., 
2009). To investigate this hypothesis, cells were treated with NF-κB inhibitor; SN-50 (5 µM or 
10µM) or EGTA (5mM or 10mM) which were added to culture medium in separate experiments 
prior to exposing cells to chronic, severe hypoxia. Cell viability was measured by the MTT 
assay. The inhibitors had no effect on H9C2 cells under normoxic conditions (Figure 5.12A). 
 
The metabolic activity of cells was significantly reduced during chronic, severe hypoxia alone 
compared to that of control cells at 21% O2 in the presence of NF-κB inhibitor (5 µM; 
0.473±0.014, P<0.001 and 10 µM; 0.390±0.0104, P<0.001) and EGTA (5mM; 0.543±0.011, 
P<0.001 or 10mM; 0.467±0.007, P<0.001), suggesting that hypoxic cell injury is increased with 
the inhibition of NF-κB and Ca2+ (Figure 5.12B) (see Table 5.1 for summary of results). 
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Figure 5.12  NF-κB and intracellular Ca2+- mediated cellular protection against cell death 
during chronic, severe hypoxia. H9C2 cells at 70-80% confluence were loaded with O2 
equilibrated HEPES buffered-phenol red-free DMEM at 21% (A) or 2% (B) O2 and then 
immediately cells were  treated with 5µM or 10µM NF-κB  inhibitor (SN-50) or 5mM or 10mM 
EGTA and vehicle for control cells at t= -2min and exposed for  2% O2 chronic, severe hypoxia. 
MTT was added 2h prior to completion of 4h hypoxia and MTT reduction was determined at 
570nm in a microplate reader. Cell viability was analysed with respect to control cells 
maintained at the same O2 tension for the same time period. *** (control vs. Treatment; SN-50 
or EGTA) represent P < 0.001 (one-way ANOVA), Tukey’s post-hoc test. 
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5.4 Discussion 
In summary, the present study shows that rat cardiomyoblasts under acute, severe hypoxia die by 
necrosis, but depletion of ATP during has not contributed to significant necrotic cell death. 
Mitochondrial complex I inhibition affords protection against apoptosis and necrosis, but 
mitochondrial uncoupling protect cells against necrosis only during acute, severe hypoxia. In 
contrast, apocynin treatment or inhibition of NOS isoforms protect cells against mild hypoxia 
induced apoptosis. Moreover, the activity of redox sensitive transcription factor, NF-κB and 
extracellular [Ca
2+
] is required to maintain metabolism during chronic, severe hypoxia (see 
Figure 5.13 and Table 5.1).  
 
Cell death is a critical cellular process involved in the pathogenesis of myocardial hypoxia and 
hypoxia-reperfusion injury. Hypoxia-induced cell death can take place via apoptosis or necrosis.  
However, investigation of the significance of myocyte-initiated cell death to overall myocardial 
injury in vivo is technically difficult due to the heterogeneity of cell types in the heart, 
involvement of neurohormonal systems and inflammatory tissue damage. Therefore, cultures of 
cardiomyoblasts provide a convenient approach to overcome those complications. The data show 
that severe hypoxia can induce a time-dependent reduction in metabolic activity in viable cells as 
measured by MTT assay, and impaired mitochondrial energy production and ion homeostasis 
may lead to cell injury and cell death. In an MTT assay, in the presence of oxidised equivalents 
from the mitochondrial respiratory chain, 3-[4, 5-dimethylthiazol-2-yl] - 2, 5 
diphenyltetrazolium bromide (MTT) is reduced by succinate dehydrogenase (SDH) in viable 
cells to insoluble violet formazan crystals (van de Loosdrecht et al., 1994). Crawford et al. 
(2003) reported a decrease in activity of SDH in mitochondrial complex II during hypoxia. 
Changes to the activity SDH affects the efficiency of MTT reduction in hypoxic cells, but this 
may be independent of cell death. In contrast, Hohl et al. (1987) demonstrated an increase in 
SDH activity during hypoxia and which was sensitive to rotenone treatment. Kinnula and 
Juujärvi. (1976) reported the absence of SDH activity during 3h anoxia in newborn rat heart and 
liver cells. An increase in PI uptake during both acute and chronic, severe hypoxia indicates 
necrotic cell death and probably late apoptotic cell death too.  
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This is further reflected in the decreased mitochondrial metabolic activity during acute, severe 
hypoxia. However, there was no evidence for cells with fragmented nuclei that may reflect late 
apoptotic conditions. Cellular necrosis is associated with tissue inflammation and cytolysis in 
cell cultures when they are exposed to hypoxia. Cellular ATP depletion that occurs in apoptosis 
may lead to necrosis; therefore mechanisms of cell death are quite likely to be overlapping via 
both necrosis and apoptosis (Lieberthal et al., 1998). Therefore, technically it is difficult to 
understand particular cell death mechanism in a cell culture system as these processes are 
frequently overlapped during hypoxia. It is mainly due to cells undergoing with natural apoptosis 
and their apoptotic bodies may not be cleared out, as there is not a phagocytic clearance system 
in in vitro cell culture system. Even though the sequence of cell death events is widely accepted, 
most probably with necrosis, the associated mechanisms and temporal relationship to events of 
apoptosis in the mitochondria during hypoxia are enigmatic to date.  
 
Recent reports describe an elevation of intracellular [Ca
2+
], which can cause depolarization of 
mitochondria during hypoxia (Kim et al., 2003; Crow et al., 2004; Crompton, 1999). The present 
study did not assess intracellular Ca
2+
 level; however, the experiments reported here show that 
blockade of Ca
2+
 uptake into cells by chelation of extracellular Ca
2+
 with EGTA increased cell 
death in hypoxia but not normoxia, suggesting that Ca
2+
 influx is important in mediating cellular 
defence against hypoxia-induced cell death. This is consistent with finding of Persson-Rothert et 
al. (1994) who demonstrated. Intracellular Ca
2+
 is important to maintain mitochondrial 
membrane potential via Ca
2+
 buffering (Crompton, 1999). However, the majority of studies 
report that chelating Ca
2+
 may disrupt Ca
2+
 influx into mitochondria and thereby reduce MPTP 
opening and consequently reduce apoptosis (Halestrap et al., 2004). Other sources of Ca
2+
 
available including endoplasmic reticulum stores (Hajnóczky et al., 2006; Gibson and Huang, 
2004; Crompton, 1999), may release Ca
2+
 and increase the intracellular Ca
2+
concentration to 
induce cell death during hypoxia. There is evidence for the accumulation of oxidised DNA, 
protein and lipids during ischaemia (England et al., 2003; Berlett and Stadtman, 1997). Indeed, 
the present studies show an increase in protein carbonyls in H9C2 cell lysates after severe 
hypoxia for 30mins, but this does not persist at 4h.  
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Therefore, an increase in O2
-• 
production may have contributed to form protein carbonyls whilst 
maintaining steady state of O2
-• 
production or early accumulation of oxidised proteins in the 
absence of a detectable increase in ROS may arise from the absence of effective proteaosome 
induction or autophagy (Asa B. Gustafsson and Roberta A. Gottlieb, 2008). Early accumulation 
of oxidised proteins may cause severe damage to cells, and selective death may remove the cells 
that are heavily oxidised resulting in less protein carbonyl detection in resistant cells at later 
times (4h) (Yaglom et al., 2003). This is consistent with the evidence for cell death (PI: hoechst 
ratio) after 30 min of severe hypoxia. In conditions where severe hypoxia is prolonged for 4h, 
cardiac myoblasts display increased PI uptake and reduced MTT reductive activity compared to 
control cells or cells under acute, severe hypoxia. This was associated with a significant rise in 
O2
-• 
levels, measured as DHE oxidation. Cleavage of procaspase-3 in cells can be stimulated by 
short term exposure to O2
-• 
(Madesh and Hajnoczky, 2001). However, chronic, severe hypoxia-
mediated apoptosis was prevented only in the presence of rotenone. The prevention of necrosis, 
measured as PI uptake, and MTT reductive activity was also preserved by L-NAME.  
 
Taking these findings together, indicates that increased ROS/RNS levels detected during 
chronic, severe hypoxia are associated with toxicity and that inhibiting ROS/RNS affords 
protection. The cleavage of procaspase-3 suggest the opening of MPTP during chronic, severe 
hypoxia possibly as a response to increased O2
-• 
production (Kim et al., 2003; Crompton, 1999). 
However, inhibition of NOS isoforms indicates that limited production of 
•
NO has contributed to 
reduce the cellular toxicity, probably by forming less ONOO
-
. There are several reports which 
claim that cardiac cell death is induced by increased production of ONOO
- 
(Levrand et al., 2006; 
Borutaite and Brown, 2005). It has been reported that a reduction of cardiac dysfunction is 
observed in hypoxic mice when they were pre-treated with 2mM L-NAME (Mammen et al., 
2003). The suppression of procaspase-3 cleavage in the presence of rotenone and associated 
reduction of DHE oxidation indicate that mitochondrial-based O2
-• 
is responsible for the 
induction of apoptosis during severe hypoxia. Indeed, others have shown the cardiac protection 
of ischaemic-rabbit hearts in the presence of rotenone with decreased production of ROS from 
mitochondrial complex I (Lesnefsky et al., 2004).  
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Therefore, the present study confirms cardiac protection observed during chronic, severe 
hypoxia in the presence of FCCP and rotenone and is consistent with previous findings (Brennan 
et al., 2006b; Brennan et al., 2006a; Lesnefsky et al., 2004). 
  
 (A) 
Condition Acute, severe hypoxia  
(2% O2, 30min) 
Acute, mild hypoxia 
(10% O2, 30min) 
Acute normoxia 
(21% O2, 30min) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
Metabolic 
activity 
↓* Χ ↑ Χ Χ Χ Χ ↑ Χ Χ Χ Χ Χ Χ Χ 
Necrosis ↑* ↓ ↓ Χ ↓ Χ Χ ↑ Χ Χ Χ Χ Χ Χ Χ 
ATP 
depletion 
Χ - - - - Χ - - - - Χ - - - - 
Apoptosis Χ - - - - Χ - - - - Χ - - - - 
Protein 
carbonyls 
↑* - - - - Χ - - - - Χ - - - - 
 
(B) 
Condition Chronic, severe hypoxia  
(2% O2, 4h) 
Chronic, mild hypoxia  
(10% O2 ,4h) 
Chronic normoxia  
(21% O2, 4h) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
Metabolic 
activity 
↓* ↑ Χ Χ ↑ Χ* Χ ↓ ↓ ↓ Χ Χ Χ Χ Χ 
Necrosis ↑* ↓ Χ ↓ ↓ Χ* Χ Χ Χ Χ Χ Χ Χ Χ Χ 
ATP 
depletion 
↑*  
¤ 
↑ ↑ - - ↑* - - - - Χ ↑ ↑ - - 
Apoptosis ↑* ↓ ↓ ↑* ↓ ↑* ↑* ↑* ↓ ↓ Χ Χ Χ Χ Χ 
Protein 
carbonyls 
Χ* - - - - Χ* - - - - Χ - - - - 
 
Table 5.1  Summary of results in acute (A) and chronic (B) hypoxia.  
Key:  Ctl - control, ROT-rotenone, FCP- FCCP, APO- apocynin and LNM- L-NAME. 
          ↑*  - Significant increase in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↓*  - Significant decrease in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↑    - Significant increase in treated cells vs. control cells at same O2 tension. 
          ↓    - Significant decrease in treated cells vs. control cells at same O2 tension. 
          Χ   - In treated cells, no significant difference vs. control cells at same O2 tension or if in  
                  control cells (2% O2 or 10% O2), no significant difference vs. normoxic cells or in  
                  normoxic cell shows the basal effect. 
           Χ*- No significant effect in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
           ¤   - Significant increase in control cells (2% O2) vs. cells at 10%O2     
           -       Not available. 
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Chronic, mild hypoxia has induced procaspase-3 cleavage even in the absence of detectable 
increases in O2
-• 
production and lack of ATP production (25% ATP depletion during chronic, 
mild hypoxia). This is associated with significantly increased 
•
NO production in the absence of 
increased O2
-•
. Procaspase-3 cleavage was inhibited in the presence of L-NAME, reducing NOS-
dependent 
•
NO production. In contrast, the absence of necrotic cell death or change in MTT 
reductive activity indicates steady state mitochondrial function. However, MPTP opening is 
required for the activation of procaspase-3. Crompton et al. (1999) reported procaspase-3 
cleavage that associated with MPTP opening in the absence of mitochondrial O2
-•
. This probably 
occurred via the induction of pro-apoptotic factors with available ATP, the other authors noted 
that apoptosis was induced during chronic, severe hypoxia, when 50% of ATP was depleted. 
Interestingly, the suppression of procaspase-3 cleavage in the presence of apocynin may suggest 
a NOX-independent effect as there is no O2
-• 
produced during chronic, mild hypoxia (Heumuller 
et al., 2008; Touyz, 2008).  
 
It has been reported hypoxia-induced HIF-1α activation is associated with transcription of 
cellular antioxidant genes. The NF-κB transcription factor is known as both a death factor and a 
survival factor during oxidative stress. The present study indicates that inhibition of NF-κB 
exacerbates the hypoxia induced cell death, suggesting that NF-κB mediates a hypoxia-induced 
antioxidant defence mechanism as previously reported ischaemia in rat cerebral endothelial cells 
(Lee, 2003). Therefore, NF-κB may play a vital role in hypoxic defence mechanism, probably by 
expression of antioxidant genes including MnSOD.  
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Figure 5.13  Hypoxia or hypoxia/reperfusion-induced ROS/RNS generation and cell death. 
.   - increase or    - decrease. 
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CHAPTER 6 
HYPOXIA/REPERFUSION-INDUCED 
ROS/RNS GENERATION AND 
ASSOCIATED CELL DEATH 
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6.1 Preface 
This chapter describes the generation of O2
-•
 and 
•
NO during acute, severe hypoxia/reperfusion 
and chronic, severe hypoxia/reperfusion and their association with mitochondrial metabolic 
dysfunction. O2
-• 
and 
•
NO combine at diffusion controlled rates to produce ONOO
-
 and may 
affect cell function. The independent contribution of different radical sources was investigated 
using inhibitors of mitochondrial uncoupling, the superoxide scavenger MnTBAP, and a 
•
NO 
donor. The goal of this chapter was to identify whether ROS/RNS generation was more 
significant during reperfusion than hypoxia alone and to understand the sources of ROS/RNS. 
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6.2 Introduction  
6.2.1 Hypoxia/reperfusion-induced ROS/RNS generation 
Reperfusion of hypoxic tissue is an important mechanism of cell and tissue injury. 
Hypoxia/reperfusion (H/R) increases ROS/RNS and attenuation of these radical species can 
protect cardiomyocytes from the irreversible damage of hypoxia/reperfusion (Li and Jackson, 
2002).  While the rapid restoration of blood supply to hypoxic tissue is imperative to minimise 
injury, paradoxically, reperfusion itself can lead to excessive injury in the form of cardiac 
dysfunction, reperfusion arrhythmias and irreversible myocardial infarction. The severity of 
hypoxia influences the outcome for cell damage during reperfusion. Hypoxic tolerance for 
various tissues differs and depends on their metabolic rate and intrinsic adaptive potential (Li et 
al., 2002). Acute, sublethal hypoxia has no reported deleterious effects and can enhance 
resistance to reperfusion injury (preconditioning). The extent of cellular injury after 
hypoxia/reperfusion is due to a balance of energy availability, mitochondrial ROS/RNS 
generation and adaptation. Other sources of ROS in cardiovascular tissue include the NADPH 
oxidase complex (Lopez-Barneo et al., 2001) and xanthine oxidase (Lee et al., 2009). ROS 
production during hypoxia/reperfusion may be due to other sources than mitochondria.  
 
The membrane associated NADPH oxidase complex that generates O2
-•
 under normoxic 
conditions has been implicated in ROS generation during ischaemia/reperfusion (Walder et al., 
1997). NADPH oxidase is a major source of ROS generation in the intact heart, whose activity 
appears to be increased by several stimuli such as PKC, angiotensin II, and TNFα in vascular 
diseases (Murdoch et al., 2006). Moreover, the membrane oxidase complex is an important 
source of ROS in ischaemic mouse lungs and other oxygenated tissues (Li and Jackson, 2002). 
•
NO has favourable and unfavourable activities in cardiac ischaemia/reperfusion injury (Brown 
and Borutaite, 2007); many of the deleterious effects in cardiomyocytes can be attributed to the 
overproduction of 
•
NO by NOS isoforms, most probably due to activation of iNOS and/or eNOS 
during hypoxia (Zenebe et al., 2007). During the early stage of reperfusion, the myocardium 
produces a large concentrated burst of 
•
NO.  
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At the same time that 
•
NO is being produced, large amounts of O2
-• 
are also generated and these 
molecules combine at diffusion controlled rates to produce ONOO
-
. 
•
NO outcompetes SOD for 
O2
-• 
(Beckman and Koppenol, 1996), so under normoxia the dismutation of O2
-•
 by SOD is likely 
to predominate over ONOO
- 
genesis due to the low concentration of 
•
NO available. However, 
when both 
•
NO and O2
-• 
increase during reperfusion, 
•
NO can outcompete intracellular SOD for 
the reaction with O2
-•
.  
 
It is worthwhile to consider that in a physiological CO2/HCO3
-
 environment, 
•
NO reacts with 
CO2 to form nitrosoperoxycarbonate anion (ONOOCO2
-
). The protonation and homolytic 
cleavage of this molecule results in NO2, 
•
OH and CO2 and ultimate cellular injury is associated 
with highly reactive NO2 and 
•
OH in addition to peroxynitrite (Zweier et al., 1999; Lepore, 
2000). The accumulation of ONOO
-
 is associated with cell injury or cell death, possibly due to 
lipid peroxidation and nitration of tyrosine residues. It has been reported that ONOO
-
 can 
irreversibly inhibit mitochondrial complexes I, II, IV and V. Further, ONOO
-
 can react with 
NADH present in complex I and change the mitochondrial redox state. Jiao et al. (2009) and  
Lalu et al. (2002)   showed an increase in tissue injury with 
•
NO/ONOO
-
, where cardiac cell 
death was attenuated by inhibiting ONOO
-
 formation. 
•
NO from mtNOS can combine with O2
-•
 
to form ONOO
- 
within the mitochondrial compartments (Ghafourifar and Cadenas, 2005).  
 
This ONOO
- 
derived from mtNOS can cause oxidation of mitochondrial components and result 
in release of key mitochondrial pro-apoptotic factors such as cytochrome c (Ghafourifar et al., 
1999) and thereby activate caspase-3 cleavage in apoptotic cell death. In contrast to the cytotoxic 
effects of 
•
NO, 
•
NO generation during ischaemia-reperfusion may act as an antioxidant in 
mitochondria to attenuate hypoxia/reperfusion injury. 
•
NO can inhibit lipid peroxidation and 
exert protective effects in many in vitro and in vivo hypoxia/reperfusion models (Li and Jackson, 
2002). The pre-exposure of cardiomyocytes to hypoxia increases iNOS mRNA and protects 
against subsequent chronic ischaemia (Rakhit et al., 2000). ONOO
-
 can also act as a signalling 
molecule in cardiac protection during reperfusion-injury (Ottenheijm et al., 2006).  
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The non-selective NOS inhibitor; LNAME, blocked cardiac preconditioning, but addition of the 
•
NO donor; S-nitroso-N-acetyl-L-penicillamine (SNAP), protected cells during reoxygenation 
(Gonon et al., 2004; Li et al., 1999b). Therefore, the protective effects of 
•
NO depend critically 
on the severity of hypoxia (pO2), its duration and the balance of 
•
NO and O2
-•
 production at 
intracellular level (Huang et al., 1997).  
 
6.2.2 ROS generation from NADPH oxidase 
Structurally, NADPH oxidase is a multimeric enzyme that is constructed of core membrane-
bound flavocytochrome comprising a catalytic NOX subunit and smallest p22phox subunit. 
Currently, there are five NOX isoforms (NOX1–5) which have been identified in different 
tissues (Bedard and Krause, 2007). Among them, NOX2 and NOX4 are the main isoforms of 
NADPH oxidase complex that are expressed in cardiac cells (Bendall et al., 2002). In order to 
activate, NOX4 or NOX2 (or gp91phox), the complex association of cytosolic regulatory 
subunits (p47phox, p67phox, p40phox and Rac1) are required (Bedard and Krause, 2007). The 
GTPase binding protein Rac1 regulates membrane NADPH oxidase activity, NF-κB activation 
and mouse liver necrosis during liver ischaemia-reperfusion (Ozaki et al., 2000). The increase in 
subunit expression and/or the translocation of regulatory subunits (in particular p47phox) from 
cytosol to the membrane are necessary to stimulate NOX2 activation and ROS production 
(Bedard and Krause, 2007).  
 
Recently, it has been reported that NADPH oxidase activity is increased in the left and right 
ventricle of myocardium of patients with end-stage of heart failure (Elisabetta et al., 2008). In 
summary, there are many possible sources of ROS/RNS that may contribute to 
hypoxia/reperfusion injury and their respective roles in affecting cardiac myocyte metabolism 
are investigated in the following chapter. 
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6.3 Results 
6.3.1 Hypoxia/reoxygenation decreased metabolic activity and viability of cardiac 
myoblasts 
The overproduction of ROS/RNS during hypoxia/reperfusion may lead to mitochondrial 
dysfunction with associated cell death (Petrosillo et al., 2005; Abramov et al., 2007).  To test this 
hypothesis, the following experiments were performed to determine acute or chronic 
hypoxia/reperfusion-induced metabolic change and cell death. As illustrated in figure 6.1A, 
hypoxia (30min)/reoxygenation (2h) did not induce a significant reduction in cell viability or 
mitochondrial metabolic activity compared to normoxia or hypoxia-maintained control cells 
(91.78±4.81% vs. 100.00±6.13%, P>0.05). However, the hypoxia control at 2% O2 for 2.5h 
showed a significant reduction in metabolic activity and cell viability compared to the normoxia 
control (78.05±4.26 vs. 100.00±6.13%, P<0.0001). Moreover, hypoxia (30min)/reoxygenation 
(2h) promoted mitochondrial metabolism by 14% compared to the hypoxia-maintained control 
during the reoxygenation period (91.78±4.81% vs. 78.05±4.26%; P<0.05).  
 
When cells were exposed to reoxygenation (2h) after chronic, severe hypoxia (2% O2, 4h), and 
mitochondrial metabolic activity was measured by MTT assay, figure 6.1B, shows a significant 
reduction in metabolic activity compared to normoxia controls (85.21±1.41% vs. 100.00±1.77%, 
P<0.001). Chronic, severe hypoxic controls showed a greater loss of mitochondrial metabolic 
activity compared to normoxia controls (77.78±1.51% vs. 100.00±1.77%, P<0.0001). However, 
total protein concentration after chronic, severe hypoxia/reoxygenation showed the greatest trend 
for loss (Figure 6.1C) (see Table 6.1 for summary of results). 
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Figure 6.1  Hypoxia/reoxygenation effects on metabolic activity and protein concentration 
of cells. H9C2 cells were seeded at 3x10
4
/well in 24-well plate and cultured until 70-80% 
confluence in DMEM, 10% FBS at 37°C in 5% CO2 humidified atmosphere. At 70-80% 
confluence, cells were washed three times with PBS solution and 2% O2 equilibrated, HEPES-
buffered, phenol red-free DMEM was added and cells were exposed for hypoxia in a chamber at 
2% O2 for 30min (acute hypoxia, A) or 4h (chronic hypoxia, B) and protein concentration (C). 
After hypoxia, the medium was replaced with reoxygenated (21% O2+79% N2) medium for 
experimental cells (hypoxia/reoxygenation) and normoxic controls, and fresh O2 pre-equilibrated 
(2% O2 + 98% N2) medium in hypoxic control cells (sustained hypoxia). Then, experimental and 
control cells were treated with MTT reagent and incubated for 2h in either severe hypoxia or 
normoxia in the chamber. After 2h incubation, cells were lysed and re-incubated for further 16h 
at 37°C in 5% CO2 in humidified atmospheric conditions. The optical density was measured at 
570nm. Data represents the mean±S.E.M of three independent experiments conducted in 
triplicates. * represents P < 0.05 and *** represents P < 0.001 (one-way ANOVA), Tukey’s 
post-hoc test. 
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Figure 6.2 Hypoxia/reoxygenation-induced O2
-•
 and 
•
NO generation. H9C2 cells were seeded 
at 3x10
4
/well in 24-well plate and cultured in DMEM, 10% FBS at 37°C in 5% CO2 humidified 
atmosphere. At 70-80% confluence, cells were washed three times with PBS solution and 2% O2 
equilibrated, HEPES-buffered, phenol red-free DMEM was added and cells were exposed for 
hypoxia in a chamber at 2% O2 for 30min or 4h. After hypoxia, the medium was replaced with 
reoxygenated (21% O2+79% N2) medium for experimental cells and normoxic controls, and 
fresh O2 pre-equilibrated (2% O2+98% N2) medium for hypoxic control cells and then exposed 
for 2h reoxygenation or normoxia. Then, cells in acute hypoxia were treated at t=1h and 45min 
with 20µM DHE for acute hypoxia/reoxygenation (A) whereas, cells in chronic, severe hypoxia 
were treated at t=5h and 15minMTT with 20µM DHE (B) or at t=5h and 30min with 10µM DAF 
(C) and further incubated until completion of 2h reoxygenation. Then, cells were lysed and 
fluorescence was measured at 37°C in Spectramax GEMINI EM fluorescence reader at 
Excitation: 488nm, Emission; 570nm, cut off filter; 550nm. The optical density was measured at 
570nm. Data represents the mean±S.E.M of three independent experiments conducted in 
triplicates. ** represents P < 0.01 and *** represents P < 0.001 (one-way ANOVA), Tukey’s 
post-hoc test. 
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6.3.2 Hypoxia/reoxygenation induced O2
-•
 generation 
A greater, significant increase in O2
-•
 production during hypoxia/reperfusion than hypoxia alone 
was previously reported to result in mitochondrial dysfunction and triggered cell death during 
reperfusion (Li and Jackson, 2002). To investigate whether hypoxia/reoxygenation may increase 
O2
-•
 production more than hypoxia alone in rat myoblasts, O2
-•
 production was measured as 
described in section 2.3.9.2. 
 
 As shown in figure 6.2B  but not figure 6.2A, DHE fluorescence was significantly increased 
after 2h but not 30min reoxygenation compared to hypoxic and normoxic controls, suggesting a 
significant increase in O2
-•
 production during the reoxygenation period alone after chronic, 
severe hypoxia (161.96±14.00% of normoxic control, P<0.0001). The DHE fluorescence in cells 
after reoxygenation increased by ~14% compared to that of cells maintained in chronic, severe 
normoxia (100%), but was not significantly different under the conditions employed in this 
study. Hypoxic controls alone significantly increased DHE fluorescence compared to normoxia 
(142.25±13.69%, P<0.001). In contrast, acute, severe hypoxia/reoxygenation did not 
significantly increase DHE fluorescence, however acute hypoxia alone showed an increasing 
trend of DHE fluorescence compared to normoxia (Figure 6.2A).  
 
6.3.3 Hypoxia/reoxygenation increases 
•
NO generation 
It has been reported that an increase in myocardial 
•
NO production occurs during 
hypoxia/reperfusion. To test this hypothesis, 
•
NO generation during chronic, severe 
hypoxia/reoxygenation was measured by quantitative oxidation of DAF-2-DA (a fluorescent 
probe for 
•
NO/ONOO
-
) following the method described in section 2.3.9.2. As illustrated in 
figure 6.2C, chronic, severe hypoxia/reoxygenation significantly increased DAF fluorescence 
compared to normoxia (141.26±21.83% vs. 100.00±15.92, P<0.001). In control hypoxic cells, 
the increase in DAF fluorescence was also significant compared to normoxia (128.35±19.71% of 
control, P<0.01).  
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Chronic, severe hypoxia/reoxygenation showed a trend towards an increase in DAF fluorescence 
compared to the hypoxic control, but was not statistically significant (Figure 6.2C). 
 
6.3.4 Respiratory chain inhibition or uncoupling, or inhibition of NADPH oxidase complex 
decrease DHE oxidation during chronic, severe hypoxia/reoxygenation 
To identify whether mitochondria and NADPH oxidase-dependent production of O2
-•
 are 
implicated in the toxicity of hypoxia/reperfusion, the effect of H9C2 incubation with 
mitochondrial complex 1 inhibitor rotenone (20µM), the uncoupler FCCP (1µM) or the NADPH 
oxidase (NOX) inhibitor apocynin (100µM) were examined during chronic severe hypoxia (4h) 
and reoxygenation (2h). Control cells received an equal volume of vehicle and were exposed to 
hypoxia or normoxia for 6h. MnTBAP was employed as a O2
-•
 scavenger. 
 
As illustrated in figure 6.3C, the mitochondrial uncoupler FCCP, and the inhibitor of respiratory 
chain rotenone, had no effect on DHE oxidation during the last 2h of normoxia. However, the 
presence of rotenone or FCCP reduced DHE oxidation significantly during chronic, severe 
hypoxia/reoxygenation and chronic, severe hypoxia alone (FCCP; 62.42±2.21% or rotenone; 
62.42±7.05% of control, P<0.0001) (Figure 6.3A and 6.3B).  
 
In contrast, apocynin treatment significantly reduced DHE oxidation by 19% during chronic, 
severe hypoxia/reoxygenation (81.00±2.47% compared to untreated H/R cells P< 0.05) (Figure 
6.3A). In control hypoxic or normoxic cells, apocynin failed to protect against DHE oxidation as 
shown in figures 6.3B and 6.3C. In the presence of MnTBAP, DHE oxidation was significantly 
decreased during chronic, severe hypoxia/reoxygenation, or hypoxia and normoxia (Figures 
6.3A, 6.3B and 6.3C) (see Table 6.1 for summary of results). 
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Figure 6.3  Effects of mitochondrial uncouplers and inhibitors of the respiratory chain and 
respiratory burst on O2
-•
 generation during chronic, severe hypoxia/reoxygenation. H9C2 
cells were seeded at 3x10
4
/well in 24-well plate and cultured for 48h in DMEM, 10%FBS at 
37°C in 5% CO2 in humidified atmosphere. At 70-80% confluence, cells were washed three 
times with PBS solution and 2% O2 equilibrated, HEPES-buffered, phenol red-free DMEM was 
added. Control cells were maintained in 21% O2. After 4h hypoxia, old culture medium was 
replaced with reoxygenated (21% O2+79% N2, A) medium in experimental cells and fresh O2 
pre-equilibrated (2% O2 + 98% N2, B or 21% O2 +79% O2, C) medium in control cells. 
Experimental cells were independently treated with 1µM FCCP or 20µM rotenone or 100µM 
apocynin or 50µM MnTBAP. Control cells received an equal volume of vehicle. Then, cells 
were exposed to reoxygenation for 2h at 21% O2 in the chamber and at t=5h and 15min, cells 
were treated with 20µM DHE and further incubated for 45min.The fluorescence was measured 
at 37°C in Spectramax GEMINI EM fluorescence reader at Excitation: 488nm, Emission: 
570nm, cut off filter: 550nm. Data represent the mean±SEM fluorescence of three independent 
experiments conducted in triplicates. * represents P < 0.05 or ** for P<0.001 or *** for 
P<0.0001 (one-way ANOVA), Tukey’s post-hoc test. 
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             (C)           Normoxia (6h) 
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Figure 6.4  Effects of mitochondrial uncouplers, inhibitors of the respiratory chain and 
NOS isoforms on RNS generation during chronic, severe hypoxia/reoxygenation. H9C2 
cells were seeded at 3x10
4
/well in 24-well plate and cultured for 48h in DMEM, 10%FBS at 
37°C in 5% CO2 in humidified atmosphere. At 70-80% confluence, cells were washed three 
times with PBS solution and 2% O2 or 21% O2 equilibrated, HEPES-buffered, phenol red-free 
DMEM was added. After 4h hypoxia, culture medium was replaced with reoxygenated (21% 
O2+79% N2, A) medium in experimental cells and fresh O2 pre-equilibrated (2% O2 + 98% N2, B 
or 21% O2 +79% O2, C) medium in control cells. Cells were independently treated with 1µM 
FCCP or 40µM rotenone or 100µM L-NAME. Control cells received an equal volume of 
vehicle. Then, cells were exposed to reoxygenation for 2h at 21% O2 in the chamber and at t=5h 
and 15min, cells were treated with 10µM DAF-2-DA and further incubated for 30min.The 
fluorescence was measured at 37°C in Spectramax GEMINI EM fluorescence reader at 
Excitation: 491nm, Emission; 513nm, cut off filter; 495nm. Data represent the mean±SEM 
fluorescence of three independent experiments conducted in triplicates. * represents P < 0.05 or 
** for P<0.001 or *** for P<0.0001 (one-way ANOVA), Tukey’s post-hoc test. 
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6.3.5 Respiratory chain inhibition, uncoupling and inhibition of NOS isoforms decrease 
DAF-2-DA oxidation during chronic, severe hypoxia/reoxygenation 
It has been reported that up-regulation of NOS isoforms increases 
•
NO during 
hypoxia/reperfusion (Lacza et al., 2001). In contrast, Lacza et al. (2006) reported that the heart 
mitochondrion is capable of significant RNS production via the respiratory chain which is 
independent of the mitochondrial NOS and arginine pathway. To investigate this hypothesis, 
hypoxia/reperfusion induced 
•
NO production was assessed during reoxygenation period, in the 
presence of mitochondrial complex I inhibitor rotenone (40µM), uncoupler; FCCP (1 µM) and 
non-selective NOS inhibitor; L-NAME (100 µM). Hypoxic and normoxic controls received an 
equal volume of vehicle and were exposed to hypoxia (6h) or normoxia (6h). 
 
As illustrated in figure 6.4C, the mitochondrial uncoupler FCCP had no significant effect on 
DAF oxidation during last 2h of normoxia (6h). The presence of rotenone, FCCP and non-
selective NOS inhibitor reduced DAF oxidation significantly compared to untreated normoxic 
cells during  last 2h of hypoxia (rotenone; 70.32±6.83%, P<0.0001, L-NAME; 80.85±6.02%, P< 
0.05 of control DAF fluorescence) (Figure 6.4B). The effect of the inhibitors; rotenone or L-
NAME and the mitochondrial uncoupler FCCP had a similar effect on DAF oxidation during 
hypoxia/reoxygenation too (Figure 6.4A).  
 
The presence of rotenone, FCCP or L-NAME reduced DAF oxidation significantly during 
chronic, severe hypoxia/reoxygenation (rotenone; 61.00±11.74% FCCP; 66.32±12.15% and 
69.30±14.62% as % of controls in the absence of inhibitors) or chronic, severe hypoxia 
(rotenone; 59.29±3.27% FCCP; 78.95±5.39% and L-NAME; 76.44±4.52 as % of control in the 
absence of inhibitors) (see Table 6.1 for summary of results).  
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6.3.6 The effect of MnTBAP and L-NAME on metabolic activity during hypoxia   
/reoxygenation 
To identify whether O2
-•
, 
•
NO and/or ONOO
-
 production are implicated in the toxicity of 
hypoxia/reoxygenation, the effects of MnTBAP and L-NAME were studied during chronic, 
severe hypoxia/reoxygenation. As illustrated in figure 6.5A, treatment of hypoxic cells with 
MnTBAP during the reperfusion period resulted in a significantly increased mitochondrial 
metabolic activity compared to untreated cells. In contrast, inhibition of NOS isoforms with L-
NAME showed an exacerbation of hypoxia/reoxygenation-induced impairment of mitochondrial 
metabolic activity by ~17% compared to untreated cells (83.17±1.23% of control P<0.05) 
(Figure 6.5A).  
 
In cells maintained in hypoxia in the presence of L-NAME during the last 2h of sustained 6h 
hypoxia, the mitochondrial metabolic activity was also increased (~12%) significantly compared 
to untreated cells (111.66±3.42% of control P<0.001), suggesting that 
•
NO production may 
contribute to impaired metabolic activity (Figure 6.4B). MnTBAP treated cells also showed a 
significantly enhanced metabolic activity during hypoxia.  
 
Treatment with the 
•
NO donor, spermine nonoate, did not significantly affect 
hypoxia/reoxygenation induced mitochondrial metabolic activity compared to untreated, and L-
NAME treated cells (spermine nonoate, 99.94±9.4% vs. L-NAME; 83.17±1.23% , P<0.001), 
Spermine nonoate, L-NAME and MnTBAP had no effect on metabolic activity during normoxia 
for 6h (Figure 6.5C) (see Table 6.1 for summary of results). 
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Figure 6.5   Effect of MnTBAP, L-NAME and spermine nonoate on hypoxia/reoxygenation 
induced cell death in rat cardiomyoblasts. H9C2 cells were seeded at 3x10
4
/well in 24-well 
plate and cultured for 48h in DMEM, 10% FBS at 37°C in 5% CO2 and humidified atmosphere. 
At 70-80% confluence, cells were washed three times with PBS solution and 2% or 21% O2 
equilibrated, HEPES-buffered, phenol red-free DMEM was added. After 4h hypoxia, culture 
medium was replaced with reoxygenated (21% O2+79% N2, A) medium in experimental cells 
and fresh O2 pre-equilibrated (2% O2 + 98% N2, B or 21% O2 +79% O2, C) medium in control 
cells. Cells were independently administered with 10µM SN-50 or 50µM MnTBAP or 100µM 
L-NAME or 100µM spermine nonoate. Untreated cells received an equal volume of vehicle. 
Then, cells were treated with the MTT reagent and experimental cells were reoxygenated for 2h 
at 21% O2 in the chamber whereas control cells at hypoxia and normoxia. After completing 
hypoxic or normoxic incubations, cells were lysed at t= 6h and reincubated for further 16h at 
37°C in 5% CO2 in humidified atmospheric conditions. The optical density was measured at 
570nm. Data represents the mean±S.E.M of three independent experiments conducted in 
triplicates. *** represents P < 0.0001 and ** for P<0.001 (one-way ANOVA), Tukey’s post-hoc 
test. 
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6.3.7 Inhibition of NF-κB did not exacerbate or inhibit changes to metabolic activity during 
hypoxia/reoxygenation. 
As shown in figure 6.5A, the inhibition of NF-κB activation with SN-50 during reoxygenation 
period did not affect the cellular metabolic activity compared to untreated cells. Treatment with 
SN-50 in control hypoxic cells during the last 2h of hypoxia did not cause a significant change in 
metabolic activity (Figure 6.5B), unlike the inhibition of NF-κB activation with SN-50 during 
chronic, severe hypoxia (Figure 5.12B). 
 
6.4 Discussion 
6.4.1 Hypoxia/reoxygenation-induced ROS/RNS generation and cell death 
Reperfusion refers to the restoration of an oxygenated blood supply to a tissue after a period of 
ischaemia, which has the potential to save tissue from hypoxic/anoxic cell death, but, 
paradoxically, oxygenation may result in permanent damage. Growing evidence from animal 
studies and clinical observations indicates that reperfusion itself can cause cellular or tissue 
injury by increasing free radicals and/or other inflammatory factors as reported by many authors 
(Li and Jackson, 2002; Penna et al., 2009; Jiao et al., 2009; Dhalla and Duhamel, 2007). 
However, the specific mechanism(s) of reperfusion injury, the nature and extent of free radicals 
produced and the effects of severity and duration of previous hypoxia within the cardiac cells 
have not been well documented.  
 
It is clear from the present work that chronic, severe hypoxia (4h) and reperfusion (2h) cause 
overproduction of O2
-• 
/ 
•
NO in rat cardiomyoblasts, probably thereby reducing metabolic 
activity. However, during the present conditions, acute, severe hypoxia (30min)/reoxygenation 
(2h) does not cause any increase in O2
-•
. 
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 Two important sources of O2
-•
/
•
NO generation; mitochondria and NOX have been identified in 
neurones during 2h reoxygenation after 30min ischaemia (Abramov et al., 2007) and 
mitochondria during 15min reoxygenation after 30min ischaemia in cardiomyocytes (Petrosillo 
et al., 2005). In contrast, the present work has shown that acute, severe hypoxia/reoxygenation 
did not elicit increased production of O2
-•
. This was actually a reduction in O2
-•
 production from 
mitochondria, probably due to restoration of the membrane potentials during reoxygenation. 
Chapter 5 showed that during 30min severe hypoxia alone, cell death and the decrease in 
metabolic activity was manifest in the absence of a detectable change in O2
-•
 production (Figure 
4.1). Metabolic recovery of cells during reoxygenation after a brief period of severe hypoxia 
(30min) compared to sustained hypoxia that restores metabolism to normoxic controls is 
consistent with the cardiac protection during reperfusion as previously reported by Serviddio et 
al. (2005).  
 
Sirviddio et al. (2005) showed the recovery of mitochondrial function in rat hearts during 40min 
reperfusion period after 45min ischaemia in respect of mitochondrial glutathione and protein 
oxidation levels. However, the Sirviddio et al. (2005), reperfusion strategy followed hypoxia 
with 3min reperfusion with 150mmHg O2 and 47min reperfusion with 600mmHg O2 .  
 
Reperfusion after chronic, severe hypoxia also elicited a significant recovery of mitochondrial 
metabolism compared to hypoxia alone as measured by the MTT assay, but cells did not recover 
to the extent seen in normoxia. It may suggest that reperfusion after chronic, severe hypoxia is 
the turning point between irreversible cell damage or hypoxic recovery. Jiao et al. (2009) 
recently reported significant apoptotic and necrotic cell death during 3h reperfusion after 30min 
ischaemia induced by coronary occlusion in mouse heart. Potential sources of free radicals 
during hypoxia/reperfusion include mitochondria, NADPH oxidase, NOS isoforms and xanthine 
oxidase as previously reported (Abramov et al., 2007; Meneshian and Bulkley, 2002; Giordano, 
2005; Asimakis et al., 2002; Frantseva et al., 2001).  
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The relative contribution of these systems to cellular outcome during reperfusion after different 
severities of hypoxia has not yet been elucidated. The evidence for the presence of xanthine 
oxidase is lacking in H9C2 cardiomyoblasts and cardiomyocytes. Moreover, Elisabetta et al. 
(2008) showed the failure of xanthine oxidase inhibitor; oxypurinol to inhibit ROS production 
during hypoxia/reperfusion in H9C2 myoblasts. Initial studies in this thesis were not able to 
demonstrate any effect of oxypurinol and therefore, its application was not considered further. In 
the present study, cardiomyoblasts exposed to chronic, severe hypoxia/reoxygenation showed an 
increase in intracellular O2
-•
 and 
•
NO production as measured by DHE and DAF-2-DA 
fluorescent probes respectively. O2
-•
 generation during the reoxygenation phase after hypoxia 
was remarkably suppressed by the superoxide scavenger MnTBAP and this scavenger exerted 
significant protection against chronic, severe hypoxia-induced metabolic inhibition, measured by 
MTT assay.  
 
In the presence of FCCP (mitochondrial uncoupler) and rotenone (complex 1 inhibitor), the 
increase in O2
-•
 and 
•
NO production during chronic, severe hypoxia/reoxygenation and chronic, 
severe sustained hypoxia was abolished, suggesting the contribution of mitochondria as a major 
source of ROS/RNS production during sustained hypoxia and hypoxia/reperfusion. The O2
-•
-
inhibitory effect of FCCP suggests that the loss of mitochondrial membrane potential in 
sustained hypoxia and reoxygenation was the crucial effect. In contrast, Abramov et al. (2007) 
reported a lack of protective effect of FCCP on O2
-•
 generation in neurons during 
ischaemia/reperfusion, which may indicate the contribution of alternative sources of O2
-•
 
production including NADPH oxidase and/or xanthine oxidase or metabolic differences between 
the cell types. Harrison et al. (2003) reported differences in ATP synthase activity in 
compensating ATP demand in neurones and cardiomyocytes.  
In the present study, a significant reduction in O2
-• 
production was obtained during 
hypoxia/reoxygenation but not sustained hypoxia, with apocynin. This indicates the activation of 
NADPH oxidase was responsible for some of the global O2
-•
 production in chronic, severe 
hypoxia/reoxygenation in addition to mitochondrial O2
-•
.  
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The failure of apocynin treatment to inhibit O2
-•
 production in control hypoxic cells (6h) 
indicates the absence of NADPH oxidase activity in these cells. Therefore, these findings 
suggest that activation of NADPH oxidase complex occurs during reoxygenation to produce O2
-•
 
and is in agreement with other investigators (Elisabetta et al., 2008). Others have used different 
hypoxia/reoxygenation conditions and systems than employed in the present study.  
 
Elisabetta et al. (2008) made H9C2 cells anoxic in an anaerobic medium (serum, glucose and 
pyruvate free, 95%N2 and 5%CO2) for 24h and then followed up for 60min during reperfusion in 
normoxic culture medium. Abramov et al. (2007) made neurones chemically anoxic for 30min in 
culture medium (serum and glucose free, 100% N2 or argon) and then exposing cells for 1h 
normoxia. Both investigators reported the sole contribution of NADPH oxidase complex to O2
-•
 
production during the reperfusion phase. Use of 2% O2 tension in the presence of glucose is 
more pathophysiologically likely and has been used here to study free radical generation under 
oxidative stress. Cellular O2 depletion occurs at a faster rate than glucose depletion during 
hypoxia, and inhibition of glucose metabolism in the absence of O2 accelerates consumption of 
the reductant, glutathione, which depends on cellular NADPH for regeneration from the oxidised 
glutathione disulphide form, and poses an additional stress before reperfusion occurs. The 
current strategy has supported the assessment of individual contributions and balance between 
mitochondria and NADPH oxidase to produce O2
-•
 during reperfusion. Therefore, activation of 
different complexes to produce O2
-•
 mainly depends on the severity and duration of hypoxia 
and/or reperfusion and the cell type. 
 
The present data also confirm 
•
NO production during hypoxia/reoxygenation; the inhibition of 
mitochondrial complex I with rotenone blocks electron flux from mitochondrial complex I and 
has a significant impact on 
•
NO generation during sustained hypoxia or reoxygenation. DAF 
fluorescence increases following intracellular oxidation by 
•
NO and/or ONOO
-
. Increased 
production of both O2
-•
 and 
•
NO during hypoxia/reoxygenation may increase ONOO
- 
formation.  
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During reperfusion, at high concentrations, 
•
NO can outcompete intracellular SOD for reaction 
with O2
-•
. ONOO
- 
is formed at a ratio of 1:1, 
•
NO and O2
-•
 (Jiao et al., 2009). In addition, SOD 
activity may be diminished during reperfusion by O2
-•
 (Maulik et al., 1995). As a result, there 
may be sustained ONOO
- 
production. Therefore, the significant reduction of DAF fluorescence 
in the presence of FCCP or rotenone may indicate the absence of O2
-•
 to form ONOO
- 
with 
modest available 
•
NO. Moreover, the disruption of the mitochondrial respiratory chain either 
reduces NOS (mtNOS) activity or the 
•
NO that can be generated by either direct 
disproportionation or reduction of nitrite to 
•
NO under the acidic and highly reduced conditions 
of hypoxia is eliminated (Zweier et al, 1999). Zenebe et al. (2007) and Lacza et al. (2001) 
reported activation of mtNOS in rat hearts by increasing Ca
2+
 during hypoxia/reperfusion, 
thereby enhancing ONOO
-
 and triggering apoptosis.  
 
The reduction in DAF fluorescence in rotenone or FCCP-treated cells during severe 
hypoxia/reoxygenation support the hypothesis of greater contribution of mitochondria to 
generate 
•
NO or ONOO
-
 under these conditions. In the presence of L-NAME, decreased DAF 
nitrosation was observed during sustained hypoxia and hypoxia/reoxygenation and that 
significant reduction may reflect the NOS-dependent 
•
NO production. However, ~30% decrease 
in DAF fluorescence in the presence of L-NAME during reoxygenation and ~20% decrease in 
DAF fluorescence during sustained hypoxia suggests ineffective inhibition or significant non-
enzymatic production of 
•
NO/related species. Lacza et al. (2006) reported the heart 
mitochondrion is capable of significant 
•
NO production via the respiratory chain which is 
independent from mitochondrial NOS and cellular arginine pathway. Lacza et al. (2006) further 
suggested pre-accumulated mitochondrial nitrosothiols could act as 
•
NO donors to produce RNS 
after reaction with O2
-•
. However, functional up-regulation of 
•
NO production from nitrosothiols 
during mild hypoxia is not demonstrated by the current study; therefore further work is 
warranted to clarify the issue.  
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Overproduction of ONOO
-
 can induce lipid, protein and DNA oxidation and ultimately lead to 
cellular dysfunction, induce necrosis and/or apoptosis. Therefore, attempts at blocking either 
•
NO and O2
-•
 overproduction during hypoxia/reperfusion may attenuate tissue injury. The current 
study has demonstrated the inhibition of cells with non-specific NOS inhibitor, L-NAME can 
attenuate 
•
NO production via NOS isoforms and reduce DAF fluorescence during 
hypoxia/reoxygenation whilst the SOD mimetic and ONOO
-
 scavenger, MnTBAP can block the 
formation ONOO
-
 and O2
-•
 (Levrand et al., 2006; Levrand et al., 2005). In contrast to the effects 
of L-NAME, dismutation of O2
-•
 with MnTBAP elicited significant protection against 
hypoxia/reoxygenation-induced loss of metabolic activity, providing evidence for mitochondrial 
metabolic recovery. In the presence of L-NAME during the last 2h of sustained severe hypoxia 
(6h), cells were protected against hypoxia (6h)-induced metabolic loss. The effect of L-NAME 
during sustained hypoxia (6h) alone underlines the efficacy of blocking one arm of ONOO
-
 
formation and the resulted protection against irreversible cell damage induced by hypoxia. This 
data is consistent the protective role of L-NAME against chronic, severe hypoxia-induced 
necrotic and apoptotic cell death as previously described in sections 5.4.4 and 5.4.7. To support 
this, increased 
•
NO production by mitochondria may have deleterious effects for mitochondrial 
regulation (Li et al., 2002). During the late stage of severe hypoxia (2% O2; 4h or 2% O2, 6h), 
•
NO production was significantly increased.  
 
Recent reports suggest the functional activation of the NOS system to produce more 
•
NO during 
hypoxia in cardiomyocytes and coronary microvessels under lower O2 tension (Strijdom et al., 
2006). In contrast, in the presence of L-NAME, the complete inhibition of 
•
NO production via 
NOS isoforms worsens the hypoxia/reperfusion injury. The addition of the 
•
NO donor, spermine 
nonoate (200µM) did not affect the loss of cell viability compared to the viability of control 
hypoxic cells. However, the release of 
•
NO from spermine nonoate was not confirmed by the 
Griess assay, nor was a dose response curve established – it is known that the effects of •NO to 
protect or damage biological systems are highly dose dependent.  
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Therefore, the cardiac protective role of 
•
NO during reperfusion period requires further 
investigation. In support of this hypothesis, Li et al. (2002) reported significantly worsened 
effects of lung injury during air ventilation when cells were pre-treated with L-NAME. These 
authors showed an accumulation of NOS substrates in lungs that were exposed to 
ischaemia/reperfusion. Moreover, Li et al. (2004) suggested an antioxidant effect of 
•
NO that 
protected against ischaemia/reperfusion in lung injury. Kawahara et al. (2006) reported the 
enhanced production of 
•
NO in cardiomyocytes that was critical in compromising cellular ATP 
supply, but conferred a protective role against ischaemia-reperfusion injury. Taken together, the 
current study suggests that the decrease in cell viability or metabolic loss during 
hypoxia/reoxygenation can been attributed to overproduction of ONOO
-
 in the face of 
significantly increased O2
-•
 with partially or increasingly available 
•
NO (Lalu et al., 2002, 
Yasmin et al., 1997). In support of this, Radi at al. (2002) reported a 100-fold increase in ONOO
-
 
production with 10-fold increase in 
•
NO and O2
-•
.  
 
6.4.2 NF-κB activation during hypoxia/reoxygenation 
Inhibition of NF-κB with SN-50 did not exacerbate hypoxia/reoxygenation-induced or hypoxia-
induced metabolic change during the last 2h of normoxia (reoxygenated cells) or hypoxia 
(control cells). In contrast, when SN-50 was added to cells for 4h during severe hypoxia, loss of 
metabolic activity was significantly increased as measured by MTT reduction (Figure: 5.12). 
These data suggest that NF-κB is activated during hypoxia, probably to induce antioxidants 
or/and protective genes but that further exposure to hypoxia (+2h) or reoxygenation (+2h) cause 
a reduction in metabolic activity that is NF-κB independent.  
 
In summary, the present study has confirmed the dual contribution of mitochondria and NADPH 
oxidase to produce O2
-•
 during the early phase of reoxygenation (2h) after chronic, severe 
hypoxia (4h). Chronic, severe hypoxia (4h)/reoxygenation (2h) and sustained hypoxia (6h) 
decrease metabolic activity, but reperfusion only partially restores the metabolic activity.  
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Acute, severe hypoxia (30min)/reoxygenation (2h) did not significantly increase O2
-•
 production, 
and cells recovered from metabolic loss during the reoxygenation period. The 
•
NO production 
during chronic, severe hypoxia/reoxygenation is partly NOS-dependent. The NOS-dependent 
•
NO generation during reoxygenation after hypoxia is cardiac protective against 
hypoxia/reoxygenation-induced cell dysfunction. 
 
Condition Chronic, severe 
hypoxia/reperfusion 
Sustained, severe hypoxia 
Control (2% O2, 6h) 
Normoxia 
Control (21% O2, 6h) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
O2
-· ↑* ↓ ↓ ↓ Χ ↑* ↓ ↓ Χ Χ Χ Χ Χ Χ Χ 
•NO ↑* ↓ ↓ - ↓ ↑* ↓ ↓ - ↓ Χ Χ Χ - Χ 
Inhbitors Ctl MnBP SPN APO LNM Ctl MnBP SPN APO LNM Ctl MnBP SPN APO LNM 
Metabolic 
activity 
↓* ↑ Χ - ↓ ↓*   
 
↑ Χ - ↑ Χ Χ Χ - Χ 
 
 
Table 6.1  Summary of results of chronic, severe hypoxia/reperfusion induced-ROS/RNS 
                  generation and metabolic inhibition.  
Key:  Ctl - control, ROT-rotenone, FCP- FCCP, APO- apocynin, LNM- L-NAME, MnBP-  
           MnTBAP and SPN- spermine Nonoate. 
          ↑*  - Significant increase in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↓*  - Significant decrease in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↑    - Significant increase in treated cells vs. control cells at same O2 tension. 
          ↓    - Significant decrease in treated cells vs. control cells at same O2 tension. 
          Χ   - In treated cells, no significant difference vs. control cells at same O2 tension or if in  
                  control cells (2% O2 or 10% O2), no significant difference vs. normoxic cells or in  
                  normoxic cell shows the basal effect. 
          Χ*-  No significant effect in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ¤   -  Significant increase in control cells (2% O2) vs. cells at 10%O2     
          -       Not available. 
 
 
 
 
 
 
204 
 
CHAPTER 7 
ANALYSIS OF REDOX-SENSITIVE 
TRANSCRIPTION FACTORS; NF-κB AND 
Nrf2 DURING HYPOXIA AND 
REOXYGENATION 
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7.1 Preface  
This chapter describes the optimisation of transfection conditions including DNA to 
Lipofectamine ratio to achieve the highest transfection efficiency and determine the activity of 
nuclear factor kappa B (NF-κB) and nuclear factor erythroid-2 related factor 2 (Nrf2) after 
exposing cells to hypoxia alone and hypoxia/reoxygenation. Activation of redox sensitive 
transcription factors; NF-κB and Nrf2 was studied during chronic, severe hypoxia and chronic, 
severe hypoxia/reoxygenation. To find out any cytoprotective role of NF-κB expression, cell 
viability of H9C2 cardiomyoblasts was assessed with inhibition of NF-κB during chronic, severe 
hypoxia. The activation of redox sensitive transcription factor Nrf2 was studied during hypoxia 
and hypoxia/reoxygenation. Nrf2 activation was further assessed in the presence of the SOD 
mimetic; MnTBAP, NOS inhibitor; L-NAME and the nitric oxide donor; spermine nonoate to 
determine the contribution of O2
-•
, 
•
NO and related species such as ONOO
-
 to activate Nrf2 
during chronic, hypoxia and hypoxia/reoxygenation. A possible mechanism for Nrf2 activation 
during hypoxia and hypoxia/reperfusion is discussed. 
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7.2 Introduction  
7.2.1 NF-κB activation during hypoxia 
Hypoxia is a stress condition of low O2 concentration. It has clinical significance in 
cardiovascular disease-related conditions such as myocardial infarction, ischaemia reperfusion 
and heart failure. However, cells have their own natural defence mechanisms to protect against 
hypoxia-induced deleterious effects by expressing a number of genes as a result of transcription 
factor activation during hypoxia. The regulated genes/transcription factors include erythropoietin 
and vascular endothelial growth factor by hypoxia inducible factor (Hif-1α), heat shock proteins 
by heat shock factors. However, the cellular signals that mediate the activation of transcription 
factors by hypoxia alone have not been clearly elucidated. It has been reported that growing 
numbers of stress-related genes are involved in the activation of transcription factor, NF-κB 
(Kukreja, 2002). It is evident that activation of NF-κB occurs rapidly upon ischaemic insult in 
many tissues such as renal epithelial cells (Lee and Han, 2005), brain, liver and myocardium 
(Kukreja, 2002). Li et al. (1999a) reported a 2-fold increase of NF-kB DNA binding activity in 
rat heart following a brief period of ischaemia. 
 
The NF-κB-dependent activation of gene transcription does not require de novo protein synthesis 
and this is a characteristic feature of early response gene inducers. This feature allows activated 
NF-κB to bind to a promoter site where it can initiate the rapid synthesis of protective and 
signaling proteins after exposure to various stress conditions including hypoxia. The activation 
of NF-κB during hypoxia or ischaemia or reperfusion is complex as the family of transcription 
factors autoregulate themselves. There are three distinct subunits of NF-κB found in a cells; p50, 
p65 and IkBα. The major isoforms of NF-κB is inactive in the cytoplasm with the inhibitory 
subunit, IkBα, bound to the p50-65 heterodimer. Upon activation, phosphorylation of the IkBα 
subunit takes place and results in the cleavage of IkBα. Then, the p50-p65 heterodimer complex 
is translocated from the cytoplasm to the nucleus where it binds with high affinity kB binding 
motifs.   
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In vitro studies have shown that c-AMP-dependent kinases, membrane-associated kinases and 
heme-regulated kinases are responsible for the activation of NF-κB (Lee, 2003; Kukreja, 2002; 
Guro et al., 2001). It has been reported that ROS, TNF-α , PMA and LPS cause activation of 
membrane associated kinases (src, ras and raf) which lead to dissociation of IkBα and the 
activation of NF-κB  (Kukreja, 2002). NF-κB has been reported to regulate iNOS gene 
expression in rat glioma cells stimulated by TNF-α and LPS (Lee et al., 2003) and increases the 
production of 
•
NO in LPS treated cells (Lee et al., 2003). Moreover, NF-κB activation induces 
anti-apoptotic genes and proteins such as cellular inhibitors of apoptosis (cIAP-2), Bcl-2, haem 
oxygenase-1 (HO-1) and MnSOD (Koong et al., 1994; Lee, 2003). It has been documented that 
activation of NF-κB may reflect an early response for the transcription of redox-sensitive genes 
whose products may have a vital role during defence mechanism against hypoxia. Indeed, the 
activation of the NF-κB signaling pathway is sufficient to suppress cell death of ventricular 
myocytes during chronic, severe hypoxia for 24h (Regula et al., 2004).  
 
In contrast, it has been reported that reduction of infarct size occurred in rat hearts when NF-κB 
activation was inhibited by specific peptide inhibitors; PR11 and PR39 (Adrienn et al., 2003). 
Moreover, Zingarelli et al. (2002) have reported that the sesquiterpene lactone parthenolide; the 
inhibitor of Ikk and NF-κB activation, reduced reperfusion injury in rat hearts. Xuan et al. (1999) 
reported that activation of NF-κB is essential to achieve ischaemia preconditioning after 24h. 
However, prolonged activation of NF-κB may contribute to cardiac dysfunction and 
ischaemia/reperfusion injury through over expression of myocardial cytokines (Kukreja, 2002). 
Therefore, various explanations about the role of NF-κB during hypoxia or ischaemia with 
regard to cell death and cardiac protection must be investigated. 
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7.2.2 Nrf2 activation during hypoxia and hypoxia/reperfusion 
It has been widely accepted that exposure to ischaemia or hypoxia or reperfusion leads to 
induction of protective genes, however, the mechanism of their induction remains unclear. 
Transcriptional up-regulation of cytoprotective genes is responsible for buffering the cell’s 
―antioxidant capacity‖. These genes are responsible for maintenance of cellular glutathione 
content and conjugational activity. Moreover, they play a vital role in detoxification of damaging 
radical products of oxidative stress which include glutathione S-tranferase, aldehyde 
dehydrogenases, haem oxygenase-1, ferritin and quinine oxidoreductases such as NADPH 
quinone oxidoreductase (Nioi et al., 2003).  
 
Nrf2 activation during hypoxia or ischaemia/reperfusion occurs due to an alteration in the redox 
state of cells by increased amounts of ROS/RNS which can activate an antioxidant response to 
protect themselves from future oxidant damage (Nioi et al., 2003). Nrf2 is a flavoprotein which 
catalyses the two electron reduction of quinones, thereby inhibiting redox cycling of xenobiotics. 
Recent studies indicate that Nrf2 is essential for transcriptional activation of mouse NQO1 and 
other cytoprotective genes following treatment with electrophiles (Itoh et al., 1997). Therefore, 
Nrf2 transcription factor is reported as a master regulator of this specific antioxidant phenotype 
(Mathers, 2004).  
 
The promoter regions of the Nrf2 dependent genes are cis-acting sequences and antioxidant 
response elements (AREs). AREs have been identified in variety of genes including NQO1. The 
consensus sequence of ARE is important in transcriptional activation of NQO1 upon oxidative 
stress. During oxidative stress, Nrf2 can bind with the ARE sequence and thereby increased 
antioxidant-gene expression occurs (Itoh et al., 1997). During normoxia, this transcription factor 
is held in the cytoplasm by a cytoskeletal-associated inhibitory protein; Kelch-like ECH-
associated protein 1(KEAP1), however, Nrf2 is constantly targeted for proteasomal degradation.  
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During oxidative stress, thiol oxidation occurs in cysteine residues of the hinge region of 
KEAP1, resulting in a conformational change in KEAP1 with the loss of Nrf2 binding and 
proteosomal targeting of KEAP 1 (Li et al., 2004). Then, Nrf2 accumulates and localizes to the 
nucleus and with its cofactors, up-regulates cytoprotective genes through the transcriptional 
activation of ARE. A reduction in infarcted volume is observed following focal cerebral 
ischaemia in the presence of the Nrf2 inducer; sulforaphane (Shah et al., 2007).  
 
Moreover, Lee and Johnson, (2004 ) showed that neural cells that lacked Nrf2 (Nrf2-/- mice) 
were more susceptible to oxidative stress than control neurons from control animals (Nrf2 +/+ 
wild mice), however, when the cells (Nrf2-/- mice) were transfected with a functional Nrf2 
construct, they became resistant to oxidative stress. Dhakshinamoorthy and Porter, (2004) 
reported that dominant negative-Nrf2 stable neuroblastoma cells were more prone to apoptosis 
induced by nitric oxide when they were silenced with siRNA.  
 
The contribution of 
•
NO and/or O2
-•
 or related species including ONOO
-
 to modulate Nrf2 
activity and thereby affect cell death has not yet been studied in detail during hypoxia or 
hypoxia/reperfusion. Excessive production of O2
-•
 and 
•
NO may result overproduction of ONOO
-
 
which is known to cause cell death and has been implicated in the pathophysiology of 
ischaemia/reperfusion and inflammation. However, ONOO
-
 produced in low amounts may serve 
as an intracellular signal molecule inducing the adaptive survival response to cellular stress. In 
this context, it has been reported that expression of several phase II detoxifying or antioxidant 
enzymes such as glutathione S-transferase and Mn superoxide dismutase (MnSOD) occurs in the 
presence of ONOO
-
 (Kang et al., 2002; Li et al., 2006). Moreover, ONOO
-
 has also been 
reported to induce HO-1 in rat liver in vivo (Motterlini et al., 1996). The underlying mechanisms 
of ONOO
-
 or other ROS/RNS including O2
-•
 and 
•
NO to protect cardiomyoblasts via modulation 
of NF-κB and/or Nrf2 during hypoxia/reperfusion remains to be clarified. 
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7.3 Results  
7.3.1 DNA: Lipofectamine 2000 ratio 
In order to achieve higher transfection efficiency, the ratio of total DNA and Lipofectamine 2000 
was optimised for each transfection with pGL 3 [nqo1/luc] plasmid for Nrf2 activation and pGL3 
[3enh/conA/luc] for NF-κB  activation and pGL 4.4 [hRluc/TK] for TKRL activation in control 
cells as described in section 2.3.21.1 and 2.3.21.2. 
 
Lipofectamine 2000 is supplied as a 1mg/ml solution. According to the manufacturer’s 
instructions, generally the mass ratio of DNA to Lipofectamine 2000 is 1:2 to 1:3; however a 
greater ratio can be employed in transfection. As shown in Figure 7.1, the amount of plasmid 
DNA is held constant at 1.2µg (experimental plasmid DNA to control plasmid at 1:10 ratio) and 
a significant increase in Con A promoter mediated luciferase gene expression was observed at 
1:4 ratio (DNA to Lipofectamine 2000), whereas a significant increase in ARE/NQO1 mediated 
luciferase gene expression was observed at both 1:3 and 1:4 ratio. Therefore, all subsequent 
experiments were conducted using 1:4, plasmid DNA to Lipofectamine 2000 ratio.  
 
7.3.2 NF-κB   and Nrf2 activation during chronic, severe hypoxia 
It has been reported that a marked increase in NF-κB activation occurs during hypoxia (Koong et 
al., 1994). To test the hypothesis that NF-κB  mediates a cellular defence mechanism during 
chronic, severe hypoxia, H9C2 cells at 90-95% confluence were co-transfected with pGL3 
[3enh/conA/luc]/ pGL 4.4 [hRluc/TK] : Lipofectamine at 1:4 ratio and incubated for 24h at 37ºC 
in a humidified atmosphere of 5% CO2 and 95% air. After 24h, cells were washed with PBS and 
loaded with 2% O2 equilibrated, HEPES buffered phenol red-free DMEM and incubated at 2% 
O2 for 4h and then firefly to renila luciferase luminescence was measured as previously 
described in Section 2.3.21.2. 
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Figure 7.1  Effect of plasmid DNA: Lipofectamine 2000 ratio on reporter transfection 
efficiency. H9C2 cells grown at 90-95% confluence in 24-well plates were washed with PBS 
and Opti-MEM and transfected with NF-κB  plasmid; pGL 3 [3enh/conA/luc]) DNA with control 
plasmid; pGL 4.4 [hRluc/TK] DNA in total of 1.2µg/ml DNA to Lipofectamine 2000 at 1:3 and 
1:4 ratios. Same procedure was applied to Nrf2 plasmid; pGL3 [nqo1/luc]/TKRL plasmid with 
pGL 4.4 [hRluc/TK]. Following transfection, cells were incubated for 24h. Then, cells were 
washed gently, loaded with phenol red-free medium containing 1µg/ml LPS and incubated for 
4h at 37ºC in a humidified atmosphere of 5% CO2 and 95% air. Plates were centrifuged and 
medium was replaced with 100µl of phenol red-free DMEM. Then, firefly to renila luciferase 
luminescence was measured at 542nm in a Spectramax luminometer at room temperature. Data 
were normalised as described in section 2.3.21.2. Data represents the mean±S.E.M of three 
independent experiments conducted in triplicates. *** represents P < 0.0001 and ** represents 
P<0.001 (one-way ANOVA), Tukey’s post-hoc test. 
 
As illustrated in Figure 7.2 and 7.3, an increase in luciferase gene expression suggest that 
chronic, severe hypoxia significantly increased the NF-κB /DNA  and Nrf2/DNA binding 
activity compared to control cells maintained at 21% O2 normoxia (P<0.001). Cells treated with 
the NF-κB inhibitor; SN-50 showed suppression of NF-κB - activation as indicated by a lower 
value ratio of firefly/renila luminescence. The suppression of NF-κB /DNA binding was 
significant in the presence of the NF-κB  inhibitor; SN-50 in positive LPS-treated controls, 
whereas LPS treatment-induced significant NF-κB  (Figure. 7.2) and Nrf2 activity (Figure. 7.3) 
compared to untreated control cells as indicated by luciferase gene expression and luminescence 
(P<0.001,control vs. treatment). 
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Figure 7.2  Effect of hypoxia on NF-κB /DNA binding activity in H9C2 cells subjected to 
chronic, severe hypoxia. H9C2 cells grown at 90-95% confluence in 24-well plates were 
washed with PBS and Opti-MEM and transfected with pGL 3 [3enh/conA/luc]/ pGL 4.4 
[hRluc/TK]  plasmids (1.2µg/ml): Lipofectamine 2000 complexes at 1:4 ratio for NF-κB  
expression and cells were then incubated for further 24h. Then, cells were washed gently, loaded 
with 2% O2 equilibrated, HEPES buffered phenol red-free DMEM and incubated at 2% O2 for 
4h. Positive control cells were loaded with phenol red-free DMEM, containing 1µg/ml LPS and 
incubated for 4h at 37ºC in a humidified atmosphere of 5% CO2 and 95% air. After 4h, plates 
were centrifuged and medium was replaced with 100µl of phenol red-free DMEM and firefly to 
renila luciferase luminescence was measured at 542nm in a Spectramax luminometer at room 
temperature. Data were normalised as described in section 2.2.8.9.2. Data represents the 
mean±S.E.M of three independent experiments conducted in triplicates. * represents P < 0.05 
(one-way ANOVA), Tukey’s post-hoc test. 
 
 
7.3.3 Nrf2 activation during hypoxia and hypoxia/reoxygenation 
A marked increase in the activation of antioxidant transcription factor Nrf2 during ischaemia- 
reperfusion has been reported (Leonard et al., 2006). To ascertain whether this occurs in H9C2 
cells during chronic, severe hypoxia or hypoxia/reperfusion, cells at 90-95% confluence were co-
transfected with pGL 3 [nqo1/luc] plasmid harbouring the  NQO1 promoter / pGL 4.4 
[hRluc/TK] control plasmid : Lipofectamine  at 1:4 ratio and incubated for 24h at 37ºC in a 
humidified atmosphere of 5% CO2 and 95% air.  
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After 24h, cells were washed with PBS and loaded with 2% O2 equilibrated, HEPES buffered 
phenol red-free DMEM and incubated at 2% O2 for 4h. For reperfusion, the medium was 
replaced with pre-equilibrated oxygenated medium and incubated for a further 2h at 21% O2. 
The firefly to renila luciferase luminescence ratio was measured as described in section 2.3.21.2. 
 
 
 
 
 
 
 
 
 
Figure 7.3  Effect of hypoxia on Nrf2/DNA binding activity in H9C2 cells subjected to 
chronic, severe hypoxia. H9C2 cells grown at 90-95% confluence in 24-well plates were 
washed with PBS and Opti-MEM and transfected with pGL3[nqo1/luc]/pGL 4.4 [hRluc/TK]  
plasmids (1.2µg/ml): Lipofectamine 2000 complexes at 1:4 ratio for NF-κB  expression and cells 
were then incubated for a further 24h. Then, cells were washed gently, loaded with 2% O2 
equilibrated, HEPES buffered phenol red-free DMEM and incubated at 2% O2 for 4h. Positive 
control cells were loaded with phenol red-free DMEM, containing 1µg/ml LPS and incubated for 
4h at 37ºC in a humidified atmosphere of 5% CO2 and 95% air. After 4h, plates were centrifuged 
and medium was replaced with 100µl of phenol red-free DMEM and firefly to renila luciferase 
luminescence was measured at 542nm in a Spectramax luminometer at room temperature. Data 
were normalised as described in section 2.3.21.2. Data represents the mean±S.E.M of three 
independent experiments conducted in triplicates. *** represents P < 0.0001 and ** represent 
P<0.001 (one-way ANOVA), Tukey’s post-hoc test. 
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Figure 7.4   Effect of severe hypoxia and hypoxia/reoxygenation on Nrf2/DNA binding 
activity in H9C2 cells. H9C2 cells grown at 90-95% confluence in 24-well plates were washed 
with PBS and Opti-MEM and transfected with pGL3 [3enh/conA/luc]/pGL 4.4 [hRluc/TK] 
(1.2µg/ml): Lipofectamine 2000 complexes at 1:4 ratio for NF-κB to TKRL expression and cells 
were then incubated for a further 24h. Then, cells were washed gently, loaded with 2% O2 
equilibrated, HEPES buffered phenol red-free DMEM and incubated at 2% O2 for 4h. Control 
normoxic cells were incubated at 21% O2 for 4h and positive control cells were loaded with 
phenol red-free DMEM, containing 100µM H2O2 and incubated for 6h at 37ºC in a humidified 
atmosphere of 5% CO2 and 95% air. After 4h, experimental cells were centrifuged and medium 
was replaced with pre-equilibrated (21% O2) medium and further incubated for 2h at 21% O2. 
Control pates were centrifuged and medium was replaced with preequilibrated medium (2% O2 
or 21% O2) accordingly and further incubated for 2h. After 6h (hypoxia/reoxygenation or 
sustained hypoxia or normoxia), plates were gently centrifuged and medium was replaced with 
100µl of phenol red-free DMEM and firefly to renila luciferase luminescence was measured at 
542nm in a Spectramax luminometer at room temperature. Data were normalised as described in 
section 2.3.21.2. Data represents the mean±S.E.M of three independent experiments conducted 
in triplicates. *** represents P < 0.0001 and ** represents P<0.001 (one-way ANOVA), Tukey’s 
post-hoc test. 
 
The transfection of H9C2 cells with pGL 3 [nqo1/luc] plasmid leads to ARE-mediated luciferase 
gene expression (Nioi et al., 2003). Figure 7.3 confirms that chronic,severe hypoxia promotes 
Nrf2 activity.  
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As illustrated in figure 7.4, Nrf2 DNA/binding activity was significantly increased during 
chronic, severe hypoxia/reoxygenation and sustained hypoxia alone when compared to normoxia 
alone (P<0.001, hypoxia vs. hypoxia/reoxygenation). However, Nrf2, DNA/binding activity after 
during hypoxia/reoxygenation was not significantly different to chronic, severe hypoxia (6h) 
alone. The positive control, LPS-treated cells showed a significant increase in Nrf2/DNA 
binding activity after 4h compared to control normoxic cells (Figure 7.3), whereas the positive 
control, H2O2 (6h) cells showed a trend for increased Nrf2/DNA binding response, but it was not 
significant compared to control normoxic cells (Figure 7.4) (see Table 7.1 for summary of 
results).  
 
7.3.4 Nrf2 activation during severe hypoxia/reoxygenation in the presence of SOD mimetic; 
MnTBAP, non-selective NOS inhibitor; L-NAME and 
•
NO donor; spermine nonoate. 
 
In order to find out the effect of O2
-•
 and 
•
NO on Nrf2 activation during severe 
hypoxia/reperfusion, cells were initially exposed to chronic, severe hypoxia for 4h and then  
subjected to reoxygenation (2h) in the presence of a SOD mimetic; 50µM MnTBAP, or a non-
selective NOS inhibitor; L-NAME or the 
•
NO donor; spermine nonoate.  
 
In the presence of MnTBAP, ARE-mediated luciferase gene expression in sustained hypoxia and 
hypoxia/reoxygenation was significantly reduced, suggesting the suppression of Nrf2/DNA 
binding activity in ARE/NQO1 promoter region compared to normoxia alone. It further showed 
that O2
-•
 is important in activation of Nrf2 gene transcription during both hypoxia and 
hypoxia/reoxygenation. The non-selective inhibition of NOS isforms in the presence of L-
NAME, resulted in a decrease in ARE/NQO1 mediated luciferase gene expression during 
sustained hypoxia (6h), but it was not significant compared to normoxic controls (Figure 7.5A).  
 
216 
 
In contrast, in the presence of L-NAME, ARE/NQO1 mediated luciferase gene expression was 
significantly reduced during hypoxia/reoxygenation compared to normoxic controls, suggesting 
that 
•
NO generation is important for Nrf2 activation during reoxygenation period.  
 
In the present study, there is no significant increase in Nrf2 activity in the presence of the 
•
NO 
donor; spermine nonoate as measured by luciferase gene expression during 
hypoxia/reoxygenation and normoxia. Perhaps, Nrf2 activation is 
•
NO concentration-dependent 
or may require alternative species to induce activation (Figure 7.5B and 7.5C).  
 
In the presence of MnTBAP, ARE/NQO1 mediated luciferase gene expression was not 
significantly changed during normoxia, suggesting that O2
-•
 generation during normoxia does not 
contribute to Nrf2 activation. Moreover, the addition of the 
•
NO donor; spermine nonoate during 
normoxia did not increase the activation of Nrf2/DNA binding significantly with ARE/NQO1 
promoter gene (Figure 7.5C), suggesting that 
•
NO alone is not responsible for Nrf2 activation 
(see Table 7.1 for summary of results). 
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Figure 7.5 ROS or RNS-dependent activation of Nrf2 gene expression during 
hypoxia/reoxygenation. H9C2 cells grown at 90-95% confluence in 24-well plates were washed 
with PBS and Opti-MEM and co-transfected with pGL 3 [nqo1/luc] plasmid / pGL 4.4 
[hRluc/TK] plasmid (1.2µg/ml): Lipofectamine 2000 complexes at 1:4 ratio and cells were then 
incubated for a further 24h. After that, cells were washed gently and loaded with 2% O2 
equilibrated, HEPES buffered phenol red-free DMEM and incubated at 2% O2 for 4h. After 
hypoxia, existing culture medium was replaced with pre-equilibrated reoxygenated medium 
containing 50µM MnTBAP or 100µM L-NAME or 100µM spermine (Sp) nonoate and further 
incubated for 2h at 21% O2. Hypoxic and normoxic controls were also treated as appropriate. 
After hypoxia (A) or reoxygenation (B) alone or normoxia (C), firefly to renila luciferase 
luminescence was measured at 542nm in a Spectramax luminometer at room temperature. Data 
were normalised as described in section 2.3.21.2. Data represents the mean±S.E.M of three 
independent experiments conducted in triplicate. ** represents P<0.001 and *** represents P < 
0.0001 (one-way ANOVA), Tukey’s post-hoc test. 
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7.4 Discussion 
7.4.1 NF-κB activation during hypoxia 
The present study indicates that the transcription factor, NF-κB may play a role in cardiac 
protection against hypoxic injury. This is supportive of previous data, that NF-κB activation may 
play a vital role in ischaemic preconditioning (Kukreja, 2002). Others have shown that the NF-
κB pathway is involved in the activation of apoptosis through suppression of bcl-2 as previously 
reported in aortic endothelial cells during hypoxia (Matsushita et al., 2000). In the present study, 
a significant increase in con-A promoter mediated luciferase gene expression suggests an 
increase in the activation of NF-κB /DNA binding during chronic, severe hypoxia compared to 
normoxia treated controls. The observed increase in NF-κB activation associates with O2
-•
 
production during chronic, severe hypoxia (section 4.4.1). The inhibition of NF-κB activation in 
the presence of the NF-κB inhibitor, SN-50 was associated with an increase in cell death by 40% 
and the presence of SN-50 reduced NF-κB activation to the same as observed in normoxia 
controls in the current reporter assay. 
 
 A statistically significant increase in LPS-induced NF-κB activation was observed, and was 
inhibited by SN-50 according to the conditions employed in present system. A significant 
increase in NF-κB activity occurred at 4h during glucose-oxygen deprivation in cerebral 
endothelial cells with a 10% reduction in cell viability after 8h of oxygen-glucose deprivation 
(Lee, 2003). In contrast, H9C2 cells showed higher sensitivity in the current cell-system of 2% 
O2 hypoxic medium containing 4.5g/L glucose and significant cell death was induced at 4h.  
Koong et al. (1994) showed the activation of NF-κB during 0.02% hypoxia for 4h in Jurkat-T 
cells grown in culture medium containing 10% FBS and 4.5g/L glucose. However, hypoxia-
induced cell death was not measured. Regula et al. (2004) reported a significant decrease in 
apoptotic cell death during hypoxia (pO2 <5mmHg, 24h) in ventricular myocytes transfected 
with luciferase reporter plasmid after activation of IkB-wt mediated NF-κB gene transcription 
compared to normoxic cells.  
219 
 
To test the role of hypoxia alone, measurement of cell metabolic activity during chronic, severe 
hypoxia in cardiomyoblasts transfected with the luciferase reporter plasmid containing NF-κB 
promoter site has been studied. Therefore, the present system investigates the balance between 
hypoxia-induced cell death and NF-κB activation-induced cell protection. 
 
It is presumed that redox imbalance during hypoxia may have led to IkBα phosphorylation and 
ubiquitination (4h), during chronic, severe hypoxia leading to NF-κB release. Subsequent 
nuclear translocation of the activated p65 subunit (containing transactivation domain) then 
activates the con-A promoter of the plasmid and thereby, induces luciferase gene expression in 
transiently transfected H9C2 cells (Gao et al., 2005). Ischaemic preconditioning is an important 
area for potential treatment of ischaemic reperfusion injury. Myocardial protection by NF-κB 
activation leads to a reduction of inflammation or upregulation of protective enzymes such as 
MnSOD and iNOS (Adrienn et al., 2003; Nguyen et al., 2009; Rushworth et al., 2008). In 
summary, the present study suggests NF-κB activation as a therapeutic target to protect cells 
against myocardial hypoxic injury. It has been reported that activation of NF-κB occurs during 
myocardial reperfusion (Regula et al., 2004). Therefore, further work should investigate the 
effect of hypoxia/reperfusion on NF-κB activation and its association with hypoxia/reperfusion-
induced cell death using this reporter cell line. 
 
7.4.2 Nrf2 activation during chronic, severe hypoxia and hypoxia/reoxygenation 
ROS/RNS generated during hypoxia, hypoxia/reperfusion have been proposed to act as 
signalling intermediates for cellular defence, or preconditioning, however downstream targets 
have not been fully elucidated. Nrf2 activation occurs due to an alteration in the redox state of 
cell in the presence of increased amounts of ROS/RNS. Therefore, the present study examined 
the pattern of Nrf2 mediated reporter gene expression during chronic, severe hypoxia and 
hypoxia/reperfusion (severe hypoxia for 4h+reoxygenation for 2h) and also has investigated the 
role of O2
-•
 and 
•
NO production in Nrf2 activation.  
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According to recent reports, Nrf2-mediated antioxidant gene expression affords a highly specific 
and co-ordinated response to protect the cells against hypoxia or hypoxia reperfusion-induced 
oxidative stress (Nguyen et al., 2009; Dreger et al., 2009; He et al., 2009).  
 
Moreover, the activation of Nrf2 has been identified as an inducer of antioxidant genes; NQO1, 
MnSOD, iNOS and the GST pathway (Rushworth et al., 2008; Nioi et al., 2003; Nguyen et al., 
2009). Evidence to support this has been gained by increased activation of ARE/NQO1 mediated 
Nrf2 reporter gene expression during chronic, severe hypoxia and hypoxia/reoxygenation 
compared to normoxic controls.  
 
The current study presents evidence that supports the concept that hypoxia and 
hypoxia/reoxygenation-dependent activation of Nrf2 is mediated through ROS/RNS production. 
This was evidenced through the use of superoxide dismutase mimetic; MnTBAP, which resulted 
in an inhibition of activation of Nrf2 during hypoxia and hypoxia/reperfusion. Previous work 
(chapter 4) confirmed the significant reduction of O2
-•
 production in the presence of MnTBAP, 
during chronic, severe hypoxia. Similarly, in the presence of the non-selective NOS inhibitor; L-
NAME, Nrf2 activation was significantly decreased during hypoxia reoxygenation, suggesting 
that 
•
NO generation may have contributed to Nrf2 activation, but not O2
-•
 generation alone.  
 
During hypoxia alone, the presence of L-NAME showed a trend to protect against Nrf2 
activation, but was not statistically significant. In contrast, in the presence of MnTBAP, 
•
NO 
generation from NOS would induce Nrf2, but no activation of Nrf2 was observed, suggesting 
that 
•
NO alone is not responsible for Nrf2 activation. This is further evident as there is no 
significant increase in Nrf2 activation upon addition of 
•
NO donor, spermine nonoate in hypoxia, 
hypoxia/reperfusion and normoxia.Supporting this, Li et al. (2006) reported that ONOO
-
 
activates Nrf2 via PI3K/Akt signalling and enhances Nrf2–ARE binding, which leads to 
upregulation of HO-1 expression in nitrosative stress in PC12 cells.  
221 
 
During hypoxia/reoxygenation in the presence of L-NAME, the significant inhibition of Nrf2 
activation suggests a requirement for 
•NO production possibly to make ONOOˉ, as an Nrf2 
inducer. In contrast, Nrf2 activation during normoxia was not affected by the presence of 
MnTBAP, L-NAME and spermine nonoate. In summary, the present study concludes that Nrf2 
activation depends on O2
-.
 and 
•NO, probably to generate ONOOˉ during hypoxia and 
hypoxia/reperfusion.  
 
(A) 
Condition Chronic, severe hypoxia  
(2% O2, 4h) 
Chronic, mild hypoxia  
(10% O2 ,4h) 
Chronic normoxia  
(21% O2, 4h) 
Inhibitors Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM Ctl ROT FCP APO LNM 
NFkB 
activity 
↑* - - - - - - - - - Χ Χ Χ Χ Χ 
Nrf2 
activity 
↑* - - - - - - - - - Χ Χ Χ Χ Χ 
 
(B) 
Condition Chronic, severe 
hypoxia/reperfusion 
Sustained, severe hypoxia 
Control (2% O2, 6h) 
Normoxia 
Control (21% O2, 6h) 
Inhbitors Ctl MnBP SPN APO LNM Ctl MnBP SPN APO LNM Ctl MnBP SPN APO LNM 
Nrf2 
activation 
↑* ↓ Χ - ↓ ↑* ↓ Χ - ↓ Χ Χ Χ - Χ 
 
Table 7.1  Summary of results of chronic, severe hypoxia and hypoxia/reperfusion 
                  induced - NFkB and Nrf2 activation.             
       Key:  Ctl - control, ROT-rotenone, FCP- FCCP, APO- apocynin, LNM- L-NAME, 
                  MnBP- MnTBAP and SPN- spermine Nonoate. 
          ↑*  - Significant increase in control cells (2% O2 or 10% O2) vs. normoxic control cells. 
          ↓    - Significant decrease in treated cells vs. control cells at same O2 tension. 
          Χ   - In treated cells, no significant difference vs. control cells at same O2 tension or if in  
                  control cells (2% O2 or 10% O2), no significant difference vs. normoxic cells or in  
                  normoxic cell shows the basal effect. 
          -       Not available. 
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CHAPTER 8 
DISCUSSION, CONCLUSION  
AND FUTURE WORKS 
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8.1 Discussion 
Pathobiology of ischaemia‐reperfusion injury in the myocardium has long been established in in 
vivo and in vitro vascular research. Antioxidants in cardiomyocytes maintain redox homeostasis 
and any perturbation of its status has distinctive deleterious effects. It appears that while 
excessive generation of reactive species (Chapter 4 and Chapter 6) leads to cellular injury 
(Chapter 5 and Chapter 6), their regulated generation may cause transient and reversible 
modifications leading to signal transduction for induction of adaptive responses (Chapter 7). 
Taken together, the present study demonstrated that generation of reactive oxygen‐nitrogen 
species in cardiomyocytes plays a central role in mediating both cardiac injury and 
cardioprotection. 
 
It has been suggested that increased levels of ROS are produced during hypoxia although others 
have disputed this (Waypa and Schumacker, 2005; Toescu, 2004; Duranteau et al., 1998). Others 
propose that ROS production during hypoxia is an artifact of analytical methods, where 
hydroethidine may be acting as a mitochondrial membrane potential sensor detecting 
depolarisation that occurs during hypoxia (Budd et al., 1997). However, these arguments can be 
discounted if the fluorescence of superoxide-dependent oxidation product, 2-OH-E
+
 is analysed 
rather than oxidised ethidine and if changes observed after hypoxia are maintained in lysates; 
after lysis, all oxidised hydroethidine is released from organelles and effects on fluorescence due 
to different pH between subcellular compartmentalization are eliminated (Luetjens et al., 2000; 
Zhao et al., 2003).  
In this study, analysis of H9C2 cell fluorescence attributable to 2-OH-E
+
 was not different 
between lysates and intact cells supporting the hypothesis of present study that an increase in 
fluorescence during hypoxia is attributable to mitochondrial superoxide anion radical production 
(Chapter 4). Moreover, to minimize the contribution of artefactual oxidation due to 
photooxidation, all experiments were conducted in the dark and old culture medium was 
replaced with fresh pre-equilibrated medium to minimize background fluorescence prior to 
analysis (Chapter 3).  
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Fluorescence of DHE or DAF was measured or visualized according to optimum incubation 
times in respect to stability of oxidized probe, minimal fluorescent decay and low light excitation 
in order to minimise photo-activation (Chapter 4) (Abramov et al., 2007; McArdle et al., 2005; 
Murrant et al., 1999). 
 
The present study describes a systematic, time and dose-dependent study of the kinetics and 
effects of ROS/RNS formation during hypoxia in H9C2 rat cardiac myoblasts which show 
morphological, biochemical and electrophysiological properties of cardiac cells but with the 
advantage of being derived from a single clonal population (Hescheler et al., 1991). The present 
study has established a culture system which mimics a physiological ischaemic period. Cells 
were maintained in DMEM as O2 depletion occurs at a faster rate than glucose depletion during 
hypoxia, and inhibition of glucose metabolism accelerates consumption of the reductants, 
glutathione, as cellular NADPH is depleted, posing hypoxic cells under additional oxidative 
stress.  
 
Cardiac myoblasts exposed to 0.23mg/L O2 (severe hypoxia) showed a reduction in metabolic 
activity associated with oxidative phosphorylation and a reduction in membrane integrity (PI 
uptake) during acute and chronic, severe hypoxia. During acute, severe hypoxia, cell death was 
manifest in the absence of a detectable change in O2
-•
 or 
•
NO production (Table 8.1A), whereas 
others have reported induction of ROS/RNS in different hypoxic models (Abramov et al., 2007; 
Becker et al., 1999). Together these data suggest that either; (1) the steady state O2
-•
 or 
•
NO level 
is unchanged during an acute hypoxic event; or (2) the steady state of O2
-•
 in the cell is 
maintained although its rate of production may be increased as it is rapidly removed through 
dismutation by SOD and subsequent degradation by catalase or by reaction with other molecules 
e.g. proteins, lipids and DNA or production of ONOO
- 
(Aulak et al., 2004). In the present study, 
there was ample evidence for an accumulation of protein carbonyls during acute severe hypoxia 
which fits with this hypothesis (Kowaltowski and Vercesi, 1999; Levraut et al., 2003) (Table 
8.1A).  
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Intracellular 
•
NO production during acute, severe hypoxia may trigger tyrosine nitration which is 
a biomarker for 
•
NO generation in cells (Aulak et al., 2004). Present study has not described the 
investigation of tyrosine nitration, although it is warranted as a future direction. Cell death 
during chronic, severe hypoxia; metabolic loss, necrosis and apoptosis was associated with 
significantly increased O2
-•
 and 
•
NO levels, measured by DHE and DAF respectively. There is a 
high chance of ONOO
- 
formation with the increased production of both O2
-•
 and 
•
NO. 
•
NO 
production during chronic, severe or mild hypoxia is partly NOS-dependent as evident by the 
decrease in DAF fluorescence in the presence of L-NAME (Table 8.1A).  
 
It is presumed that mtNOS contributes to 
•
NO production during hypoxia and hypoxia 
reperfusion (Zenebe et al., 2007; Lacza et al., 2001; Kojima et al., 1998; Brown and Borutaite, 
2007), although eNOS or iNOS in the cytosol may also be important. The study of isolated 
mitochondria during chronic, severe hypoxia is warranted to measure 
•
NO generation in the 
presence of L-NAME. ONOO
-
 can cause irreversible damage to all mitochondrial compartments, 
leading to mitochondrial dysfunction (Brown and Borutaite, 2007; Brown, 1999; Borutaite and 
Brown, 2005). Therefore, cell death during hypoxia may reflect both ROS/RNS effects. The 
reported increase of NF-κB and Nrf2 activity during chronic, severe hypoxia suggests the 
activation of gene expression at a point of balance between protection and cell death (Table 
8.1A). However, ONOO
-
 is reported as an inhibitor of NF-κB/DNA binding (Levrand et al., 
2006; Levrand et al., 2005; Liaudet et al., 2009).  In contrast, Matata and Galiñanes, (2002) 
reported the activation of NF-κB using micro molar concentrations of ONOO-. It is likely that 
NF-κB activation or inhibition by ONOO- is dose, time and cell type-dependent. The increase in 
PI uptake during acute, severe hypoxia suggests necrotic cell death during acute or chronic, 
severe hypoxia and is associated with accumulation of protein carbonyls (Shimizu et al., 1996; 
England et al., 2003). Closer examination by fluorescence microscopy confirmed the presence of 
both necrotic and ―late‖ apoptotic cells, during chronic, severe hypoxia, but not in acute, severe 
hypoxia. Necrosis can be initiated by quantitative ATP depletion (Gasbarrini et al., 1992; 
Nicotera et al., 1986) and elevation of intracellular Ca
2+
 which may disrupt the cytoskeleton and 
membrane integrity by activating Ca
2+
-dependent proteases (Shimizu et al., 1996).  
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However, the present study does not support this hypothesis as ATP depletion does not change 
during acute, severe hypoxia. Early accumulation of oxidized proteins in the absence of 
detectable increase in ROS/RNS may reflect rapid oxidation of protein carbonyls in the absence 
of effective proteasome induction or autophagy (Asa B. Gustafsson and Roberta A. Gottlieb, 
2008). The most severely damaged cells that are heavily oxidised may undergo selective death 
with the more adapted, viable cells exhibiting lower levels of protein carbonyls at 4h (Asa B. 
Gustafsson and Roberta A. Gottlieb, 2008) (Table 8.1A).  
 
However, the effects of significant ATP depletion during chronic, severe hypoxia, the likely 
elevation of intracellular Ca
2+
 and the activation of Ca
2+
- dependent proteases (Nicotera et al., 
1986; Gasbarrini et al., 1992) were excluded. Incorporation of 5 or 10mM EGTA into the 
medium exacerbated cell death during chronic, severe hypoxia. Instead dysfunctional 
mitochondria or other organelles due to increased protein carbonyl formation by overproduction 
of O2
-•
 or protein/tyrosine nitration induced by overproduction of 
•
NO/ONOO
- 
may account for 
toxicity of hypoxia.  
The increase in protein oxidation is likely to occur at the mitochondrion, thereby stimulating 
autophagy and may contribute to further organelle dysfunction under prolonged hypoxia (Zorov 
et al.,2006; Kowaltowski and Vercesi, 1999). In addition, triggering of the mitochondrial 
permeability transition (Crompton, 1999) may occur leading to apoptosis. Increased production 
of 
•
NO during chronic, mild hypoxia did not trigger loss of mitochondrial metabolism, necrosis 
or ATP depletion, but did trigger apoptosis (Brown and Borutaite, 2007; Brown, 1999; Davidson 
and Duchen, 2006). Therefore, the study of mitochondrial permeability transition, cytochrome c 
release or other apoptogenic factors in the cytoplasm is warranted after chronic, mild hypoxia. 
Activation of apoptosis observed under these conditions involved 
•
NO, as the presence of L-
NAME was associated with suppression of procaspase-3 cleavage. In contrast, a decrease in 
MTT activity in the presence of L-NAME indicates 
•
NO generation and its association to 
maintain balance of ETS, probably by contributing mitochondrial 
•
NO production from mt-NOS 
(Table 8.1A).  
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However, further works might be warranted to investigate this hypothesis to determine if 
•
NO is 
produced by cytosolic NOS or mt-NOS (Nagendran and Michelakis, 2009; Nisoli and Carruba, 
2006). Rotenone or FCCP treatment did not protect against chronic, mild hypoxia-induced 
apoptosis. The availability of ATP is important for cytoplasmic cytochrome c mediated 
oligomerisation of Apaf-1 and thereby formation of the apoptosome complex, after permeability 
transition has taken place and with the rupture of mitochondrial outer membrane. During 
hypoxia, the ATP requirement of apoptosis was met via the TCA with accumulated 
NAD
+
/FAD
2+
 or glycolysis with abundantly available glucose in the culture medium (Kim et al., 
2003; Tsujimoto and Shimizu, 2007; Eguchi et al., 1997; Enari et al., 1998; Tatsumi et al., 2003; 
Crompton, 1999). Indeed, apoptosis has been reported to occur in cardiomyocytes with exclusive 
supply of ATP through glycolysis (Tatsumi et al., 2003). ATP production from glycolysis and 
intracellular high energy stores can contribute 50% of total ATP production under anaerobic 
conditions (Kim et al., 2003).  
 
The effect of rotenone in mitigating the toxicity associated with severe, chronic hypoxia implies 
a different mechanism of toxicity at 4h compared to that toxicity at 30minutes that may be 
principally driven by accumulation of protein damage, but not ATP depletion at 30 mins (Becker 
et al., 1999), whereas at 4h, the ability of rotenone to prevent ROS formation is of greater 
significance (Table 8.1A). This hypothesis is supported by the observations that ATP levels drop 
by 50% during chronic (4h) hypoxia and are reduced by a further 50% in the presence of 
rotenone, however the additional depletion of ATP caused by rotenone is not associated with any 
further loss in viability, rather it protects cells against necrosis and apoptosis. It is interesting that 
suppression of apoptosis in the presence of rotenone during chronic, severe hypoxia associates 
with reduction of O2
-•
 production despite further ATP depletion. To support this hypothesis 
further, FCCP treatment during chronic, severe hypoxia elicited inhibition of a cleavage of 
procaspase-3, with further depletion of ATP, similar to rotenone treatment (Table 8.1A). In the 
presence of FCCP, uncoupling of mitochondria during severe hypoxia allows the dissipation of 
reducing equivalents more readily thereby allowing the TCA cycle to continue unhindered for 
removal of lactate in a situation when the cell is dependent on anaerobic glycolysis for ATP 
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production (Abramov et al., 2007). In the presence of L-NAME, chronic, severe hypoxia-
induced cell death via necrosis and apoptosis was significantly reduced, suggesting that 
•
NO is 
responsible for associated cytoxicity (Strijdom et al., 2006; Zweier et al., 1995). NOS isoforms 
are responsible in production of 
•
NO during chronic, mild hypoxia, and the induction of 
apoptosis where L-NAME treatment showed a significant protection against cell death. During 
chronic, severe hypoxia, fragmented cell structure/nuclei were observed in Hoescht 33342 
stained (blue) cells for early apoptotic cells and fragmented nuclei as stained with PI (red) for 
late apoptotic cells (Tsujimoto and Shimizu, 2007; Shimizu et al., 1996) in the absence of 
necrotic nuclei.  
 
Cellular ―acidosis‖ during chronic, severe hypoxia due to lactic acid accumulation inhibits pore 
opening and may act as a protective mechanism against apoptosis (Kim et al., 2003; Crompton, 
1999). However, in the present model, hypoxia induced ROS/RNS-mediated mitochondrial 
dysfunction is suggested to have overcome those inhibitory processes to induce apoptosis by 
cleaving procaspase-3. During chronic, severe hypoxia, when electron transport has ceased, it is 
reported that the membrane potentials are developed at the expense of ATP depletion by the 
mitochondrial ATP synthase (Kim et al., 2003). In the present model, ATP availability is 
assumed to be sufficient to promote apoptosis events. The decrease in metabolic activity during 
acute, severe hypoxia parallels the decrease activity of succinate dehydrogenase in mitochondrial 
complex II during hypoxia (Crawford et al., 2003). During acute or chronic, severe hypoxia, the 
mitochondrial membrane potential decreases lost owing to reversal of electron flow through ETS 
in the presence of a limiting O2 supply. Therefore, the loss of membrane potential would 
decrease oxidation of NADH in complex I and FADH2 in complex II, thereby decreasing the 
activity of both dehydrogenase enzymes present in complex I and II. Supporting this, increased 
production of O2
-•
 inactivates complex I; NADH dehydrogenase and complex II; succinate 
dehydrogenase (Powell and Jackson, 2003). However, the absence of ATP depletion during 
acute, severe hypoxia confirms the closely matched balance between ATP production and ATP 
demand when cells are metabolically compromised (Vogt et al., 2002).  
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•
NO alone can cause reversible inhibition of cytochrome c oxidase and complex I, and may 
therefore contribute to mitochondrial O2
-•
 production and irreversible damage caused by ONOO
-
 
(Arciello et al., 2010). Metabolic activity was retained during chronic, severe hypoxia in the 
presence of L-NAME, MnTBAP and rotenone independently, suggesting involvement of O2
-•
 
and 
•
NO, possibly via ONOO
-
 production to inhibit the ETS (Powell and Jackson, 2003; 
Hassouna et al., 2006; Levrand et al., 2006). Complex I generated O2
-•
 has also been implicated 
in altered neuronal cell metabolism during hypoxia (Guglielmotto et al., 2009). In contrast, 
mitochondrial complex II or III has been proposed as a O2
-•
 generation site in the rat heart 
(Chandel et al., 2000), but this has not been investigated in this thesis. Rotenone inhibits 
irreversibly the dehydrogenase enzyme present in mitochondrial complex I, and this probably 
results in a decrease in NADH oxidation which leads to greater loss of membrane potential in the 
absence of electron flux through ETS, thereby reducing O2
-•
 production. In support of this 
hypothesis, the irreversible inhibition of mitochondrial complex I in rabbit hearts showed 
protection against ischaemic damage by preserving of cardiolipin and cytochrome c content 
(Lesnefsky et al., 2004).  
 
Complex 1 is reported as the major ROS generation centre with complex III (Chandel and 
Schumacker, 1999; Chandel et al., 1998; Chandel et al., 2000; Duranteau et al., 1998; Chandel 
and Budinger, 2007). The electron leakage from complex I leads to formation of O2
-•
 via two 
mechanisms; forward and reverse electron transfer (Tahara et al., 2009). Forward transfer is due 
to electron leakage from NADH oxidation which may then generate O2
-•
 at different sites; the 
FMN group, low-potential Fe-S centres and Q binding sites within complex I. Rotenone blocks 
Q binding and maximizes FMN and Fe-S centre reduction (Tahara et al., 2009) in addition to 
inhibiting electron flux from NADH oxidation. Therefore, reduction of O2
-•
 production from 
complex I, in the presence of rotenone reduces the mitochondrial dysfunction due to O2
-•
 and 
ONOO
-
 mediated oxidation and inhibition, thereby promoting FADH2 oxidation via increased 
succinate dehydrogenase activity. Therefore, rotenone decreases production of O2
-•
 during 
hypoxia and reduces PI uptake; necrosis and apoptosis probably by reducing protein carbonyl 
and nitrotyrosine formation.  
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The suppression of procaspase-3 cleavage indicates the inhibition of one or more upstream 
processes; release of cytochrome c and  Apaf-1 after opening of the MPTP and ATP- dependent 
oligomerisation of Apaf-1 to induce apoptosome complex. ROS production during hypoxia has 
been attributed to NADPH oxidase activity by several authors (Abramov et al., 2007; Zulueta et 
al., 1997). Apocynin-inhibitable NADPH oxidase activity did not contribute to increased ROS 
production as neither DHE oxidation nor caspase 3 activity were altered in H9C2 cells 
maintained in chronic severe hypoxia. Apocynin did afford protection against necrosis induced 
by chronic severe hypoxia and apoptosis induced by chronic, mild hypoxia (Heumuller et al., 
2008; Touyz, 2008). Consistent with previous works, the present study did not show any 
protective effects of the xanthine oxidase inhibitor, allopurinol, neither on viability or detectable 
ROS production (Becker et al., 1999).  
 
The foregoing discussion has focused on the effects of 2% O2 hypoxia on O2
-•
 steady state levels, 
metabolic activity and viability of cardiacmyoblasts. For the purposes of current experiments, 
21% O2 conditions is referred as normoxia, although this is unphysiological (Zuurbier et al., 
1999). Instead, estimates of O2 tension in tissue vary between 10-14% O2 and will fluctuate 
during physiological stress and pathophysiological conditions which reduce O2 delivery to 
tissues (Zuurbier et al., 1999).   
 
In this regard, present studies of the effects of 10% O2 and on cardiac myoblasts and referred to 
this as mild hypoxia. The H9C2 cultured cells used in this investigation were maintained and 
adapted to 21% O2 during routine culture over many passages (cells between 14-18 passages 
were used) and are therefore expected to have adapted to living under high O2 tension. This may 
have some impact on the levels of ―antioxidant‖ enzymes present and therefore the cells ability 
to withstand ROS/RNS. Cells under 10% O2 did not exhibit any significant change in metabolic 
activity, propidium iodide uptake or DHE oxidation compared to 21% O2, except, 
•
NO 
generation during chronic, mild hypoxia. However, 
•
NO generation and apoptosis were increased 
in cells maintained at 10% O2 for 4h (Table 8.1A).  
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In the presence of FCCP, the increase in steady state metabolic activity and the significantly 
increased PI uptake, during acute, mild hypoxia suggest FCCP toxicity, although this effect did 
not persist under conditions of chronic, mild hypoxia. However, FCCP did not protect against 
changes to O2
-•
 steady state levels and increased 
•
NO levels, nor against PI uptake induced by 
chronic hypoxia alone despite FCCP being effective in ROS inhibition during severe hypoxia 
(Table 8.1A). This suggests that the respiratory chain is exquisitely sensitive to small fluxes in 
O2 tensions. The effects of uncoupling and inhibition of mitochondrial complex may have 
significantly reduced ATP production, although there is no observed necrotic cell death or 
decreased metabolic activity in the presence of rotenone and FCCP during mild, severe hypoxia 
which concurs with previous work  (Brennan et al., 2006b; Brennan et al., 2006a).  
 
As reperfusion has been considered a major inducer of ROS/RNS after hypoxia and cause of 
death, the kinetics and nature of their production was investigated in cardiomyocytes. The 
recovery of metabolic activity during acute, hypoxia/reperfusion compared to hypoxia indicates 
the capacity to restore membrane potential (Serviddio et al., 2005). However, an increase in 
irreversible necrotic cell death was expected, reflecting the increased PI uptake during acute, 
severe hypoxia alone, associated with protein carbonyl formation (Chapter 5) (Table 8.1A). In 
fact, 30min hypoxia followed by reoxygenation or sustained hypoxia had little effect on 
ROS/RNS or viability. During chronic, severe hypoxia/reoxygenation, the decrease in metabolic 
activity of H9C2 cells compared to cells grown under normoxia and measured by MTT reduction 
was associated with the increase in O2
-•
 and 
•
NO production (Table 8.1B).  
 
However, restoration of metabolic activity during chronic, severe hypoxia indicates 
repolarisation the mitochondrial membrane precluding the irreversible damage to mitochondrial 
complexes. It is interesting to speculate that  sustained reperfusion (2h)  after chronic, severe 
hypoxia is the turning point between irreversible cell damage and hypoxic recovery, as evident 
by significant viability loss after long periods of reperfusion (Jiao et al., 2009).  
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The irreversible damage reported during chronic, severe hypoxia in the present study resulted in 
necrotic and apoptotic cell death during chronic, severe hypoxia/reoxygenation. In the presence 
of rotenone or FCCP, the reduction in O2
-•
 and 
•
NO levels during sustained hypoxia or 
reperfusion indicated the contribution of mitochondria as a major ROS/RNS producer. Inhibition 
of enhanced O2
-•
 production during reperfusion in the presence of apocynin, but not during 
hypoxia alone indicates the induction of NADPH oxidase complex activation during reperfusion 
as a major contributor to O2
-•
 (Table 8.1B). However, its activation is evasive as there is a trend 
to increasing O2
-•
 during normoxia in the presence of apocynin. Apocynin may function as 
antioxidant rather than impairing NADPH oxidase complex in H9C2 cells which are non-
phagocytes (Heumuller et al., 2008).  
Other investigators reported the contribution of NADPH oxidase activity in H9C2 cells to 
generate ROS under different ischaemia/reperfusion periods in anoxic culture medium 
(Elisabetta et al., 2008). It appears that activation of different sources to produce O2
-•
 depends on 
severity and duration of hypoxia and/or reperfusion.  
 
Decreased 
•
NO production in the presence of L-NAME suggest 
•
NO generation is partly NOS-
dependent during chronic, severe hypoxia/reperfusion. There may be alternative non-enzymatic 
sources that are activated to generate 
•
NO (Lacza et al., 2006; Lepore, 2000; Brown and 
Borutaite, 2007; Zweier et al., 1999) or related species as evident by ~ 25% decrease in NOS- 
dependent 
•
NO production when normoxic cells were co-incubated with L-NAME. Having 
elucidated the temporal relationship between ROS/RNS generation, cell dysfunction and death 
during hypoxia and hypoxia/reperfusion, the possible effects of ROS/RNS in inducing gene 
expression were investigated using reporter assay for NF-κB and Nrf2.  
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Figure 8.1 Summary of chronic, severe hypoxia-induced O2
-•
/
•
NO generation and cell 
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The significant increase in NF-κB/DNA binding suggests the increased activation of NF-κB 
during chronic, severe hypoxia and probably may be associated with the increased production of 
ROS/RNS (Baeuerle and Baltimore, 1996, Baldwin, 1996) (Table 8.1A). Therefore, use of 
ROS/RNS specific inhibitors or scavengers could be used to test this hypothesis. However, 
understanding of the mechanism of hypoxia-dependent activation of NF-κB remains limited 
(Taylor and Cummins, 2009). Cell death reported in the presence of NF-κB inhibitor, SN-50 
may describe the importance of NF-κB activation as an adaptive response during chronic, severe 
hypoxia. Several authors have reported the increased activity of NF-κB and associated cardiac 
protection during ischaemia and ischaemia/reperfusion (Li et al., 1999; Regula et al., 2004; 
Adrienn et al., 2003; Nguyen et al., 2009; Lee, 2003). In contrast, other authors reported that NF-
κB co-ordinates cell homeostasis during stress and control the balance between cell survival and 
cell death (Perkins, 1997).  Therefore, therapeutic interventions should be carefully weighed 
given its potential dual role (Adrienn et al., 2003).  Figure 8.1 illustrate the summary of key 
events in respect to ROS/RNS generation and cell death during chronic, severe hypoxia in the 
present study. 
 
A study by Lee and Johnson. (2004) showed that neural cells from Nrf2-/- mice were more 
sensitive to oxidative stress than were neurons from control animals, but, they became less prone 
to oxidative stress when the cells were transfected with a functional Nrf2 construct (Lee and 
Johnson, 2004 ). Similarly, transient ischaemia followed by reperfusion induced more extensive 
brain damage in Nrf2-/- mice than in WT mice (Shah et al., 2007). Moreover, Nrf2-KO diabetic 
mice showed increased apoptosis by increasing ROS compared to Nrf2-WT diabetic mice and 
the authors suggested that Nrf2 induced expression of antioxidant defence genes to scavenge the 
overproduced ROS (He et al., 2009). In the present study, Nrf2 activation during sustained 
hypoxia may mediate Nrf2-mediated antioxidant defence, probably by increasing expression of 
SOD1, NQO1 and/or GST when ROS/RNS are overproduced. In other words, when ROS/RNS 
are overproduced, Nrf2 is activated to scavenge ROS/RNS by increasing the expression of 
antioxidant genes or detoxifying genes (Figure 8.2). However, further work is required to 
resolve the importance of Nrf2 activation using Nrf2-KO/WT cell line under hypoxia and 
reperfusion. 
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In the presence of MnTBAP, cellular protection during reoxygenation was achieved in the 
absence of O2
-•
 and/or ONOO
-
, though 
•
NO is abundant. Due to unavailability of ONOO
- 
in the 
presence of MnTBAP, there is no Nrf2 activation, nor ONOO
-
 induced cytotoxicity. However, 
exacerbation of cell death in the presence of L-NAME during reoxygenation may be associated 
with the lack of 
•
NO-mediated protective mechanism against excessive generation of O2
-•
 during 
reoxygenation (Table 8.1B) (Figure 8.3). It has been reported that overproduction of O2
-• 
occurs
 
during hypoxia/reperfusion more than hypoxia alone in many redox models (Abramov et al., 
2007; Li and Jackson, 2002).  
 
But, the present system did not show an excessive generation of O2
-• 
during 
hypoxia/reoxygenation compared to sustained hypoxia, though the protective role of 
•
NO 
broadly agreed with other investigators (Beckman and Koppenol, 1996; Gonon et al., 2004; 
Dhakshinamoorthy and Porter, 2004; Jones et al., 1999) (Table 8.1B). A study by Kanno et al. 
(2000) showed that attenuation of myocardial ischaemia/reperfusion injury in eNOS-KO mice by 
super-induction of iNOS to produce 
•
NO during early ischaemia was an adaptive mechanism 
(Kanno et al., 2000), but, it occurred prior to reperfusion, probably to induced preconditioning 
pathway. However, 
•
NO mediated protection during reperfusion in the present system remains to 
be resolved.  
 
Similar to the effects observed in sustained hypoxia, the presence of MnTBAP (Figure 8.3B) 
and L-NAME (Figure 8.3A), the decreases in Nrf2 activation during reoxygenation possibly due 
to inhibition of O2
-•
- dependent formation of ONOO
- 
(Figure 8.3) (Table 8.1B). Supporting this 
idea, previous workers have shown that ONOO
-
 produced from NOS-dependent 
•
NO or 
exogenous ONOO
-
 donors, but not 
•
NO donors alone, caused an induction of GST gene 
expression in hepatoma cells via activation of Nrf2/ARE (Kang et al., 2002). In PC12 cells, 
ONOO
-
 activates Nrf2 via PI3K/Akt signalling and enhances Nrf2–ARE binding to upregulate 
HO-1 expression in nitrosative stress (Li et al., 2006).  
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The exacerbation of cell death was observed in the presence of L-NAME during reoxygenation, 
suggesting that NO-mediates protective mechanisms during reperfusion which is broadly in 
agreement with other investigators (Beckman and Koppenol, 1996, Gonon et al., 2004, 
Dhakshinamoorthy and Porter, 2004, Jones et al., 1999) (Figure 8.3A). Overproduction of O2
-•
 
during hypoxia/reperfusion compared to hypoxia alone has been reported redox models by many 
authors (Abramov et al., 2007, Li and Jackson, 2002), although, the present system did not show 
an excessive generation of O2
-•
 compared to sustained hypoxia (Table 8.1B). Kanno et al., 2000 
showed the attenuation of myocardial ischemia/reperfusion injury in eNOS-KO mice by 
superinduction of iNOS, with production of 
•
NO during early ischemia as an adaptive 
mechanism (Kanno et al., 2000), probably inducing a preconditioning pathway.  
 
Moreover, the absence of eNOS in mouse heart exacerbated the ischaemia/reperfusion injury in 
eNOS-KO mice (Jones et al., 1999). Similarly, the administration of 
•
NO donors prevents 
ischaemia/reperfusion injury (Mizuno et al., 1998). In contrast, other studies using 
pharmacological inhibition of NOS and eNOS-KO mice showed protective effects against 
ischaemia/reperfusion injury in the heart. Comparisons between these studies are difficult 
because of differences in agents and experimental design (Parrino et al., 1998). The mechanism 
involved in 
•
NO-mediated cellular protection and 
•
NO/O2
-•
 mediated activation during 
hypoxia/reperfusion is unknown. In the present study, targeting ROS/RNS formation has been 
proposed as a promising therapeutic strategy. Several approaches that have successfully reduced 
tissue damage in animal or cell culture models by scavenging ROS/RNS, but, have failed to be 
beneficial in clinical trials (Fang et al., 2009).  
 
Also, the present study reflects the clinical importance of 
•
NO donors or the therapeutic 
activation of NOS isoforms to induce 
•
NO during reperfusion after ischaemia in heart patients. 
Nevertheless, the beneficial effects in treating ischaemia/reperfusion injury by therapeutic NOS-
gene transfer has been reported very recently (Szelid et al., 2009). Improved understanding of 
•
NO dose and time-dependent effects on reperfusion injury is needed.  
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In contrast, cell metabolic activity was increased in conditions where Nrf2 activity was 
decreased in the presence of MnTBAP during both sustained, severe hypoxia and severe 
hypoxia/reoxygenation. Similarly, cell metabolic activity was increased in the presence of L-
NAME during sustained hypoxia, but not during reoxygenation (Table 8.1B). Therefore, Nrf2 
activation and cell survival in the present system may be independent during sustained hypoxia 
and reoxygenation. The association of cell survival and Nrf2 activation during sustained hypoxia 
and reoxygenation does not imply causality, although the given outcome in the presence of 
inhibitors. However, the effect of inhibitors depends on three factors; (1) specificity of inhibitor; 
(2) length of pre-incubation required to have an effect; and (3) concentration of inhibitor 
required to have an effect under conditions in the present study. 
 
According to hypotheses in the present study; (1) hypoxia increases ROS and RNS, and their 
effects may be cytotoxic and/or required for survival, with both pathways probably being 
activated during severe hypoxia (NF-kB being protective in first instance and Nrf-2 being 
protective), however the effects of ROS and RNS depends on their  relative concentration and 
duration; and (2) that chronic, severe hypoxia/reoxygenation further increases ROS/RNS and in 
this instance, the balance of outcome is a greater drive towards cell death, probably NF-κB 
mediated if apoptosis is occurring or independent of transcription factor activity during necrosis 
with death being O2
-•
 dependent and protected by 
•
NO. However, further increase in 
•
NO may be 
cytoprotective by scavenging a more damaging O2
-• 
anion and this effect may be gene expression 
dependent or independent. In addressing these hypotheses, the present study supports hypothesis 
1, but not hypothesis 2 as there is no significant increase in ROS/RNS or cell death during 
chronic, severe hypoxia/reoxygenation compared control cells in sustained, severe hypoxia 
(Table 8.1B). This is possibly due to presence of glucose in culture medium throughout hypoxia. 
Therefore, present model validates the current paradigm in which O2 depletion precedes glucose 
depletion in in vivo models. 
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8.2 Conclusion 
8.2.1 Hypoxia 
In the present work, both mitochondria and NOS are shown to contribute to overproduction of 
O2
-•
 and 
•
NO during chronic hypoxia. Rat cardiomyoblasts during chronic, severe hypoxia elicit 
a significant increase in O2
-•
/
•
NO production and ATP depletion with decreased metabolic 
activity. Cell death during chronic, severe hypoxia is via necrosis and apoptosis. Chronic, mild 
hypoxia induces apoptosis, with increased production of 
•
NO, ATP depletion and decreased 
metabolic activity. Significant production of O2
-•
, but not depletion of ATP during chronic, 
severe   hypoxia (2% O2; 4h) has contributed to significant necrotic cell death and induction of 
apoptosis. Treatment with rotenone afforded protection against apoptosis and necrosis, and this 
associated with a reduction of O2
-•
 production and enhanced metabolism during chronic hypoxia. 
L-NAME afforded protection against necrosis, but not apoptosis during chronic, severe hypoxia 
and this associated with the reduction of NOS-dependent 
•
NO production and enhanced 
metabolic activity.  
 
Significant O2
-•
 production during chronic, severe hypoxia did not change in the presence of 
apocynin, but apocynin afforded protection against necrosis, probably via its antioxidant 
property as previously reported (Heumuller et al., 2008). Induction of apoptosis during chronic, 
mild hypoxia associates with a significant production of NOS-dependent 
•
NO and reduction in 
•
NO levels by L-NAME treatment affords a protection against apoptosis. Rat cardiomyoblasts do 
not show any significant change in O2
-•
 steady state or ATP levels in acute, severe hypoxia 
despite being metabolically compromised, exhibiting elevated levels of protein carbonyls and 
showing evidence of necrosis. Autophagy may contribute to the observed loss of viability (Asa 
B. Gustafsson and Roberta A. Gottlieb, 2008), however, if mitochondrial respiration is 
uncoupled (i.e.: FCCP treatment) cell survival and metabolism under acute, severe hypoxia 
conditions are enhanced in the absence of necrosis. The inhibition of mitochondria at complex I 
during acute and chronic, severe hypoxia prevents necrosis.  
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Both mitochondrial uncoupling and complex I inhibition afforded protection during acute, severe 
hypoxia, via a O2
-•
-dependent pathway. These data suggest that it is the management of 
mitochondrial ROS and NOS-dependent 
•
NO levels rather than ATP that is required for 
improved survival during hypoxia. Chronic, severe hypoxia activates both NF-κB and Nrf2. Nrf2 
activation during severe, hypoxia is O2
-•
 and 
•
NO -dependant, probably via ONOO
-
. NF-κB 
activation during chronic, severe hypoxia mediates the cellular defence mechanism against 
hypoxia-induced metabolic inhibition via an unknown mechanism. Taken together, the data 
suggest delicate balance exists between cell survival (promoted by NF-κB mediated antioxidant 
system) and cell death (induced by O2
-•
 and 
•
NO produced during hypoxia). 
 
8.2.2 Hypoxia/reoxygenation 
Mitochondria, NOX and NOS contribute to significant ROS/RNS production during 
hypoxia/reoxygenation thereby, inducing metabolic inhibition in mitochondria. Chronic, severe 
hypoxia/reoxygenation partially restores the metabolic activity lost under hypoxia in the 
conditions employed in this study. The mitochondria and NOX jointly produce O2
-•
 during 
reperfusion after chronic, severe hypoxia in rat cardiomyoblasts. Mitochondrial inhibition or 
uncoupling during the reoxygenation period or the last 2h of sustained hypoxia significantly 
reduces O2
-•
 production. NOX appears to elicit O2
-•
 production during reoxygenation, but not 
during sustained hypoxia as evident by inhibition of DHE oxidation with apocynin treatment, 
although this remains to be confirmed with more specific NOX inhibitors.  
 
Both mitochondria and NOS contribute to 
•
NO production during reoxygenation and sustained 
hypoxia. 
•
NO generation during reoxygenation or sustained hypoxia partly depends on NOS and 
•
NO released from non-enzymatic sources. Also, mitochondrial inhibition and uncoupling 
reduced 
•
NO production during reoxygenation and sustained hypoxia. Significant production of 
O2
-•
 during reoxygenation or sustained hypoxia is cardiotoxic and causes metabolic inhibition. In 
contrast, 
•
NO generation during reoxygenation is cardiacprotective, but, it is cardiotoxic during 
sustained hypoxia. Cardiotoxicity of 
•
NO may associate with increased production of O2
-•
, 
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probably to make ONOO
-
 during sustained hypoxia. Therefore, cardiacprotection of 
•
NO during 
reoxygenation may associate with the activation of antioxidant defence in rat cardiomyoblasts, 
independent to Nrf2 activation. Cardio-protection or cardio-toxicity may depend on 
•
NO 
concentration, severity and duration of hypoxia or reoxygenation. Both sustained severe hypoxia 
and chronic, severe hypoxia/reoxygenation activates Nrf2 gene expression and depends on O2
-•
 
and 
•
NO, probably to make ONOO
-
. Cell survival mechanism and activation of Nrf2 may be 
independent in the situation of hypoxia/reoxygenation or sustained hypoxia. But, Nrf2 activation 
probably associate with antioxidant gene expression during hypoxia alone or 
hypoxia/reoxygenation if both O2
-•
 and 
•
NO are sufficiently available. 
 
8.3 Future directions 
In the present study, the molecular mechanisms underlying O2
-•
 and 
•
NO-mediated cell death via 
apoptosis remain unknown and warrant further investigation. Apoptosis is an ATP-dependent 
cell death programme in the myocardium; inhibition of this process may have cardioprotective 
effects under many pathological conditions and represents a potential target for therapeutic 
intervention to prevent ischemia/reperfusion damage. This work has demonstrated the 
suppression of apoptosis despite the depletion of ATP, by curtailing mitochondrial O2
-•
 
production in the presence of rotenone. Expressing of upstream targets of apoptosis; ATP 
dependent-pro-apoptotic proteins: Puma, Noxa, Bax and Bak, and anti-apoptotic proteins: Bcl-2, 
Bcl-xL may further clarify their roles during apoptosis via cytochrome c release during chronic, 
severe hypoxia. In order to further investigate the mitochondria as a source of 
•
NO that 
scavenges O2
-•
 during chronic, severe hypoxia, the assessment of 3-nitrotyrosine (3-NT) 
formation as a biomarker of ONOO
-
 formation is proposed. Peptide sequencing of those nitrated 
proteins may identify specific proteins undergoing nitration during chronic hypoxia and thereby, 
locate their organelle of origin. This information may assist understanding of ROS/RNS-
mediated cell death mechanism during chronic, severe hypoxia. Cells operate a delicate balance 
between the protective oxidants/antioxidant signalling versus deleterious effect of ROS/RNS.   
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It is now known that low concentrations of ROS/RNS play a vital role in induction of 
cardioprotective mechanism (Penna et al., 2009). In this thesis, the excessive generation of 
ROS/RNS in hypoxia/reoxygenation, their cytotoxic role, and finally their signalling effects to 
activate redox transcription factors; Nrf2 and NF-κB probably as a defence mechanism during 
hypoxia has been demonstrated. However, the site and specific ROS/RNS-mediated NF-κB 
activation and the effects of activation during chronic hypoxia still remain unknown. Therefore, 
O2
-•
 and 
•
NO effects on NF-κB activation and their targeted gene expression during chronic 
severe hypoxia warrants further investigation.  
 
The present study demonstrates that Nrf2 activation is O2
-•
/
•
NO dependent and there a high 
chance of making ONOO
-
 to induce Nrf2 activation. Therefore, finding the specific radical 
species required for activation of redox transcription factors; including Nrf2 and NF-κB may 
point to new avenues of therapeutic interventions. It is well established that the master regulator 
of antioxidant response element is Nrf2. The specific downstream targeted gene expression 
involved in antioxidant/detoxifying mechanisms and apoptosis during hypoxia/reperfusion 
remains to be elucidated. Therefore, future works are warranted to investigate Nrf2 mediated 
defence mechanism during hypoxia or hypoxia/reoxygenation using methods such as silencing 
Nrf2 activity with siRNA and gene expression systems for antioxidants (i.e.; MnSOD, GST and 
NOS) (Nguyen et al., 2009; Heiss et al., 2009; Jaiswal, 2004; Nioi et al., 2003).  
The present data suggest that NOS activation and probably, non-enzymatic 
•
NO production 
during reoxygenation is cardiacprotective.In contrast, the spermine nonoate 
•
NO donor (100µM) 
did not show any affordable protection during hypoxia/reoxygenation. Recent reports have 
shown dose-dependency of protection by an exogenous 
•
NO donor during ischemia/reperfusion 
injury in rat and guinea pig hearts (Schulz et al., 2004). Therefore, future works are warranted to 
investigate the dose dependency of exogenous 
•
NO donors in cardiacprotection of H9C2 cells 
during hypoxia/reoxygenation. Under the present conditions, the magnitude of enzyme-
independent 
•
NO generation exceeds the NOS-dependent 
•
NO generation during hypoxia and 
hypoxia/reoxygenation. Therefore, future works are warranted to understand its role in 
protection during hypoxia and hypoxia/reoxygenation.  
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Appendix I   Vector plasmid maps and DNA sequence information 
 
 
 
pGL3-Basic Vector 
 
This vector can be obtained from Promega Corporation, Madison, WI.  
 
 
pGL3-Basic Vector sequence reference points: 
 
Base pairs                                      4818 bases 
Promoter                                        (none) 
Enhancer                                        (none) 
Multiple cloning region                     1-58 
Luciferase gene (luc+)                        88-1740 
GLprimer2 binding site                     89-111 
SV40 late poly(A) signal                 1772-1993 
RVprimer4 binding site                     2061-2080 
ColE1-derived plasmid replication origin       2318 
beta-lactamase gene (Ampr)                 3080-3940 
f1 origin                          4072-4527 
Synthetic (upstream) poly(A) signal   4658-4811 
RVprimer3 binding site                     4760-4779 
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pGL4.74 [hRluc/TK] Vector        
 
This vector can be obtained from Promega Corporation, Madison, WI.  
 
 
 
pGL4.74 [hRluc/TK] Vector sequence reference points: 
 
Base pairs                                                 4237 
HSV-TK promoter                                            27-779 
hRluc reporter gene                                        815-1750 
SV40 late poly(A) region                                   1784-2005  
Reporter Vector primer 4 (RVprimer4) binding region      2071-2090 
ColE1-derived plasmid replication origin                  2330 
Synthetic beta-lactamase (Ampr) coding region             3119-3979 
Synthetic poly(A) signal/transcriptional pause region     4084-4237 
Reporter Vector primer 3 (RVprimer3) binding region      4186-4205 
   
Restriction enzyme that cut pGL4.74 [hRluc/TK] Vector; 
Enzyme: Hind III   No of Sites: 1   Location : 781 
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DNA sequence of chicken conalbumin (Con A) promoter and enhancer (3enh) region 
(1223bp). 
 
6041bp 
277 
 
pGL 3 [3enh/conA/luc] plasmid sequence analysis 
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DNA sequence of mouse Nqo1/ARE region (1120bp) 
 
5938bp 
Bam HI 
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pGL 3 [nqo1/luc] plasmid sequence analysis 
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(July 2008) Oxygen tension modulates oral epithelial cytokine response to 
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